<!DOCTYPE html><html lang="en" class="bg-surface-base antialiased"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, interactive-widget=resizes-content"/><link rel="stylesheet" href="/_next/static/css/62c4caba71dfda84.css" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/eb3d87f98fe1565f.css" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/1b5e561215938d4d.css" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/0227d069a630d414.css" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/f87fff2ab93d05a7.css" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm" href="/_next/static/chunks/webpack-e121ed42680f327e.js"/><script src="/_next/static/chunks/78a669d9-e7993486b22c4915.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/40c4a5a7-abdabb07419d1cfc.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/2230-f7c87dc9fa57c408.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/main-app-536d4b8fca62396a.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/63f0ec43-8ee6a76d70472249.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/7670-7326298c9856172b.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/282-691fffb366e24ca5.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/7515-336759ef5dad2b52.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/927-34e2a6da3e15e26b.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/5855-243eeca8f0e4cabd.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/4393-1c8dff25ec904469.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/2225-454cf9f44775e7ce.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/7618-43536a8fb0dd3bfe.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/7720-3a1e7e411adba2d3.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/7086-1f1c4891d766e04f.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/app/global-error-4d07d20223cd4b4c.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/8208b75a-a48e5a4507a0de91.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/5497-ab85ef3ea59dd353.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/6281-c6e84786dade3614.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/2660-d983a7f287e89f18.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/5002-9735c25beda556ba.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/3655-6717081f7512305a.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/8945-e4e3cf487f5e27c7.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/9214-a10614844a67ba31.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/4789-2080f6497f78b5b6.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/app/layout-226f2bd71acf9f9e.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/24cf1b50-159cca90b09285e0.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/9ffa21ba-c069766d809bd4c7.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/600-9a9fcafaaa6c1c4c.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/5448-2a3cfd853d899c9a.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/8-8ca70ca619d8e099.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/app/error-4a29e9399afba038.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><script src="/_next/static/chunks/app/not-found-dd95690acf732f18.js" async="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script><meta name="next-size-adjust" content=""/><title>Grokipedia</title><meta name="description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><link rel="icon" type="image/x-icon" href="/favicon.ico" sizes="48x48"/><link rel="icon" href="/images/icon-dark.png" media="(prefers-color-scheme: light)" type="image/png"/><link rel="icon" href="/images/icon-light.png" media="(prefers-color-scheme: dark)" type="image/png"/><link rel="apple-touch-icon" href="/icon-192x192.png"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><meta property="og:title" content="Grokipedia"/><meta property="og:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta property="og:url" content="https://grokipedia.com"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="website"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Grokipedia"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Grokipedia"/><meta name="twitter:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><title>Carcinogenesis</title><meta name="description" content="Cancers and tumors are caused by a series of mutations. Each mutation alters the behavior of the cell somewhat. Carcinogenesis, also called oncogenesis or tumorigenesis, is the formation of a cancer, whereby normal cells are transformed into cancer cells. The process is characterized by changes at the cellular, genetic, and epigenetic levels and abnormal cell division. Cell division is a physiological process that occurs in almost all tissues and under a variety of circumstances. Normally, the..."/><meta name="author" content="system"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><link rel="canonical" href="https://grokipedia.com/page/Carcinogenesis"/><meta property="og:title" content="Carcinogenesis"/><meta property="og:description" content="Cancers and tumors are caused by a series of mutations. Each mutation alters the behavior of the cell somewhat. Carcinogenesis, also called oncogenesis or tumorigenesis, is the formation of a cancer, whereby normal cells are transformed into cancer cells. The process is characterized by changes at the cellular, genetic, and epigenetic levels and abnormal cell division. Cell division is a physiological process that occurs in almost all tissues and under a variety of circumstances. Normally, the..."/><meta property="og:url" content="https://grokipedia.com/page/Carcinogenesis"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Carcinogenesis"/><meta property="og:type" content="article"/><meta property="article:modified_time" content="1970-01-21T09:19:12.900Z"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Carcinogenesis"/><meta name="twitter:description" content="Cancers and tumors are caused by a series of mutations. Each mutation alters the behavior of the cell somewhat. Carcinogenesis, also called oncogenesis or tumorigenesis, is the formation of a cancer, whereby normal cells are transformed into cancer cells. The process is characterized by changes at the cellular, genetic, and epigenetic levels and abnormal cell division. Cell division is a physiological process that occurs in almost all tissues and under a variety of circumstances. Normally, the..."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><link rel="icon" href="/favicon.ico" type="image/x-icon" sizes="16x16"/><meta name="sentry-trace" content="abd71f94a7eca67a4bbfd28fc0204e58-d9349d007759097e-1"/><meta name="baggage" content="sentry-environment=production,sentry-public_key=5f2258f71198ee26a355127af230c3a6,sentry-trace_id=abd71f94a7eca67a4bbfd28fc0204e58,sentry-org_id=4508179396558848,sentry-transaction=GET%20%2Fpage%2F%5Bslug%5D,sentry-sampled=true,sentry-sample_rand=0.10396546917515104,sentry-sample_rate=1"/><script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule="" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm"></script></head><body class="flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b"><div hidden=""><!--$--><!--/$--></div><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">((a,b,c,d,e,f,g,h)=>{let i=document.documentElement,j=["light","dark"];function k(b){var c;(Array.isArray(a)?a:[a]).forEach(a=>{let c="class"===a,d=c&&f?e.map(a=>f[a]||a):e;c?(i.classList.remove(...d),i.classList.add(f&&f[b]?f[b]:b)):i.setAttribute(a,b)}),c=b,h&&j.includes(c)&&(i.style.colorScheme=c)}if(d)k(d);else try{let a=localStorage.getItem(b)||c,d=g&&"system"===a?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":a;k(d)}catch(a){}})("class","theme","dark",null,["light","dark"],null,true,true)</script><header class="h-16 bg-surface-base fixed top-0 z-50 w-full"><div class="hidden h-full grid-cols-[1fr_3fr_1fr] items-center gap-4 !py-0 md:grid max-w-full py-6 px-4 w-full mx-auto"><div class="-ml-2 justify-self-start"><a class="cursor-pointer" href="/"><svg width="200" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="mx-auto flex w-full"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full px-3 shadow-none sm:w-80 focus-visible:z-1 mx-auto h-full w-full rounded-full bg-surface-l1" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div><div class="flex items-center gap-2 justify-self-end"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0" type="button" id="radix-_R_7apfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button></div></div><div class="flex h-full items-center md:hidden justify-between max-w-full py-6 px-4 w-full mx-auto pt-8"><div class="flex items-center"><div class="-ml-2"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button" aria-label="Toggle table of contents"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-list h-6 w-6"><path d="M3 12h.01"></path><path d="M3 18h.01"></path><path d="M3 6h.01"></path><path d="M8 12h13"></path><path d="M8 18h13"></path><path d="M8 6h13"></path></svg></button></div><a class="cursor-pointer" href="/"><svg width="160" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="flex items-center gap-1"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0 [&amp;_svg]:!w-5" type="button" id="radix-_R_aipfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-search h-5 w-5"><circle cx="11" cy="11" r="8"></circle><path d="m21 21-4.3-4.3"></path></svg></button></div></div></header><div class="bg-surface-base fixed right-0 top-16 z-50 h-[calc(100vh-4rem)] w-full transform border-l transition-transform duration-300 ease-in-out sm:w-1/2 md:hidden translate-x-full"><div class="flex flex-col gap-4 p-4"><div class="flex flex-row gap-2"><button class="focus-visible:ring-ring inline-flex items-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full shadow-none sm:w-80 h-10 w-full justify-start rounded-full bg-surface-l1 px-4" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div></div></div><div><div class="min-[1350px]:grid min-[1350px]:grid-cols-[1fr_3fr_1fr]"><nav class="bg-surface-base hidden h-[calc(100vh-4rem)] overflow-y-auto px-6 pb-32 min-[1350px]:sticky min-[1350px]:top-16 min-[1350px]:block scrollbar-none [-ms-overflow-style:none] [scrollbar-width:none] [&amp;::-webkit-scrollbar]:hidden [overscroll-behavior:contain] pt-8"><ul class="space-y-2 text-sm"><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#carcinogenesis" class="transition-opacity hover:opacity-100 opacity-50">Carcinogenesis</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#causes" class="transition-opacity hover:opacity-100 opacity-50">Causes</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#genetic-and-epigenetic" class="transition-opacity hover:opacity-100 opacity-50">Genetic and epigenetic</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#dna-damage" class="transition-opacity hover:opacity-100 opacity-50">DNA damage</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#contribution-of-field-defects" class="transition-opacity hover:opacity-100 opacity-50">Contribution of field defects</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#genome-instability" class="transition-opacity hover:opacity-100 opacity-50">Genome instability</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#non-mainstream-theories" class="transition-opacity hover:opacity-100 opacity-50">Non-mainstream theories</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#cancer-cell-biology" class="transition-opacity hover:opacity-100 opacity-50">Cancer cell biology</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#clonal-evolution" class="transition-opacity hover:opacity-100 opacity-50">Clonal evolution</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#biological-properties-of-cancer-cells" class="transition-opacity hover:opacity-100 opacity-50">Biological properties of cancer cells</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#cancer-as-a-defect-in-cell-interactions" class="transition-opacity hover:opacity-100 opacity-50">Cancer as a defect in cell interactions</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#mechanisms" class="transition-opacity hover:opacity-100 opacity-50">Mechanisms</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#oncogenes" class="transition-opacity hover:opacity-100 opacity-50">Oncogenes</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#proto-oncogenes" class="transition-opacity hover:opacity-100 opacity-50">Proto-oncogenes</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#tumor-suppressor-genes" class="transition-opacity hover:opacity-100 opacity-50">Tumor suppressor genes</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#multiple-mutations" class="transition-opacity hover:opacity-100 opacity-50">Multiple mutations</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#non-mutagenic-carcinogens" class="transition-opacity hover:opacity-100 opacity-50">Non-mutagenic carcinogens</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#role-of-infections" class="transition-opacity hover:opacity-100 opacity-50">Role of infections</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#bacterial" class="transition-opacity hover:opacity-100 opacity-50">Bacterial</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#viral" class="transition-opacity hover:opacity-100 opacity-50">Viral</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#helminthiasis" class="transition-opacity hover:opacity-100 opacity-50">Helminthiasis</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#epigenetics" class="transition-opacity hover:opacity-100 opacity-50">Epigenetics</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#cancer-stem-cells" class="transition-opacity hover:opacity-100 opacity-50">Cancer stem cells</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#clonal-evolution-1" class="transition-opacity hover:opacity-100 opacity-50">Clonal evolution</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#references" class="transition-opacity hover:opacity-100 opacity-50">References</a></li></ul></nav><div class="relative top-16 pb-32 pt-8 px-4 md:px-8"><div class="mx-auto max-w-[850px]"><button data-state="closed" type="button" class="flex items-center"><div class="text-fg-tertiary mb-2 flex cursor-help items-center gap-2 text-sm"><span class="inline-flex items-center justify-center p-0 m-0" data-namespace="@xai/icons" data-slot="icon" style="height:16px;width:16px"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 33 33" aria-hidden="true" class="" focusable="false" style="fill:currentColor;height:16px;width:16px"><path fill="currentColor" d="m13.237 21.04 11.082-8.19c.543-.4 1.32-.244 1.578.38 1.363 3.288.754 7.241-1.957 9.955-2.71 2.714-6.482 3.31-9.93 1.954l-3.765 1.745c5.401 3.697 11.96 2.782 16.059-1.324 3.251-3.255 4.258-7.692 3.317-11.693l.008.009c-1.365-5.878.336-8.227 3.82-13.031q.123-.17.247-.345l-4.585 4.59v-.014L13.234 21.044M10.95 23.031c-3.877-3.707-3.208-9.446.1-12.755 2.446-2.449 6.454-3.448 9.952-1.979L24.76 6.56c-.677-.49-1.545-1.017-2.54-1.387A12.465 12.465 0 0 0 8.675 7.901c-3.519 3.523-4.625 8.94-2.725 13.561 1.42 3.454-.907 5.898-3.251 8.364-.83.874-1.664 1.749-2.335 2.674l10.583-9.466"></path></svg></span><span>Fact-checked by Grok<!-- --> <!-- -->4 days ago</span></div></button><article class="text-[16px]"><h1 id="carcinogenesis" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Carcinogenesis<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">Cancers and tumors are caused by a series of mutations. Each mutation alters the behavior of the cell somewhat.</span>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Carcinogenesis</strong>, also called <strong>oncogenesis</strong> or <strong>tumorigenesis</strong>, is the formation of a cancer, whereby normal cells are transformed into cancer cells. The process is characterized by changes at the cellular, genetic, and epigenetic levels and abnormal cell division. Cell division is a physiological process that occurs in almost all tissues and under a variety of circumstances. Normally, the balance between proliferation and programmed cell death, in the form of apoptosis, is maintained to ensure the integrity of tissues and organs. According to the prevailing accepted theory of carcinogenesis, the somatic mutation theory, mutations in DNA and epimutations that lead to cancer disrupt these orderly processes by interfering with the programming regulating the processes, upsetting the normal balance between proliferation and cell death.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_k1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> This results in uncontrolled cell division and the evolution of those cells by natural selection in the body. Only certain mutations lead to cancer whereas the majority of mutations do not.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Variants of inherited genes may predispose individuals to cancer. In addition, environmental factors such as carcinogens and radiation cause mutations that may contribute to the development of cancer. Finally random mistakes in normal DNA replication may result in cancer-causing mutations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_41qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> A series of several mutations to certain classes of genes is usually required before a normal cell will transform into a cancer cell.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_81qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup> Recent comprehensive patient-level classification and quantification of driver events in TCGA cohorts revealed that there are on average 12 driver events per tumor, of which 0.6 are point mutations in oncogenes, 1.5 are amplifications of oncogenes, 1.2 are point mutations in tumor suppressors, 2.1 are deletions of tumor suppressors, 1.5 are driver chromosome losses, 1 is a driver chromosome gain, 2 are driver chromosome arm losses, and 1.5 are driver chromosome arm gains.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_k1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup> Mutations in genes that regulate cell division, apoptosis (cell death), and DNA repair may result in uncontrolled cell proliferation and cancer.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Cancer is fundamentally a disease of regulation of tissue growth. In order for a normal cell to transform into a cancer cell, genes that regulate cell growth and differentiation must be altered.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_42abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup> Genetic and epigenetic changes can occur at many levels, from gain or loss of entire chromosomes, to a mutation affecting a single DNA nucleotide, or to silencing or activating a microRNA that controls expression of 100 to 500 genes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_82abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> There are two broad categories of genes that are affected by these changes. Oncogenes may be normal genes that are expressed at inappropriately high levels, or altered genes that have novel properties. In either case, expression of these genes promotes the malignant phenotype of cancer cells. Tumor suppressor genes are genes that inhibit cell division, survival, or other properties of cancer cells. Tumor suppressor genes are often disabled by cancer-promoting genetic changes. Certain viruses, known as oncoviruses, can contribute to cancer by introducing or activating oncogenes or through other mechanisms, leading to viral transformation. It is also believed that cancer is caused due to chromosomal abnormalities as explained in chromosome theory of cancer.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup></span>
<h1 id="causes" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Causes<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<h2 id="genetic-and-epigenetic" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Genetic and epigenetic<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">There is a diverse classification scheme for the various genomic changes that may contribute to the generation of <span class="inline text-[1em] leading-7">cancer cells</span>. Many of these changes are <span class="inline text-[1em] leading-7">mutations</span>, or changes in the <span class="inline text-[1em] leading-7">nucleotide</span> sequence of genomic DNA. There are also many epigenetic changes that alter whether genes are expressed or not expressed. <span class="inline text-[1em] leading-7">Aneuploidy</span>, the presence of an abnormal number of chromosomes, is one genomic change that is not a mutation, and may involve either gain or loss of one or more <span class="inline text-[1em] leading-7">chromosomes</span> through errors in <span class="inline text-[1em] leading-7">mitosis</span>. Large-scale mutations involve either the <span class="inline text-[1em] leading-7">deletion</span> or <span class="inline text-[1em] leading-7">duplication</span> of a portion of a chromosome. <span class="inline text-[1em] leading-7">Genomic amplification</span> occurs when a cell gains many copies (often 20 or more) of a small chromosomal region, usually containing one or more oncogenes and adjacent genetic material. <span class="inline text-[1em] leading-7">Translocation</span> occurs when two separate chromosomal regions become abnormally fused, often at a characteristic location. A well-known example of this is the <span class="inline text-[1em] leading-7">Philadelphia chromosome</span>, or translocation of chromosomes 9 and 22, which occurs in <span class="inline text-[1em] leading-7">chronic myelogenous leukemia</span>, and results in production of the <span class="inline text-[1em] leading-7">BCR</span>-<span class="inline text-[1em] leading-7">abl</span> <span class="inline text-[1em] leading-7">fusion protein</span>, an oncogenic <span class="inline text-[1em] leading-7">tyrosine kinase</span>. Small-scale mutations include <span class="inline text-[1em] leading-7">point mutations</span>, <span class="inline text-[1em] leading-7">deletions</span>, and <span class="inline text-[1em] leading-7">insertions</span>, which may occur in the <span class="inline text-[1em] leading-7">promoter</span> of a gene and affect its <span class="inline text-[1em] leading-7">expression</span>, or may occur in the gene&#x27;s <span class="inline text-[1em] leading-7">coding sequence</span> and alter the function or stability of its <span class="inline text-[1em] leading-7">protein</span> product. Disruption of a single gene may also result from <span class="inline text-[1em] leading-7">integration of genomic material</span> from a <span class="inline text-[1em] leading-7">DNA virus</span> or <span class="inline text-[1em] leading-7">retrovirus</span>, and such an event may also result in the expression of viral oncogenes in the affected cell and its descendants.</span>
<h2 id="dna-damage" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">DNA damage<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">The central role of DNA damage and epigenetic defects in DNA repair genes in carcinogenesis</span>
<span class="mb-4 block break-words text-[1em] leading-7">DNA damage is considered to be the primary cause of cancer.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_45abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup> More than 60,000 new naturally occurring instances of DNA damage arise, on average, per human cell, per day, due to endogenous cellular processes (see article <span class="inline text-[1em] leading-7">DNA damage (naturally occurring)</span>).</span>
<span class="mb-4 block break-words text-[1em] leading-7">Additional DNA damage can arise from exposure to <span class="inline text-[1em] leading-7">exogenous</span> agents. As one example of an <span class="inline text-[1em] leading-7">exogenous</span> carcinogenic agent, tobacco smoke causes increased DNA damage, and this DNA damage likely cause the increase of lung cancer due to smoking.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup> In other examples, UV light from solar radiation causes DNA damage that is important in <span class="inline text-[1em] leading-7">melanoma</span>,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_k5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup> <em>Helicobacter pylori</em> infection produces high levels of <span class="inline text-[1em] leading-7">reactive oxygen species</span> that damage DNA and contribute to <span class="inline text-[1em] leading-7">gastric cancer</span>,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_145qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup> and the <em>Aspergillus flavus</em> metabolite <span class="inline text-[1em] leading-7">aflatoxin</span> is a DNA damaging agent that is causative in liver cancer.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1g5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">DNA damage can also be caused by <span class="inline text-[1em] leading-7">substances produced in the body</span>. Macrophages and neutrophils in an inflamed colonic epithelium are the source of reactive oxygen species causing the DNA damage that initiates colonic <span class="inline text-[1em] leading-7">tumorigenesis</span>,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup> and bile acids, at high levels in the colons of humans eating a high-fat diet, also cause DNA damage and contribute to colon cancer.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A deficiency in DNA repair would cause more DNA damage to accumulate, and increase the risk for cancer. For example, individuals with an inherited impairment in any of 34 <span class="inline text-[1em] leading-7">DNA repair genes</span> (see article <span class="inline text-[1em] leading-7">DNA repair-deficiency disorder</span>) are at increased risk of cancer, with some defects causing an up to 100% lifetime chance of cancer (e.g. <span class="inline text-[1em] leading-7">p53</span> mutations).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup> Such <span class="inline text-[1em] leading-7">germline mutations</span> are shown in a box at the left of the figure, with an indication of their contribution to DNA repair deficiency. However, such germline mutations (which cause highly <span class="inline text-[1em] leading-7">penetrant</span> cancer syndromes) are the cause of only about <em>one percent</em> of cancers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_106qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The majority of cancers are called non-hereditary or &quot;sporadic cancers&quot;. About 30% of sporadic cancers do have some hereditary component that is currently undefined, while the majority, or 70% of sporadic cancers, have no hereditary component.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_47abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In sporadic cancers, a deficiency in DNA repair is occasionally due to a mutation in a DNA repair gene; much more frequently, reduced or absent expression of DNA repair genes is due to <span class="inline text-[1em] leading-7">epigenetic alterations</span> that reduce or <span class="inline text-[1em] leading-7">silence gene expression</span>. This is indicated in the figure at the 3rd level from the top. For example, for 113 colorectal cancers examined in sequence, only four had a <span class="inline text-[1em] leading-7">missense mutation</span> in the DNA repair gene <span class="inline text-[1em] leading-7">MGMT</span>, while the majority had reduced MGMT expression due to <span class="inline text-[1em] leading-7">methylation</span> of the MGMT <span class="inline text-[1em] leading-7">promoter region</span> (an epigenetic alteration).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_s7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">When expression of DNA repair genes is reduced, this causes a DNA repair deficiency. This is shown in the figure at the 4th level from the top. With a DNA repair deficiency, DNA damage persists in cells at a higher than typical level (5th level from the top in figure); this excess damage causes an increased frequency of mutation and/or <span class="inline text-[1em] leading-7">epimutation</span> (6th level from top of figure). Experimentally, mutation rates increase substantially in cells defective in <span class="inline text-[1em] leading-7">DNA mismatch repair</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup> or in <span class="inline text-[1em] leading-7">Homologous recombinational</span> repair (HRR).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_k8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup> <span class="inline text-[1em] leading-7">Chromosomal rearrangements</span> and <span class="inline text-[1em] leading-7">aneuploidy</span> also increase in HRR-defective cells<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_108abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup> During repair of DNA double-strand breaks, or repair of other DNA damage, incompletely cleared repair sites can cause epigenetic gene silencing.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_148abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[31]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_168abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The somatic mutations and epigenetic alterations caused by DNA damage and deficiencies in DNA repair accumulate in <span class="inline text-[1em] leading-7">field defects</span>. Field defects are normal-appearing tissues with multiple alterations (discussed in the section below), and are common precursors to development of the disordered and over-proliferating clone of tissue in a cancer. Such field defects (second level from bottom of figure) may have numerous mutations and epigenetic alterations.</span>
<span class="mb-4 block break-words text-[1em] leading-7">It is impossible to determine the initial cause for most specific cancers. In a few cases, only one cause exists: for example, the virus <span class="inline text-[1em] leading-7">HHV-8</span> causes all <span class="inline text-[1em] leading-7">Kaposi&#x27;s sarcomas</span>. However, with the help of <span class="inline text-[1em] leading-7">cancer epidemiology</span> techniques and information, it is possible to produce an estimate of a likely cause in many more situations. For example, <span class="inline text-[1em] leading-7">lung cancer</span> has several causes, including tobacco use and <span class="inline text-[1em] leading-7">radon gas</span>. Men who currently smoke tobacco develop lung cancer at a rate 14 times that of men who have never smoked tobacco: the chance of lung cancer in a current smoker being caused by smoking is about 93%; there is a 7% chance that the smoker&#x27;s lung cancer was caused by radon gas or some other, non-tobacco cause.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_o9abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[33]</sup> These statistical correlations have made it possible for researchers to infer that certain substances or behaviors are carcinogenic. Tobacco smoke causes increased <span class="inline text-[1em] leading-7">exogenous</span> DNA damage, and this DNA damage is the likely cause of lung cancer due to smoking. Among the more than 5,000 compounds in tobacco smoke, the <span class="inline text-[1em] leading-7">genotoxic</span> DNA-damaging agents that occur both at the highest concentrations, and which have the strongest mutagenic effects are <span class="inline text-[1em] leading-7">acrolein</span>, <span class="inline text-[1em] leading-7">formaldehyde</span>, <span class="inline text-[1em] leading-7">acrylonitrile</span>, <span class="inline text-[1em] leading-7">1,3-butadiene</span>, <span class="inline text-[1em] leading-7">acetaldehyde</span>, <span class="inline text-[1em] leading-7">ethylene oxide</span> and <span class="inline text-[1em] leading-7">isoprene</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_209abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Using <span class="inline text-[1em] leading-7">molecular biological</span> techniques, it is possible to characterize the mutations, epimutations or chromosomal aberrations within a tumor, and rapid progress is being made in the field of predicting certain cancer patients&#x27; <span class="inline text-[1em] leading-7">prognosis</span> based on the spectrum of mutations. For example, up to half of all tumors have a defective p53 gene. This mutation is associated with poor prognosis, since those tumor cells are less likely to go into <span class="inline text-[1em] leading-7">apoptosis</span> or <span class="inline text-[1em] leading-7">programmed cell death</span> when damaged by therapy. <span class="inline text-[1em] leading-7">Telomerase</span> mutations remove additional barriers, extending the number of times a cell can divide. Other mutations enable the tumor to <span class="inline text-[1em] leading-7">grow new blood vessels</span> to provide more nutrients, or to <span class="inline text-[1em] leading-7">metastasize</span>, spreading to other parts of the body. However, once a cancer is formed it continues to evolve and to produce sub-clones. It was reported in 2012 that a single renal cancer specimen, sampled in nine different areas, had 40 &quot;ubiquitous&quot; mutations, found in all nine areas, 59 mutations shared by some, but not all nine areas, and 29 &quot;private&quot; mutations only present in one area.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_109qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[34]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The lineages of cells in which all these DNA alterations accumulate are difficult to trace, but two recent lines of evidence suggest that normal <span class="inline text-[1em] leading-7">stem cells</span> may be the cells of origin in cancers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[35]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aaabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[36]</sup> First, there exists a highly positive correlation (Spearman&#x27;s rho = 0.81; P &lt; 3.5 Ã— 10âˆ’8) between the risk of developing cancer in a tissue and the number of normal stem cell divisions taking place in that same tissue. The correlation applied to 31 cancer types and extended across five <span class="inline text-[1em] leading-7">orders of magnitude</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_iaabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[37]</sup> This correlation means that if normal stem cells from a tissue divide once, the cancer risk in that tissue is approximately 1X. If they divide 1,000 times, the cancer risk is 1,000X. And if the normal stem cells from a tissue divide 100,000 times, the cancer risk in that tissue is approximately 100,000X. This strongly suggests that the main factor in cancer initiation is the fact that &quot;normal&quot; stem cells divide, which implies that cancer originates in normal, healthy stem cells.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_maabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[36]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Second, statistics show that most human cancers are diagnosed in older people. A possible explanation is that cancers occur because cells accumulate damage through time. DNA is the only cellular component that can accumulate damage over the entire course of a life, and stem cells are the only cells that can transmit DNA from the zygote to cells late in life. Other cells, derived from stem cells, do not keep DNA from the beginning of life until a possible cancer occurs. This implies that most cancers arise from normal stem cells.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[35]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[36]</sup></span>
<h2 id="contribution-of-field-defects" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Contribution of field defects<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">The term &quot;<span class="inline text-[1em] leading-7">field cancerization</span>&quot; was first used in 1953 to describe an area or &quot;field&quot; of epithelium that has been preconditioned by (at that time) largely unknown processes so as to predispose it towards development of cancer.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[38]</sup> Since then, the terms &quot;field cancerization&quot; and &quot;field defect&quot; have been used to describe pre-malignant tissue in which new cancers are likely to arise.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Field defects have been identified in association with cancers and are important in progression to cancer.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[39]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[40]</sup> However, it was pointed out by Rubin<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_acabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[41]</sup> that &quot;the vast majority of studies in cancer research has been done on well-defined tumors in vivo, or on discrete neoplastic foci in vitro. Yet there is evidence that more than 80% of the somatic mutations found in <span class="inline text-[1em] leading-7">mutator phenotype</span> human colorectal tumors occur before the onset of terminal clonal expansionâ€¦&quot;<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_icabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[42]</sup> More than half of somatic mutations identified in tumors occurred in a pre-neoplastic phase (in a field defect), during growth of apparently normal cells. It would also be expected that many of the epigenetic alterations present in tumors may have occurred in pre-neoplastic field defects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mcabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In the colon, a field defect probably arises by natural selection of a mutant or epigenetically altered cell among the stem cells at the base of one of the <span class="inline text-[1em] leading-7">intestinal crypts</span> on the inside surface of the colon. A mutant or epigenetically altered stem cell may replace the other nearby stem cells by natural selection. This may cause a patch of abnormal tissue to arise. Within this first large patch in the diagram (a large clone of cells), a second such mutation or epigenetic alteration may occur, so that a given stem cell acquires an advantage compared to its neighbors, and this altered stem cell may expand clonally, forming a secondary patch, or sub-clone, within the original patch. This is indicated in the diagram by four smaller patches of different colors within the large yellow original area. Within these new patches (sub-clones), the process may be repeated multiple times, indicated by the still smaller patches within the four secondary patches (with still different colors in the diagram) which clonally expand, until stem cells arise that generate either small polyps or else a malignant neoplasm (cancer). These neoplasms are also indicated (in the diagram below the photo) by 4 small tan circles (polyps) and a larger red area (cancer). The cancer in the photo occurred in the cecal area of the colon, where the colon joins the small intestine (labeled) and where the appendix occurs (labeled). The fat in the photo is external to the outer wall of the colon. In the segment of colon shown here, the colon was cut open lengthwise to expose its inner surface and to display the cancer and polyps occurring within the inner epithelial lining of the colon.</span>
<span class="mb-4 block break-words text-[1em] leading-7">If the general process by which sporadic colon cancers arise is the formation of a pre-neoplastic clone that spreads by natural selection, followed by formation of internal sub-clones within the initial clone, and sub-sub-clones inside those, then colon cancers generally should be associated with, and be preceded by, fields of increasing abnormality, reflecting the succession of premalignant events. The most extensive region of abnormality (the outermost yellow irregular area in the diagram) would reflect the earliest event in formation of a malignant neoplasm.</span>
<span class="mb-4 block break-words text-[1em] leading-7">In experimental evaluation of specific DNA repair deficiencies in cancers, many specific DNA repair deficiencies were also shown to occur in the field defects surrounding those cancers. The table below gives examples for which the DNA repair deficiency in a cancer was shown to be caused by an epigenetic alteration, and the somewhat lower frequencies with which the same epigenetically caused DNA repair deficiency was found in the surrounding field defect.</span>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Frequency of epigenetic changes in DNA repair genes in sporadic cancers and in adjacent field defects</strong></span>







































































































<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Cancer</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Gene</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Frequency in Cancer</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Frequency in Field Defect</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Reference</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Colorectal</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">MGMT</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">46%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">34%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kceqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[44]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Colorectal</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">MGMT</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">47%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">11%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kkeqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[45]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Colorectal</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">MGMT</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">70%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">60%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kseqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[46]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Colorectal</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">MSH2</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">13%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">5%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_l4eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[45]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Colorectal</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">ERCC1</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">100%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">40%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_lceqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[47]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Colorectal</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">PMS2</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">88%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">50%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_lkeqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[47]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Colorectal</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">XPF</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">55%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">40%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_lseqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[47]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Head and Neck</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">MGMT</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">54%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">38%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_m4eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[48]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Head and Neck</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">MLH1</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">33%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">25%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mceqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[49]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Head and Neck</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">MLH1</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">31%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">20%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mkeqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[50]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Stomach</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">MGMT</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">88%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">78%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mseqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[51]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Stomach</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">MLH1</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">73%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">20%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_n4eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[52]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Esophagus</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">MLH1</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">77%â€“100%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">23%â€“79%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_nceqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[53]</sup></td></tr></tbody></table></div>
<span class="mb-4 block break-words text-[1em] leading-7">Some of the small polyps in the field defect shown in the photo of the opened colon segment may be relatively benign neoplasms. In a 1996 study of polyps less than 10mm in size found during colonoscopy and followed with repeat colonoscopies for 3 years, 25% remained unchanged in size, 35% regressed or shrank in size and 40% grew in size.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[54]</sup></span>
<h2 id="genome-instability" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Genome instability<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Cancers are known to exhibit <span class="inline text-[1em] leading-7">genome instability</span> or a &quot;mutator phenotype&quot;.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[55]</sup> The protein-coding DNA within the nucleus is about 1.5% of the total genomic DNA.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[56]</sup> Within this protein-coding DNA (called the <span class="inline text-[1em] leading-7">exome</span>), an average cancer of the breast or colon can have about 60 to 70 protein altering mutations, of which about 3 or 4 may be &quot;driver&quot; mutations, and the remaining ones may be &quot;passenger&quot; mutations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup> However, the average number of DNA sequence mutations in the entire genome (including <span class="inline text-[1em] leading-7">non-protein-coding regions</span>) within a breast cancer tissue sample is about 20,000.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_sgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[57]</sup> In an average melanoma tissue sample (melanomas have a higher <span class="inline text-[1em] leading-7">exome</span> mutation frequency),<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_14gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup>) the total number of DNA sequence mutations is about 80,000.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_18gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[58]</sup> These high frequencies of mutations in the total nucleotide sequences within cancers suggest that often an early alteration in the field defect giving rise to a cancer (e.g. yellow area in the diagram in the preceding section) is a deficiency in DNA repair. Large field defects surrounding colon cancers (extending to about 10 cm on each side of a cancer) are found<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1cgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[47]</sup> to frequently have epigenetic defects in two or three DNA repair proteins (<span class="inline text-[1em] leading-7">ERCC1</span>, <span class="inline text-[1em] leading-7">ERCC4</span> (XPF) and/or <span class="inline text-[1em] leading-7">PMS2</span>) in the entire area of the field defect. When expression of DNA repair genes is reduced, DNA damage accumulates in cells at a higher than normal rate, and this excess damage causes an increased frequency of mutation and/or epimutation. Mutation rates strongly increase in cells defective in <span class="inline text-[1em] leading-7">DNA mismatch repair</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1ugabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_20gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup> or in <span class="inline text-[1em] leading-7">homologous recombinational</span> repair (HRR).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_28gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup> A deficiency in DNA repair, itself, can allow DNA damage to accumulate, and error-prone <span class="inline text-[1em] leading-7">translesion synthesis</span> of some of the damaged areas may give rise to mutations. In addition, faulty repair of this accumulated DNA damage may give rise to epimutations. These new mutations and/or epimutations may provide a proliferative advantage, generating a field defect. Although the mutations/epimutations in DNA repair genes do not, themselves, confer a selective advantage, they may be carried along as passengers in cells when the cell acquires an additional mutation/epimutation that does provide a proliferative advantage.</span>
<h2 id="non-mainstream-theories" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Non-mainstream theories<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">There are a number of theories of carcinogenesis and cancer treatment that fall outside the mainstream of scientific opinion, due to lack of scientific rationale, logic, or evidence base. These theories may be used to justify various alternative cancer treatments. They should be distinguished from those theories of carcinogenesis that have a logical basis within mainstream cancer biology, and from which conventionally testable hypotheses can be made.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Several alternative theories of carcinogenesis, however, are based on scientific evidence and are increasingly being acknowledged. Some researchers believe that cancer may be caused by <span class="inline text-[1em] leading-7">aneuploidy</span> (numerical and structural abnormalities in chromosomes)<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[59]</sup> rather than by mutations or epimutations. Cancer has also been considered as a metabolic disease, in which the cellular metabolism of oxygen is diverted from the pathway that generates energy (<span class="inline text-[1em] leading-7">oxidative phosphorylation</span>) to the pathway that generates <span class="inline text-[1em] leading-7">reactive oxygen species</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_khqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[60]</sup> This causes an energy switch from oxidative phosphorylation to aerobic glycolysis (<span class="inline text-[1em] leading-7">Warburg effect</span>), and the accumulation of <span class="inline text-[1em] leading-7">reactive oxygen species</span> leading to <span class="inline text-[1em] leading-7">oxidative stress</span> (&quot;oxidative stress theory of cancer&quot;).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_14hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[60]</sup> Another concept of cancer development is based on exposure to weak <span class="inline text-[1em] leading-7">magnetic</span> and <span class="inline text-[1em] leading-7">electromagnetic fields</span> and their effects on <span class="inline text-[1em] leading-7">oxidative stress</span>, known as magnetocarcinogenesis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1khqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[61]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A number of authors have questioned the assumption that cancers result from sequential random mutations as oversimplistic, suggesting instead that cancer results from a failure of the body to inhibit an innate, programmed proliferative tendency.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[62]</sup> A related theory suggests that cancer is an <span class="inline text-[1em] leading-7">atavism</span>, an evolutionary throwback to an earlier form of <span class="inline text-[1em] leading-7">multicellular life</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_giabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[63]</sup> The genes responsible for uncontrolled cell growth and cooperation between <span class="inline text-[1em] leading-7">cancer cells</span> are very similar to those that enabled the first multicellular life forms to group together and flourish. These genes still exist within the genomes of more complex <span class="inline text-[1em] leading-7">metazoans</span>, such as humans, although more recently evolved genes keep them in check. When the newer controlling genes fail for whatever reason, the cell can revert to its more primitive programming and reproduce out of control. The theory is an alternative to the notion that cancers begin with rogue cells that undergo evolution within the body. Instead, they possess a fixed number of primitive genes that are progressively activated, giving them finite variability.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_siabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[64]</sup> Another evolutionary theory puts the roots of cancer back to the origin of the <span class="inline text-[1em] leading-7">eukaryote</span> (nucleated) cell by massive <span class="inline text-[1em] leading-7">horizontal gene transfer</span>, when the genomes of infecting viruses were cleaved (and thereby attenuated) by the host, but their fragments integrated into the host genome as immune protection. Cancer thus originates when a rare somatic mutation recombines such fragments into a functional driver of cell proliferation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_18iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[65]</sup></span>
<h1 id="cancer-cell-biology" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Cancer cell biology<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">Tissue can be organized in a continuous spectrum from normal to cancer.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Often, the multiple genetic changes that result in cancer may take many years to accumulate. During this time, the biological behavior of the pre-malignant cells slowly changes from the properties of normal cells to cancer-like properties. Pre-malignant tissue can have a distinctive appearance under the microscope. Among the distinguishing traits of a pre-malignant lesion are an increased number of dividing cells, variation in nuclear size and shape, variation in cell size and shape, loss of specialized cell features, and loss of normal tissue organization. Dysplasia is an abnormal type of excessive cell proliferation characterized by loss of normal tissue arrangement and cell structure in pre-malignant cells. These early neoplastic changes must be distinguished from hyperplasia, a reversible increase in cell division caused by an external stimulus, such as a hormonal imbalance or chronic irritation.</span>
<span class="mb-4 block break-words text-[1em] leading-7">The most severe cases of dysplasia are referred to as <em>carcinoma in situ</em>. In Latin, the term <em>in situ</em> means &quot;in place&quot;; <em>carcinoma in situ</em> refers to an uncontrolled growth of dysplastic cells that remains in its original location and has not shown invasion into other tissues. Carcinoma in situ may develop into an invasive malignancy and is usually removed surgically when detected.</span>
<h2 id="clonal-evolution" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Clonal evolution<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Just as a population of animals undergoes <span class="inline text-[1em] leading-7">evolution</span>, an unchecked population of cells also can undergo &quot;evolution&quot;. This undesirable process is called <span class="inline text-[1em] leading-7">somatic evolution</span>, and is how cancer arises and becomes more malignant over time.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_clabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Most changes in cellular metabolism that allow cells to grow in a disorderly fashion lead to cell death. However, once cancer begins, <span class="inline text-[1em] leading-7">cancer cells</span> undergo a process of <span class="inline text-[1em] leading-7">natural selection</span>: the few cells with new genetic changes that enhance their survival or reproduction multiply faster, and soon come to dominate the growing tumor as cells with less favorable genetic change are out-competed.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_clqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[67]</sup> This is the same mechanism by which <span class="inline text-[1em] leading-7">pathogenic</span> species such as <span class="inline text-[1em] leading-7">MRSA</span> can become <span class="inline text-[1em] leading-7">antibiotic-resistant</span> and by which <span class="inline text-[1em] leading-7">HIV</span> can become <span class="inline text-[1em] leading-7">drug-resistant</span>, and by which plant diseases and insects can become <span class="inline text-[1em] leading-7">pesticide-resistant</span>. This evolution explains why a cancer <span class="inline text-[1em] leading-7">relapse</span> often involves cells that have acquired <span class="inline text-[1em] leading-7">cancer-drug resistance</span> or resistance to <span class="inline text-[1em] leading-7">radiotherapy</span>.</span>
<h2 id="biological-properties-of-cancer-cells" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Biological properties of cancer cells<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">In a 2000 article by <span class="inline text-[1em] leading-7">Hanahan</span> and <span class="inline text-[1em] leading-7">Weinberg</span>, the biological properties of malignant tumor cells were summarized as follows:<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cmqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[68]</sup></span>
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">Acquisition of self-sufficiency in <span class="inline text-[1em] leading-7">growth signals</span>, leading to unchecked growth.</li>
<li class="text-[1em]">Loss of sensitivity to anti-growth signals, also leading to unchecked growth.</li>
<li class="text-[1em]">Loss of capacity for <span class="inline text-[1em] leading-7">apoptosis</span>, allowing growth despite genetic errors and external anti-growth signals.</li>
<li class="text-[1em]">Loss of capacity for <span class="inline text-[1em] leading-7">senescence</span>, leading to limitless replicative potential (immortality)</li>
<li class="text-[1em]">Acquisition of <span class="inline text-[1em] leading-7">sustained angiogenesis</span>, allowing the tumor to grow beyond the limitations of passive nutrient diffusion.</li>
<li class="text-[1em]">Acquisition of the ability to invade tissue and metastasize to distant sites, the defining property of invasive carcinoma and a late-appearing property of some malignant tumors.</li>
</ul>
<span class="mb-4 block break-words text-[1em] leading-7">Subsequent updates to the hallmarks framework in 2011 and 2022 have expanded this list to include additional capabilities such as evading immune destruction, enabling replicative immortality through genomic instability, and interactions with the tumor microenvironment including the microbiome.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4nqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[69]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The completion of these multiple steps would be a very rare event without:</span>
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">Loss of capacity to repair genetic errors, leading to an increased <span class="inline text-[1em] leading-7">mutation</span> rate (genomic instability), thus accelerating all the other changes.</li>
<li class="text-[1em]">Dramatic changes to <span class="inline text-[1em] leading-7">cell mechanics</span>, enabling metastatic dissemination.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_28oqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[70]</sup></li>
</ul>
<span class="mb-4 block break-words text-[1em] leading-7">These biological changes are classical in <span class="inline text-[1em] leading-7">carcinomas</span>; other malignant tumors may not need to achieve them all. For example, given that tissue invasion and displacement to distant sites are normal properties of <span class="inline text-[1em] leading-7">leukocytes</span>, these steps are not needed in the development of <span class="inline text-[1em] leading-7">leukemia</span>. Nor do the different steps necessarily represent individual mutations. For example, inactivation of a single gene, coding for the <span class="inline text-[1em] leading-7">p53</span> protein, will cause genomic instability, evasion of apoptosis and increased angiogenesis. Further, not all the <span class="inline text-[1em] leading-7">cancer cells</span> are dividing. Rather, a subset of the cells in a tumor, called <span class="inline text-[1em] leading-7">cancer stem cells</span>, replicate themselves as they generate differentiated cells.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_spabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[71]</sup> Recent studies highlight the heterogeneity within cancer stem cell populations, contributing to tumor adaptability and resistance to therapies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[72]</sup></span>
<h2 id="cancer-as-a-defect-in-cell-interactions" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Cancer as a defect in cell interactions<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Normally, once a tissue is injured or infected, damaged cells elicit inflammation by stimulating specific patterns of enzyme activity and cytokine gene expression in surrounding cells.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[73]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[74]</sup> Discrete clusters (&quot;cytokine clusters&quot;) of molecules are secreted, which act as mediators, inducing the activity of subsequent cascades of biochemical changes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[75]</sup> Each cytokine binds to specific receptors on various cell types, and each cell type responds in turn by altering the activity of intracellular signal transduction pathways, depending on the receptors that the cell expresses and the signaling molecules present inside the cell.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_eqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[76]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[77]</sup> Collectively, this reprogramming process induces a stepwise change in cell phenotypes, which will ultimately lead to restoration of tissue function and toward regaining essential structural integrity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[78]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[79]</sup> A tissue can thereby heal, depending on the productive communication between the cells present at the site of damage and the immune system.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[80]</sup> One key factor in healing is the regulation of cytokine gene expression, which enables complementary groups of cells to respond to inflammatory mediators in a manner that gradually produces essential changes in tissue physiology.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_uqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[81]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[82]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_12qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[83]</sup> Cancer cells have either permanent (genetic) or reversible (epigenetic) changes to their genome, which partly inhibit their communication with surrounding cells and with the immune system.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_16qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[84]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_18qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[85]</sup> Cancer cells do not communicate with their tissue microenvironment in a manner that protects tissue integrity; instead, the movement and the survival of cancer cells become possible in locations where they can impair tissue function.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1cqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[86]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1eqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[87]</sup> Cancer cells survive by &quot;rewiring&quot; signal pathways that normally protect the tissue from the immune system. This alteration of the immune response is evident in early stages of malignancy too.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1iqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[88]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1kqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[89]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">One example of tissue function rewiring in cancer is the activity of transcription factor <span class="inline text-[1em] leading-7">NF-ÎºB</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[84]</sup> NF-ÎºB activates the expression of numerous genes involved in the transition between inflammation and regeneration, which encode cytokines, adhesion factors, and other molecules that can change cell fate.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[90]</sup> This reprogramming of cellular phenotypes normally allows the development of a fully functional intact tissue.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[91]</sup> NF-ÎºB activity is tightly controlled by multiple proteins, which collectively ensure that only discrete clusters of genes are induced by NF-ÎºB in a given cell and at a given time.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[92]</sup> This tight regulation of signal exchange between cells protects the tissue from excessive inflammation, and ensures that different cell types gradually acquire complementary functions and specific positions. Failure of this mutual regulation between genetic reprogramming and cell interactions allows cancer cells to give rise to metastasis. Cancer cells respond aberrantly to cytokines, and activate signal cascades that can protect them from the immune system.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_oqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[84]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[93]</sup></span>
<h1 id="mechanisms" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Mechanisms<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">In order for cells to start dividing uncontrollably, genes that regulate cell growth must be dysregulated.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4rqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[94]</sup> <span class="inline text-[1em] leading-7">Proto-oncogenes</span> are genes that promote cell growth and <span class="inline text-[1em] leading-7">mitosis</span>, whereas <span class="inline text-[1em] leading-7">tumor suppressor genes</span> discourage cell growth, or temporarily halt cell division to carry out <span class="inline text-[1em] leading-7">DNA repair</span>. Typically, a series of several <span class="inline text-[1em] leading-7">mutations</span> to these genes is required before a normal cell transforms into a <span class="inline text-[1em] leading-7">cancer cell</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10rqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> This concept is sometimes termed &quot;oncoevolution.&quot; Mutations to these genes provide the signals for tumor cells to start dividing uncontrollably. But the uncontrolled cell division that characterizes cancer also requires that the dividing cell duplicates all its cellular components to create two daughter cells. The activation of aerobic glycolysis (the <span class="inline text-[1em] leading-7">Warburg effect</span>), which is not necessarily induced by mutations in proto-oncogenes and tumor suppressor genes,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_18rqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[95]</sup> provides most of the building blocks required to duplicate the cellular components of a dividing cell and, therefore, is also essential for carcinogenesis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1crqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[60]</sup></span>
<h3 id="oncogenes" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Oncogenes<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Oncogenes</span> promote cell growth in a variety of ways. Many can produce <span class="inline text-[1em] leading-7">hormones</span>, a &quot;chemical messenger&quot; between cells that encourage <span class="inline text-[1em] leading-7">mitosis</span>, the effect of which depends on the <span class="inline text-[1em] leading-7">signal transduction</span> of the receiving tissue or cells. In other words, when a hormone receptor on a recipient cell is stimulated, the signal is conducted from the surface of the cell to the <span class="inline text-[1em] leading-7">cell nucleus</span> to affect some change in gene transcription regulation at the nuclear level. Some oncogenes are part of the signal transduction system itself, or the signal <span class="inline text-[1em] leading-7">receptors</span> in cells and tissues themselves, thus controlling the sensitivity to such hormones. Oncogenes often produce <span class="inline text-[1em] leading-7">mitogens</span>, or are involved in <span class="inline text-[1em] leading-7">transcription</span> of DNA in <span class="inline text-[1em] leading-7">protein synthesis</span>, which creates the <span class="inline text-[1em] leading-7">proteins</span> and <span class="inline text-[1em] leading-7">enzymes</span> responsible for producing the products and <span class="inline text-[1em] leading-7">biochemicals</span> cells use and interact with.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Mutations in proto-oncogenes, which are the normally quiescent counterparts of <span class="inline text-[1em] leading-7">oncogenes</span>, can modify their <span class="inline text-[1em] leading-7">expression</span> and function, increasing the amount or activity of the product protein. When this happens, the proto-oncogenes become <span class="inline text-[1em] leading-7">oncogenes</span>, and this transition upsets the normal balance of <span class="inline text-[1em] leading-7">cell cycle</span> regulation in the cell, making uncontrolled growth possible. The chance of cancer cannot be reduced by removing proto-oncogenes from the <span class="inline text-[1em] leading-7">genome</span>, even if this were possible, as they are critical for the growth, repair, and <span class="inline text-[1em] leading-7">homeostasis</span> of the organism. It is only when they become mutated that the signals for growth become excessive.</span>
<span class="mb-4 block break-words text-[1em] leading-7">One of the first <span class="inline text-[1em] leading-7">oncogenes</span> to be defined in <span class="inline text-[1em] leading-7">cancer research</span> is the <span class="inline text-[1em] leading-7">ras oncogene</span>. Mutations in the Ras family of <span class="inline text-[1em] leading-7">proto-oncogenes</span> (comprising H-Ras, N-Ras, and K-Ras) are very common, being found in 20% to 30% of all human tumors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ktqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[96]</sup> Ras was originally identified in the Harvey sarcoma virus genome, and researchers were surprised that not only is this gene present in the human genome but also when ligated to a stimulating control element, it could induce cancers in cell line cultures.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_otqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[97]</sup> New mechanisms were proposed recently that the cell transformation during carcinogenesis was decided by the overall threshold of the oncogene networks (such as Ras signaling) but not by the status of the individual oncogene.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_stqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[98]</sup></span>
<h3 id="proto-oncogenes" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Proto-oncogenes<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Proto-oncogenes promote cell growth in a variety of ways. Many can produce <span class="inline text-[1em] leading-7">hormones</span>, &quot;chemical messengers&quot; between cells that encourage mitosis, the effect of which depends on the <span class="inline text-[1em] leading-7">signal transduction</span> of the receiving tissue or cells. Some are responsible for the signal transduction system and signal <span class="inline text-[1em] leading-7">receptors</span> in cells and tissues themselves, thus controlling the sensitivity to such hormones. They often produce <span class="inline text-[1em] leading-7">mitogens</span>, or are involved in <span class="inline text-[1em] leading-7">transcription</span> of DNA in <span class="inline text-[1em] leading-7">protein synthesis</span>, which create the <span class="inline text-[1em] leading-7">proteins</span> and <span class="inline text-[1em] leading-7">enzymes</span> responsible for producing the products and <span class="inline text-[1em] leading-7">biochemicals</span> cells use and interact with.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Mutations in proto-oncogenes can modify their <span class="inline text-[1em] leading-7">expression</span> and function, increasing the amount or activity of the product protein. When this happens, they become <span class="inline text-[1em] leading-7">oncogenes</span>, and, thus, cells have a higher chance of dividing excessively and uncontrollably. The chance of cancer cannot be reduced by removing proto-oncogenes from the <span class="inline text-[1em] leading-7">genome</span>, as they are critical for growth, repair and <span class="inline text-[1em] leading-7">homeostasis</span> of the body. It is only when they become mutated that the signals for growth become excessive. It is important to note that a gene possessing a growth-promoting role may increase the carcinogenic potential of a cell, under the condition that all necessary cellular mechanisms that permit growth are activated.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kvabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[99]</sup> This condition also includes the inactivation of specific tumor suppressor genes (see below). If the condition is not fulfilled, the cell may cease to grow and can proceed to die. This makes identification of the stage and type of <span class="inline text-[1em] leading-7">cancer cell</span> that grows under the control of a given oncogene crucial for the development of treatment strategies.</span>
<h3 id="tumor-suppressor-genes" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Tumor suppressor genes<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Many tumor suppressor genes effect signal transduction pathways that regulate <span class="inline text-[1em] leading-7">apoptosis</span>, also known as &quot;programmed cell death&quot;.</span>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Tumor suppressor genes</span> code for anti-proliferation signals and proteins that suppress mitosis and cell growth. Generally, tumor suppressors are <span class="inline text-[1em] leading-7">transcription factors</span> that are activated by cellular <span class="inline text-[1em] leading-7">stress</span> or DNA damage. Often DNA damage will cause the presence of free-floating genetic material as well as other signs, and will trigger enzymes and pathways that lead to the activation of <span class="inline text-[1em] leading-7">tumor suppressor genes</span>. The functions of such genes is to arrest the progression of the cell cycle in order to carry out DNA repair, preventing mutations from being passed on to daughter cells. The <span class="inline text-[1em] leading-7">p53</span> protein, one of the most important studied tumor suppressor genes, is a transcription factor activated by many cellular stressors including <span class="inline text-[1em] leading-7">hypoxia</span> and <span class="inline text-[1em] leading-7">ultraviolet radiation</span> damage.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Despite nearly half of all cancers possibly involving alterations in p53, its tumor suppressor function is poorly understood. p53 clearly has two functions: one a nuclear role as a transcription factor, and the other a cytoplasmic role in regulating the cell cycle, cell division, and apoptosis.</span>
<span class="mb-4 block break-words text-[1em] leading-7">The <span class="inline text-[1em] leading-7">Warburg effect</span> is the preferential use of glycolysis for energy to sustain cancer growth. p53 has been shown to regulate the shift from the respiratory to the glycolytic pathway.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_91qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[100]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">However, a mutation can damage the tumor suppressor gene itself, or the signal pathway that activates it, &quot;switching it off&quot;. The invariable consequence of this is that DNA repair is hindered or inhibited: DNA damage accumulates without repair, inevitably leading to cancer.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Mutations of tumor suppressor genes that occur in <span class="inline text-[1em] leading-7">germline</span> cells are passed along to <span class="inline text-[1em] leading-7">offspring</span>, and increase the likelihood for cancer diagnoses in subsequent generations. Members of these families have increased incidence and decreased latency of multiple tumors. The tumor types are typical for each type of tumor suppressor gene mutation, with some mutations causing particular cancers, and other mutations causing others. The mode of inheritance of mutant tumor suppressors is that an affected member inherits a defective copy from one parent, and a normal copy from the other. For instance, individuals who inherit one mutant <em><span class="inline text-[1em] leading-7">p53</span></em> allele (and are therefore <span class="inline text-[1em] leading-7">heterozygous</span> for mutated <em>p53</em>) can develop <span class="inline text-[1em] leading-7">melanomas</span> and <span class="inline text-[1em] leading-7">pancreatic cancer</span>, known as <span class="inline text-[1em] leading-7">Li-Fraumeni syndrome</span>. Other inherited tumor suppressor gene syndromes include <em><span class="inline text-[1em] leading-7">Rb</span></em> mutations, linked to <span class="inline text-[1em] leading-7">retinoblastoma</span>, and <em><span class="inline text-[1em] leading-7">APC</span></em> gene mutations, linked to <span class="inline text-[1em] leading-7">adenopolyposis colon cancer</span>. Adenopolyposis colon cancer is associated with thousands of polyps in colon while young, leading to <span class="inline text-[1em] leading-7">colon cancer</span> at a relatively early age. Finally, inherited mutations in <em><span class="inline text-[1em] leading-7">BRCA1</span></em> and <em><span class="inline text-[1em] leading-7">BRCA2</span></em> lead to early onset of <span class="inline text-[1em] leading-7">breast cancer</span>.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Development of cancer was proposed in 1971 to depend on at least two mutational events. In what became known as the <span class="inline text-[1em] leading-7">Knudson</span> <span class="inline text-[1em] leading-7">two-hit hypothesis</span>, an inherited, germ-line mutation in a <span class="inline text-[1em] leading-7">tumor suppressor gene</span> would cause cancer only if another mutation event occurred later in the organism&#x27;s life, inactivating the other <span class="inline text-[1em] leading-7">allele</span> of that <span class="inline text-[1em] leading-7">tumor suppressor gene</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_p3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[101]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Usually, oncogenes are <span class="inline text-[1em] leading-7">dominant</span>, as they contain <span class="inline text-[1em] leading-7">gain-of-function mutations</span>, while mutated tumor suppressors are <span class="inline text-[1em] leading-7">recessive</span>, as they contain <span class="inline text-[1em] leading-7">loss-of-function mutations</span>. Each cell has two copies of the same gene, one from each parent, and under most cases gain of function mutations in just one copy of a particular proto-oncogene is enough to make that gene a true oncogene. On the other hand, loss of function mutations need to happen in both copies of a tumor suppressor gene to render that gene completely non-functional. However, cases exist in which one mutated copy of a <span class="inline text-[1em] leading-7">tumor suppressor gene</span> can render the other, <span class="inline text-[1em] leading-7">wild-type</span> copy non-functional. This phenomenon is called the <em>dominant negative effect</em> and is observed in many p53 mutations.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Knudson&#x27;s two hit model has recently been challenged by several investigators. Inactivation of one allele of some tumor suppressor genes is sufficient to cause tumors. This phenomenon is called <span class="inline text-[1em] leading-7">haploinsufficiency</span> and has been demonstrated by a number of experimental approaches. Tumors caused by <span class="inline text-[1em] leading-7">haploinsufficiency</span> usually have a later age of onset when compared with those by a two hit process.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[102]</sup></span>
<h3 id="multiple-mutations" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Multiple mutations<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Multiple mutations in <span class="inline text-[1em] leading-7">cancer cells</span></span>
<span class="mb-4 block break-words text-[1em] leading-7">In general, mutations in both types of genes are required for cancer to occur. For example, a mutation limited to one oncogene would be suppressed by normal mitosis control and tumor suppressor genes, first <span class="inline text-[1em] leading-7">hypothesised</span> by the <span class="inline text-[1em] leading-7">Knudson hypothesis</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup> A mutation to only one tumor suppressor gene would not cause cancer either, due to the presence of many &quot;<span class="inline text-[1em] leading-7">backup</span>&quot; genes that duplicate its functions. It is only when enough proto-oncogenes have mutated into oncogenes, and enough tumor suppressor genes deactivated or damaged, that the signals for cell growth overwhelm the signals to regulate it, that cell growth quickly spirals out of control.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_l5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> Often, because these genes regulate the processes that prevent most damage to genes themselves, the rate of mutations increases as one gets older, because DNA damage forms a <span class="inline text-[1em] leading-7">feedback</span> loop.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Mutation of tumor suppressor genes that are passed on to the next generation of not merely cells, but their <span class="inline text-[1em] leading-7">offspring</span>, can cause increased likelihoods for cancers to be inherited. Members within these families have increased incidence and decreased latency of multiple tumors. The mode of inheritance of mutant tumor suppressors is that affected member inherits a defective copy from one parent, and a normal copy from another. Because mutations in tumor suppressors act in a recessive manner (note, however, there are exceptions), the loss of the normal copy creates the cancer <span class="inline text-[1em] leading-7">phenotype</span>. For instance, individuals that are <span class="inline text-[1em] leading-7">heterozygous</span> for p53 mutations are often victims of <span class="inline text-[1em] leading-7">Li-Fraumeni syndrome</span>, and that are heterozygous for <span class="inline text-[1em] leading-7">Rb</span> mutations develop <span class="inline text-[1em] leading-7">retinoblastoma</span>. In similar fashion, mutations in the <span class="inline text-[1em] leading-7">adenomatous polyposis coli</span> gene are linked to <span class="inline text-[1em] leading-7">adenopolyposis colon cancer</span>, with thousands of polyps in the colon while young, whereas mutations in <span class="inline text-[1em] leading-7">BRCA1</span> and <span class="inline text-[1em] leading-7">BRCA2</span> lead to early onset of <span class="inline text-[1em] leading-7">breast cancer</span>.</span>
<span class="mb-4 block break-words text-[1em] leading-7">A new idea announced in 2011 is an extreme version of multiple mutations, called <em><span class="inline text-[1em] leading-7">chromothripsis</span></em> by its proponents. This idea, affecting only 2â€“3% of cases of cancer, although up to 25% of bone cancers, involves the catastrophic shattering of a chromosome into tens or hundreds of pieces and then being patched back together incorrectly. This shattering probably takes place when the chromosomes are compacted during <span class="inline text-[1em] leading-7">normal cell division</span>, but the trigger for the shattering is unknown. Under this model, cancer arises as the result of a single, isolated event, rather than the slow accumulation of multiple mutations. <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[103]</sup></span>
<h3 id="non-mutagenic-carcinogens" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Non-mutagenic carcinogens<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Many <span class="inline text-[1em] leading-7">mutagens</span> are also <span class="inline text-[1em] leading-7">carcinogens</span>, but some carcinogens are not mutagens. Examples of carcinogens that are not mutagens include <span class="inline text-[1em] leading-7">alcohol</span> and <span class="inline text-[1em] leading-7">estrogen</span>. These are thought to promote cancers through their stimulating effect on the rate of cell <span class="inline text-[1em] leading-7">mitosis</span>. Faster rates of mitosis increasingly leave fewer opportunities for repair enzymes to repair damaged DNA during <span class="inline text-[1em] leading-7">DNA replication</span>, increasing the likelihood of a genetic mistake. A mistake made during mitosis can lead to the daughter cells&#x27; receiving the wrong number of <span class="inline text-[1em] leading-7">chromosomes</span>, which leads to <span class="inline text-[1em] leading-7">aneuploidy</span> and may lead to cancer.</span>
<h3 id="role-of-infections" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Role of infections<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<h4 id="bacterial" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Bacterial<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7"><em>Helicobacter pylori</em> can cause <span class="inline text-[1em] leading-7">gastric cancer</span>. Although the data varies between different countries, overall about 1% to 3% of people infected with <em>Helicobacter pylori</em> develop gastric cancer in their lifetime compared to 0.13% of individuals who have had no <em>H. pylori</em> infection.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_j9abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[104]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_l9abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[105]</sup> <em>H. pylori</em> infection is very prevalent. As evaluated in 2002, it is present in the gastric tissues of 74% of middle-aged adults in developing countries and 58% in developed countries.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_t9abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[106]</sup> Since 1% to 3% of infected individuals are likely to develop gastric cancer,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_119abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[107]</sup> <em>H. pylori</em> -induced gastric cancer is the third highest cause of worldwide cancer mortality as of 2018.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_199abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[108]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Infection by <em>H. pylori</em> causes no symptoms in about 80% of those infected.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_99qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[109]</sup> About 75% of individuals infected with <em>H. pylori</em> develop <span class="inline text-[1em] leading-7">gastritis</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_l9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[110]</sup> Thus, the usual consequence of <em>H. pylori</em> infection is chronic asymptomatic gastritis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_t9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[111]</sup> Because of the usual lack of symptoms, when gastric cancer is finally diagnosed it is often fairly advanced. More than half of gastric cancer patients have lymph node metastasis when they are initially diagnosed.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_119qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[112]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The gastritis caused by <em>H. pylori</em> is accompanied by <span class="inline text-[1em] leading-7">inflammation</span>, characterized by infiltration of <span class="inline text-[1em] leading-7">neutrophils</span> and <span class="inline text-[1em] leading-7">macrophages</span> to the gastric epithelium, which favors the accumulation of <span class="inline text-[1em] leading-7">pro-inflammatory cytokines</span> and <span class="inline text-[1em] leading-7">reactive oxygen species</span>/<span class="inline text-[1em] leading-7">reactive nitrogen species</span> (ROS/RNS).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_11aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[113]</sup> The substantial presence of ROS/RNS causes DNA damage including <span class="inline text-[1em] leading-7">8-oxo-2&#x27;-deoxyguanosine</span> (8-OHdG).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_19aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[113]</sup> If the infecting <em>H. pylori</em> carry the cytotoxic <span class="inline text-[1em] leading-7">cagA</span> gene (present in about 60% of Western isolates and a higher percentage of Asian isolates), they can increase the level of 8-OHdG in gastric cells by 8-fold, while if the <em>H. pylori</em> do not carry the cagA gene, the increase in 8-OHdG is about 4-fold.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1paabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[114]</sup> In addition to the <span class="inline text-[1em] leading-7">oxidative DNA damage</span> 8-OHdG, <em>H. pylori</em> infection causes other characteristic DNA damages including DNA double-strand breaks.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_25aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[115]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"><em>H. pylori</em> also causes many <span class="inline text-[1em] leading-7">epigenetic</span> alterations linked to cancer development.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_baqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[116]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_daqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[117]</sup> These <span class="inline text-[1em] leading-7">epigenetic</span> alterations are due to <em>H. pylori</em> -induced <span class="inline text-[1em] leading-7">methylation of CpG sites in promoters of genes</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_raqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[116]</sup> and <em>H. pylori</em> -induced altered expression of multiple <span class="inline text-[1em] leading-7">microRNAs</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_17aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[117]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">As reviewed by Santos and Ribeiro<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[118]</sup> <em>H. pylori</em> infection is associated with epigenetically reduced efficiency of the DNA repair machinery, which favors the accumulation of mutations and genomic instability as well as gastric carcinogenesis. In particular, Raza et al.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dbabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[119]</sup> showed that expression of two DNA repair proteins, <span class="inline text-[1em] leading-7">ERCC1</span> and <span class="inline text-[1em] leading-7">PMS2</span>, was severely reduced once <em>H. pylori</em> infection had progressed to cause <span class="inline text-[1em] leading-7">dyspepsia</span>. Dyspepsia occurs in about 20% of infected individuals.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_11babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[120]</sup> In addition, as reviewed by Raza et al.,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_15babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[119]</sup> human gastric infection with <em>H. pylori</em> causes epigenetically reduced protein expression of DNA repair proteins <span class="inline text-[1em] leading-7">MLH1</span>, <span class="inline text-[1em] leading-7">MGMT</span> and <span class="inline text-[1em] leading-7">MRE11</span>. Reduced DNA repair in the presence of increased DNA damage increases carcinogenic mutations and is likely a significant cause of <em>H. pylori</em> carcinogenesis.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Other bacteria might also play a role in carcinogenesis. Checkpoint control of the <span class="inline text-[1em] leading-7">cell cycle</span> and <span class="inline text-[1em] leading-7">apoptosis</span> by <span class="inline text-[1em] leading-7">p53</span> is inhibited by the <span class="inline text-[1em] leading-7">mycoplasma</span> bacterium,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_lbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[121]</sup> allowing cells with <span class="inline text-[1em] leading-7">DNA damage</span> to &quot;run an apoptotic red light&quot; and proceed through the cell cycle.</span>
<h4 id="viral" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Viral<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">Furthermore, many cancers originate from a <span class="inline text-[1em] leading-7">viral</span> <span class="inline text-[1em] leading-7">infection</span>; this is especially true in animals such as <span class="inline text-[1em] leading-7">birds</span>, but less so in <span class="inline text-[1em] leading-7">humans</span>. 12% of human cancers can be attributed to a viral infection.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_lcqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[122]</sup> The mode of virally induced tumors can be divided into two, <em>acutely transforming</em> or <em>slowly transforming</em>. In acutely transforming viruses, the viral particles carry a gene that encodes for an overactive oncogene called viral-oncogene (v-onc), and the infected cell is transformed as soon as v-onc is expressed. In contrast, in slowly transforming viruses, the virus genome is inserted, especially as viral genome insertion is an obligatory part of <span class="inline text-[1em] leading-7">retroviruses</span>, near a proto-oncogene in the host genome. The viral <span class="inline text-[1em] leading-7">promoter</span> or other transcription regulation elements, in turn, cause over-expression of that proto-oncogene, which, in turn, induces uncontrolled cellular proliferation. Because viral genome insertion is not specific to proto-oncogenes and the chance of insertion near that proto-oncogene is low, slowly transforming viruses have very long tumor latency compared to acutely transforming virus, which already carries the viral-oncogene.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Viruses that are known to cause cancer such as <span class="inline text-[1em] leading-7">HPV</span> (<span class="inline text-[1em] leading-7">cervical cancer</span>), <span class="inline text-[1em] leading-7">Hepatitis B</span> (<span class="inline text-[1em] leading-7">liver cancer</span>), and <span class="inline text-[1em] leading-7">EBV</span> (a type of <span class="inline text-[1em] leading-7">lymphoma</span>), are all DNA viruses. It is thought that when the virus infects a cell, it inserts a part of its own DNA near the cell growth genes, causing cell division. The group of changed cells that are formed from the first cell dividing all have the same viral DNA near the cell growth genes. The group of changed cells are now special because one of the normal controls on growth has been lost.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Depending on their location, cells can be damaged through radiation, chemicals from cigarette smoke, and inflammation from bacterial infection or other viruses. Each cell has a chance of damage. Cells often die if they are damaged, through failure of a vital process or the immune system, however, sometimes damage will knock out a single cancer gene. In an old person, there are thousands, tens of thousands, or hundreds of thousands of knocked-out cells. The chance that any one would form a cancer is very low.</span>
<span class="mb-4 block break-words text-[1em] leading-7">When the damage occurs in any area of changed cells, something different occurs. Each of the cells has the potential for growth. The changed cells will divide quicker when the area is damaged by physical, chemical, or viral agents. A <span class="inline text-[1em] leading-7">vicious circle</span> has been set up: Damaging the area will cause the changed cells to divide, causing a greater likelihood that they will experience knock-outs.</span>
<span class="mb-4 block break-words text-[1em] leading-7">This model of carcinogenesis is popular because it explains why cancers grow. It would be expected that cells that are damaged through radiation would die or at least be worse off because they have fewer genes working; viruses increase the number of genes working.</span>
<span class="mb-4 block break-words text-[1em] leading-7">One thought is that we may end up with thousands of vaccines to prevent every virus that can change our cells. Viruses can have different effects on different parts of the body. It may be possible to prevent a number of different cancers by immunizing against one viral agent. It is likely that HPV, for instance, has a role in cancers of the mucous membranes of the mouth.</span>
<h4 id="helminthiasis" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Helminthiasis<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">Certain parasitic worms are known to be carcinogenic.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[123]</sup> These include:</span>
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]"><em><span class="inline text-[1em] leading-7">Clonorchis sinensis</span></em> (the organism causing <span class="inline text-[1em] leading-7">Clonorchiasis</span>) and <em><span class="inline text-[1em] leading-7">Opisthorchis viverrini</span></em> (causing <span class="inline text-[1em] leading-7">Opisthorchiasis</span>) are associated with <span class="inline text-[1em] leading-7">cholangiocarcinoma</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5lgqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[124]</sup></li>
<li class="text-[1em]"><em><span class="inline text-[1em] leading-7">Schistosoma</span> species</em> (the organisms causing <span class="inline text-[1em] leading-7">Schistosomiasis</span>) is associated with <span class="inline text-[1em] leading-7">bladder cancer</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3pgqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[124]</sup></li>
</ul>
<h3 id="epigenetics" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Epigenetics<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Epigenetics</span> is the study of the regulation of gene expression through chemical, non-mutational changes in DNA structure. The theory of <span class="inline text-[1em] leading-7">epigenetics</span> in cancer pathogenesis is that non-mutational changes to DNA can lead to alterations in gene expression. Normally, <span class="inline text-[1em] leading-7">oncogenes</span> are silent, for example, because of <span class="inline text-[1em] leading-7">DNA methylation</span>. Loss of that methylation can induce the aberrant expression of <span class="inline text-[1em] leading-7">oncogenes</span>, leading to cancer pathogenesis. Known mechanisms of epigenetic change include <span class="inline text-[1em] leading-7">DNA methylation</span>, and methylation or acetylation of <span class="inline text-[1em] leading-7">histone</span> proteins bound to chromosomal DNA at specific locations. Classes of medications, known as <span class="inline text-[1em] leading-7">HDAC inhibitors</span> and <span class="inline text-[1em] leading-7">DNA methyltransferase</span> inhibitors, can re-regulate the epigenetic signaling in the <span class="inline text-[1em] leading-7">cancer cell</span>.</span>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Epimutations</span> include methylations or demethylations of the <span class="inline text-[1em] leading-7">CpG islands</span> of the <span class="inline text-[1em] leading-7">promoter</span> regions of genes, which result in repression or de-repression, respectively of gene expression.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_fiabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[125]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hiabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[126]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_jiabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[127]</sup> Epimutations can also occur by acetylation, methylation, phosphorylation or other alterations to histones, creating a <span class="inline text-[1em] leading-7">histone code</span> that represses or activates gene expression, and such histone epimutations can be important epigenetic factors in cancer.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_riabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[128]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_tiabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[129]</sup> In addition, carcinogenic epimutation can occur through alterations of chromosome architecture caused by proteins such as <span class="inline text-[1em] leading-7">HMGA2</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_15iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[130]</sup> A further source of epimutation is due to increased or decreased expression of <span class="inline text-[1em] leading-7">microRNAs</span> (miRNAs). For example, extra expression of miR-137 can cause downregulation of expression of 491 genes, and miR-137 is epigenetically silenced in 32% of colorectal cancers&gt;<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1diabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></span>
<h3 id="cancer-stem-cells" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Cancer stem cells<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">A new way of looking at carcinogenesis comes from integrating the ideas of <span class="inline text-[1em] leading-7">developmental biology</span> into <span class="inline text-[1em] leading-7">oncology</span>. The <span class="inline text-[1em] leading-7">cancer stem cell</span> <span class="inline text-[1em] leading-7">hypothesis</span> proposes that the different kinds of cells in a <span class="inline text-[1em] leading-7">heterogeneous</span> tumor arise from a single cell, termed Cancer Stem Cell. Cancer stem cells may arise from transformation of <span class="inline text-[1em] leading-7">adult stem cells</span> or <span class="inline text-[1em] leading-7">differentiated</span> cells within a body. These cells persist as a subcomponent of the tumor and retain key stem cell properties. They give rise to a variety of cells, are capable of self-renewal and <span class="inline text-[1em] leading-7">homeostatic</span> control.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_15jabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[131]</sup> Furthermore, the <span class="inline text-[1em] leading-7">relapse</span> of cancer and the emergence of <span class="inline text-[1em] leading-7">metastasis</span> are also attributed to these cells. The <span class="inline text-[1em] leading-7">cancer stem cell</span> <span class="inline text-[1em] leading-7">hypothesis</span> does not contradict earlier concepts of carcinogenesis. The cancer stem cell hypothesis has been a proposed mechanism that contributes to <span class="inline text-[1em] leading-7">tumour heterogeneity</span>.</span>
<h3 id="clonal-evolution-1" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Clonal evolution<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">While genetic and <span class="inline text-[1em] leading-7">epigenetic</span> alterations in tumor suppressor genes and oncogenes change the behavior of cells, those alterations, in the end, result in cancer through their effects on the population of <span class="inline text-[1em] leading-7">neoplastic</span> cells and their microenvironment.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dkabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[132]</sup> Mutant cells in neoplasms compete for space and resources. Thus, a clone with a mutation in a tumor suppressor gene or oncogene will expand only in a neoplasm if that mutation gives the clone a competitive advantage over the other clones and normal cells in its microenvironment.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hkabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[133]</sup> Thus, the process of carcinogenesis is formally a process of Darwinian <span class="inline text-[1em] leading-7">evolution</span>, known as <span class="inline text-[1em] leading-7">somatic or clonal evolution</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_tkabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[134]</sup></span></article><div id="references" class="min-w-0 scroll-mt-8 overflow-hidden"><div class="text-[16px]"><h2 id="references" node="[object Object]" class="mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden">References</h2></div><ol class="columns-1 gap-x-12 [counter-reset:item] md:columns-2"><li id="2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Nowell, Peter C. (1 October 1976). <a href="https://www.science.org/doi/10.1126/science.959840" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression&quot;</a>. <em>Science</em>. <strong>194</strong> (4260): 23â€“28. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/1976Sci...194...23N" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1976Sci...194...23N</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1126%2Fscience.959840" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1126/science.959840</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/0036-8075" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">0036-8075</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/959840" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">959840</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:38445059" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">38445059</a>.</span></div></li><li id="3" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Hanahan, Douglas; Weinberg, Robert A (7 January 2000). <a href="https://doi.org/10.1016%2Fs0092-8674%2800%2981683-9" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The Hallmarks of Cancer&quot;</a>. <em>Cell</em>. <strong>100</strong> (1): 57â€“70. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fs0092-8674%2800%2981683-9" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/s0092-8674(00)81683-9</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/0092-8674" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">0092-8674</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/10647931" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10647931</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:1478778" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1478778</a>.</span></div></li><li id="4" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Hahn, William C.; Weinberg, Robert A. (14 November 2002). <a href="http://www.nejm.org/doi/abs/10.1056/NEJMra021902" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Rules for Making Human Tumor Cells&quot;</a>. <em>New England Journal of Medicine</em>. <strong>347</strong> (20): 1593â€“1603. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1056%2FNEJMra021902" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1056/NEJMra021902</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/0028-4793" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">0028-4793</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12432047" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12432047</a>.</span></div></li><li id="5" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Calkins, Gary N. (11 December 1914). <a href="https://www.science.org/doi/10.1126/science.40.1041.857" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Zur Frage der Entstehung maligner Tumoren. By Th. Boveri. Jena, Gustav Fischer. 1914. 64 pages&quot;</a>. <em>Science</em>. <strong>40</strong> (1041): 857â€“859. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1126%2Fscience.40.1041.857" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1126/science.40.1041.857</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/0036-8075" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">0036-8075</a>.</span></div></li><li id="6" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Tomasetti C, Li L, Vogelstein B (23 March 2017). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852673" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention&quot;</a>. <em>Science</em>. <strong>355</strong> (6331): 1330â€“1334. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2017Sci...355.1330T" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2017Sci...355.1330T</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1126%2Fscience.aaf9011" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1126/science.aaf9011</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852673" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5852673</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/28336671" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">28336671</a>.</span></div></li><li id="7" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Wood LD, Parsons DW, Jones S, Lin J, SjÃ¶blom T, Leary RJ, et al. (November 2007). &quot;The genomic landscapes of human breast and colorectal cancers&quot;. <em>Science</em>. <strong>318</strong> (5853): 1108â€“13. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2007Sci...318.1108W" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2007Sci...318.1108W</a>. <span class="inline text-[1em] leading-7">CiteSeerX</span> <a href="https://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.218.5477" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1.1.218.5477</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1126%2Fscience.1145720" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1126/science.1145720</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17932254" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17932254</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:7586573" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">7586573</a>.</span></div></li><li id="8" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Knudson AG (November 2001). &quot;Two genetic hits (more or less) to cancer&quot;. <em>Nature Reviews. Cancer</em>. <strong>1</strong> (2): 157â€“62. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2F35101031" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/35101031</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11905807" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11905807</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:20201610" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20201610</a>.</span></div></li><li id="9" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Fearon ER, Vogelstein B (June 1990). <a href="https://doi.org/10.1016%2F0092-8674%2890%2990186-I" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;A genetic model for colorectal tumorigenesis&quot;</a>. <em>Cell</em>. <strong>61</strong> (5): 759â€“67. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2F0092-8674%2890%2990186-I" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/0092-8674(90)90186-I</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/2188735" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2188735</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:22975880" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22975880</a>.</span></div></li><li id="10" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Belikov AV (September 2017). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610194" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The number of key carcinogenic events can be predicted from cancer incidence&quot;</a>. <em>Scientific Reports</em>. <strong>7</strong> (1) 12170. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2017NatSR...712170B" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2017NatSR...712170B</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fs41598-017-12448-7" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/s41598-017-12448-7</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610194" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5610194</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/28939880" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">28939880</a>.</span></div></li><li id="11" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Belikov AV, Vyatkin A, Leonov SV (6 August 2021). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351573" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The Erlang distribution approximates the age distribution of incidence of childhood and young adulthood cancers&quot;</a>. <em>PeerJ</em>. <strong>9</strong> e11976. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.7717%2Fpeerj.11976" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.7717/peerj.11976</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351573" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8351573</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/34434669" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">34434669</a>.</span></div></li><li id="12" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Vyatkin, Alexey D.; Otnyukov, Danila V.; Leonov, Sergey V.; Belikov, Aleksey V. (14 January 2022). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759692" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Comprehensive patient-level classification and quantification of driver events in TCGA PanCanAtlas cohorts&quot;</a>. <em>PLOS Genetics</em>. <strong>18</strong> (1): e1009996. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1371%2Fjournal.pgen.1009996" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1371/journal.pgen.1009996</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759692" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8759692</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/35030162" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">35030162</a>.</span></div></li><li id="13" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Croce CM (January 2008). &quot;Oncogenes and cancer&quot;. <em>The New England Journal of Medicine</em>. <strong>358</strong> (5): 502â€“11. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1056%2FNEJMra072367" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1056/NEJMra072367</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18234754" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18234754</a>.</span></div></li><li id="14" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM (February 2005). &quot;Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs&quot;. <em>Nature</em>. <strong>433</strong> (7027): 769â€“73. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2005Natur.433..769L" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2005Natur.433..769L</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fnature03315" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/nature03315</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15685193" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15685193</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:4430576" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4430576</a>.</span></div></li><li id="15" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Balaguer F, Link A, Lozano JJ, Cuatrecasas M, Nagasaka T, Boland CR, Goel A (August 2010). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922409" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis&quot;</a>. <em>Cancer Research</em>. <strong>70</strong> (16): 6609â€“18. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1158%2F0008-5472.CAN-10-0622" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1158/0008-5472.CAN-10-0622</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922409" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2922409</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/20682795" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20682795</a>.</span></div></li><li id="16" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://hms.harvard.edu/news/how-chromosome-imbalances-can-drive-cancer" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;How Chromosome Imbalances Can Drive Cancer | Harvard Medical School&quot;</a>. <em>hms.harvard.edu</em>. 6 July 2023. Retrieved 2 April 2024.</span></div></li><li id="17" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kastan MB (April 2008). <a href="https://doi.org/10.1158%2F1541-7786.MCR-08-0020" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture&quot;</a>. <em>Molecular Cancer Research</em>. <strong>6</strong> (4): 517â€“24. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1158%2F1541-7786.MCR-08-0020" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1158/1541-7786.MCR-08-0020</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18403632" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18403632</a>.</span></div></li><li id="18" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Cunningham FH, Fiebelkorn S, Johnson M, Meredith C (November 2011). &quot;A novel application of the Margin of Exposure approach: segregation of tobacco smoke toxicants&quot;. <em>Food and Chemical Toxicology</em>. <strong>49</strong> (11): 2921â€“33. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.fct.2011.07.019" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.fct.2011.07.019</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/21802474" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21802474</a>.</span></div></li><li id="19" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kanavy HE, Gerstenblith MR (December 2011). &quot;Ultraviolet radiation and melanoma&quot;. <em>Seminars in Cutaneous Medicine and Surgery</em>. <strong>30</strong> (4): 222â€“8. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.sder.2011.08.003" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.sder.2011.08.003</a> (inactive 11 July 2025). <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22123420" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22123420</a>.<code class="text-fg-solar bg-fg-solar-opaque break-all rounded px-2 align-middle font-mono text-sm" node="[object Object]">{{cite journal}}</code>: CS1 maint: DOI inactive as of July 2025 (link)</span></div></li><li id="20" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Handa O, Naito Y, Yoshikawa T (2011). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837368" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Redox biology and gastric carcinogenesis: the role of Helicobacter pylori&quot;</a>. <em>Redox Report</em>. <strong>16</strong> (1): 1â€“7. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1179%2F174329211X12968219310756" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1179/174329211X12968219310756</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837368" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6837368</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/21605492" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21605492</a>.</span></div></li><li id="21" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Smela ME, Hamm ML, Henderson PT, Harris CM, Harris TM, Essigmann JM (May 2002). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC124458" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma&quot;</a>. <em>Proceedings of the National Academy of Sciences of the United States of America</em>. <strong>99</strong> (10): 6655â€“60. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2002PNAS...99.6655S" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2002PNAS...99.6655S</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1073%2Fpnas.102167699" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1073/pnas.102167699</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC124458" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">124458</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12011430" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12011430</a>.</span></div></li><li id="22" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Katsurano M, Niwa T, Yasui Y, Shigematsu Y, Yamashita S, Takeshima H, Lee MS, Kim YJ, Tanaka T, Ushijima T (January 2012). <a href="https://doi.org/10.1038%2Fonc.2011.241" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction&quot;</a>. <em>Oncogene</em>. <strong>31</strong> (3): 342â€“51. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fonc.2011.241" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/onc.2011.241</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/21685942" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21685942</a>.</span></div></li><li id="23" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Bernstein C, Holubec H, Bhattacharyya AK, Nguyen H, Payne CM, Zaitlin B, Bernstein H (August 2011). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149672" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Carcinogenicity of deoxycholate, a secondary bile acid&quot;</a>. <em>Archives of Toxicology</em>. <strong>85</strong> (8): 863â€“71. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1007%2Fs00204-011-0648-7" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1007/s00204-011-0648-7</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149672" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3149672</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/21267546" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21267546</a>.</span></div></li><li id="24" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Malkin D (April 2011). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135649" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Li-fraumeni syndrome&quot;</a>. <em>Genes &amp; Cancer</em>. <strong>2</strong> (4): 475â€“84. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1177%2F1947601911413466" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1177/1947601911413466</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135649" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3135649</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/21779515" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21779515</a>.</span></div></li><li id="25" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Fearon ER (November 1997). &quot;Human cancer syndromes: clues to the origin and nature of cancer&quot;. <em>Science</em>. <strong>278</strong> (5340): 1043â€“50. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/1997Sci...278.1043F" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1997Sci...278.1043F</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1126%2Fscience.278.5340.1043" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1126/science.278.5340.1043</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9353177" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9353177</a>.</span></div></li><li id="26" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (July 2000). <a href="https://doi.org/10.1056%2FNEJM200007133430201" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland&quot;</a>. <em>The New England Journal of Medicine</em>. <strong>343</strong> (2): 78â€“85. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1056%2FNEJM200007133430201" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1056/NEJM200007133430201</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/10891514" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10891514</a>.</span></div></li><li id="27" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Halford S, Rowan A, Sawyer E, Talbot I, Tomlinson I (June 2005). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774551" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;O(6)-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C&gt;A:T transitions&quot;</a>. <em>Gut</em>. <strong>54</strong> (6): 797â€“802. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1136%2Fgut.2004.059535" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1136/gut.2004.059535</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774551" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1774551</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15888787" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15888787</a>.</span></div></li><li id="28" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Narayanan L, Fritzell JA, Baker SM, Liskay RM, Glazer PM (April 1997). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20332" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Elevated levels of mutation in multiple tissues of mice deficient in the DNA mismatch repair gene Pms2&quot;</a>. <em>Proceedings of the National Academy of Sciences of the United States of America</em>. <strong>94</strong> (7): 3122â€“7. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/1997PNAS...94.3122N" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1997PNAS...94.3122N</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1073%2Fpnas.94.7.3122" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1073/pnas.94.7.3122</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20332" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20332</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9096356" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9096356</a>.</span></div></li><li id="29" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Hegan DC, Narayanan L, Jirik FR, Edelmann W, Liskay RM, Glazer PM (December 2006). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612936" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6&quot;</a>. <em>Carcinogenesis</em>. <strong>27</strong> (12): 2402â€“8. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1093%2Fcarcin%2Fbgl079" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1093/carcin/bgl079</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612936" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2612936</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16728433" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16728433</a>.</span></div></li><li id="30" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Tutt AN, van Oostrom CT, Ross GM, van Steeg H, Ashworth A (March 2002). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1084010" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Disruption of Brca2 increases the spontaneous mutation rate in vivo: synergism with ionizing radiation&quot;</a>. <em>EMBO Reports</em>. <strong>3</strong> (3): 255â€“60. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1093%2Fembo-reports%2Fkvf037" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1093/embo-reports/kvf037</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1084010" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1084010</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11850397" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11850397</a>.</span></div></li><li id="31" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">German J (March 1969). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1706430" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Bloom&#x27;s syndrome. I. Genetical and clinical observations in the first twenty-seven patients&quot;</a>. <em>American Journal of Human Genetics</em>. <strong>21</strong> (2): 196â€“227. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1706430" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1706430</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/5770175" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5770175</a>.</span></div></li><li id="32" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">O&#x27;Hagan HM, Mohammad HP, Baylin SB (August 2008). Lee JT (ed.). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491723" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island&quot;</a>. <em>PLOS Genetics</em>. <strong>4</strong> (8): e1000155. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1371%2Fjournal.pgen.1000155" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1371/journal.pgen.1000155</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491723" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2491723</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18704159" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18704159</a>.</span></div></li><li id="33" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Cuozzo C, Porcellini A, Angrisano T, Morano A, Lee B, Di Pardo A, Messina S, Iuliano R, Fusco A, Santillo MR, Muller MT, Chiariotti L, Gottesman ME, Avvedimento EV (July 2007). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913100" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;DNA damage, homology-directed repair, and DNA methylation&quot;</a>. <em>PLOS Genetics</em>. <strong>3</strong> (7): e110. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1371%2Fjournal.pgen.0030110" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1371/journal.pgen.0030110</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913100" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1913100</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17616978" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17616978</a>.</span></div></li><li id="34" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Villeneuve PJ, Mao Y (November 1994). &quot;Lifetime probability of developing lung cancer, by smoking status, Canada&quot;. <em>Canadian Journal of Public Health</em>. <strong>85</strong> (6): 385â€“8. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/7895211" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">7895211</a>.</span></div></li><li id="35" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. (March 2012). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878653" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Intratumor heterogeneity and branched evolution revealed by multiregion sequencing&quot;</a>. <em>The New England Journal of Medicine</em>. <strong>366</strong> (10): 883â€“92. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1056%2FNEJMoa1113205" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1056/NEJMoa1113205</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878653" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4878653</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22397650" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22397650</a>.</span></div></li><li id="36" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">LÃ³pez-LÃ¡zaro M (August 2015). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242319" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Stem cell division theory of cancer&quot;</a>. <em>Cell Cycle</em>. <strong>14</strong> (16): 2547â€“8. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1080%2F15384101.2015.1062330" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1080/15384101.2015.1062330</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242319" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5242319</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/26090957" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">26090957</a>.</span></div></li><li id="37" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">LÃ³pez-LÃ¡zaro M (May 2015). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468332" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The migration ability of stem cells can explain the existence of cancer of unknown primary site. Rethinking metastasis&quot;</a>. <em>Oncoscience</em>. <strong>2</strong> (5): 467â€“75. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.18632%2Foncoscience.159" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.18632/oncoscience.159</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468332" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4468332</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/26097879" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">26097879</a>.</span></div></li><li id="38" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Tomasetti C, Vogelstein B (January 2015). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446723" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions&quot;</a>. <em>Science</em>. <strong>347</strong> (6217): 78â€“81. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1126%2Fscience.1260825" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1126/science.1260825</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446723" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4446723</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/25554788" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">25554788</a>.</span></div></li><li id="39" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Slaughter DP, Southwick HW, Smejkal W (September 1953). <a href="https://doi.org/10.1002%2F1097-0142%28195309%296%3A5%3C963%3A%3AAID-CNCR2820060515%3E3.0.CO%3B2-Q" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin&quot;</a>. <em>Cancer</em>. <strong>6</strong> (5): 963â€“8. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2F1097-0142%28195309%296%3A5%3C963%3A%3AAID-CNCR2820060515%3E3.0.CO%3B2-Q" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/1097-0142(195309)6:5&lt;963::AID-CNCR2820060515&gt;3.0.CO;2-Q</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/13094644" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">13094644</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:6736946" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6736946</a>.</span></div></li><li id="40" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Bernstein C, Bernstein H, Payne CM, Dvorak K, Garewal H (February 2008). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744582" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Field defects in progression to gastrointestinal tract cancers&quot;</a>. review. <em>Cancer Letters</em>. <strong>260</strong> (1â€“2): 1â€“10. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.canlet.2007.11.027" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.canlet.2007.11.027</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744582" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2744582</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18164807" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18164807</a>.</span></div></li><li id="41" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Nguyen H, Loustaunau C, Facista A, Ramsey L, Hassounah N, Taylor H, Krouse R, Payne CM, Tsikitis VL, Goldschmid S, Banerjee B, Perini RF, Bernstein C (2010). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149991" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer&quot;</a>. <em>Journal of Visualized Experiments</em> (41): 1931. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3791%2F1931" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3791/1931</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149991" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3149991</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/20689513" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20689513</a>.</span></div></li><li id="42" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Rubin H (March 2011). &quot;Fields and field cancerization: the preneoplastic origins of cancer: asymptomatic hyperplastic fields are precursors of neoplasia, and their progression to tumors can be tracked by saturation density in culture&quot;. <em>BioEssays</em>. <strong>33</strong> (3): 224â€“31. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Fbies.201000067" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/bies.201000067</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/21254148" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21254148</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:44981539" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">44981539</a>.</span></div></li><li id="43" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Tsao JL, Yatabe Y, Salovaara R, JÃ¤rvinen HJ, Mecklin JP, Aaltonen LA, TavarÃ© S, Shibata D (February 2000). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC15581" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Genetic reconstruction of individual colorectal tumor histories&quot;</a>. <em>Proceedings of the National Academy of Sciences of the United States of America</em>. <strong>97</strong> (3): 1236â€“41. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2000PNAS...97.1236T" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2000PNAS...97.1236T</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1073%2Fpnas.97.3.1236" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1073/pnas.97.3.1236</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC15581" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15581</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/10655514" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10655514</a>.</span></div></li><li id="44" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW (March 2013). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749880" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cancer genome landscapes&quot;</a>. review. <em>Science</em>. <strong>339</strong> (6127): 1546â€“58. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2013Sci...339.1546V" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2013Sci...339.1546V</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1126%2Fscience.1235122" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1126/science.1235122</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749880" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3749880</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/23539594" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23539594</a>.</span></div></li><li id="45" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR, Einspahr JG, Buckmeier J, Alberts DS, Hamilton SR, Issa JP (September 2005). <a href="https://doi.org/10.1093%2Fjnci%2Fdji275" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;MGMT promoter methylation and field defect in sporadic colorectal cancer&quot;</a>. <em>Journal of the National Cancer Institute</em>. <strong>97</strong> (18): 1330â€“8. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1093%2Fjnci%2Fdji275" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1093/jnci/dji275</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16174854" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16174854</a>.</span></div></li><li id="46" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH (October 2011). &quot;Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence&quot;. <em>Langenbeck&#x27;s Archives of Surgery</em>. <strong>396</strong> (7): 1017â€“26. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1007%2Fs00423-011-0812-9" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1007/s00423-011-0812-9</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/21706233" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21706233</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:8069716" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8069716</a>.</span></div></li><li id="47" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Svrcek M, Buhard O, Colas C, Coulet F, Dumont S, Massaoudi I, et al. (November 2010). &quot;Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers&quot;. <em>Gut</em>. <strong>59</strong> (11): 1516â€“26. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1136%2Fgut.2009.194787" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1136/gut.2009.194787</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/20947886" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20947886</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:206950452" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">206950452</a>.</span></div></li><li id="48" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Facista A, Nguyen H, Lewis C, Prasad AR, Ramsey L, Zaitlin B, Nfonsam V, Krouse RS, Bernstein H, Payne CM, Stern S, Oatman N, Banerjee B, Bernstein C (April 2012). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351028" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Deficient expression of DNA repair enzymes in early progression to sporadic colon cancer&quot;</a>. <em>Genome Integrity</em>. <strong>3</strong> (1): 3. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1186%2F2041-9414-3-3" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1186/2041-9414-3-3</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351028" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3351028</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22494821" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22494821</a>.</span></div></li><li id="49" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Paluszczak J, Misiak P, Wierzbicka M, WoÅºniak A, Baer-Dubowska W (February 2011). &quot;Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa&quot;. <em>Oral Oncology</em>. <strong>47</strong> (2): 104â€“7. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.oraloncology.2010.11.006" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.oraloncology.2010.11.006</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/21147548" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21147548</a>.</span></div></li><li id="50" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Zuo C, Zhang H, Spencer HJ, Vural E, Suen JY, Schichman SA, Smoller BR, Kokoska MS, Fan CY (October 2009). &quot;Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma&quot;. <em>Otolaryngologyâ€“Head and Neck Surgery</em>. <strong>141</strong> (4): 484â€“90. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.otohns.2009.07.007" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.otohns.2009.07.007</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/19786217" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">19786217</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:8357370" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8357370</a>.</span></div></li><li id="51" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Tawfik HM, El-Maqsoud NM, Hak BH, El-Sherbiny YM (2011). &quot;Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene&quot;. <em>American Journal of Otolaryngology</em>. <strong>32</strong> (6): 528â€“36. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.amjoto.2010.11.005" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.amjoto.2010.11.005</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/21353335" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21353335</a>.</span></div></li><li id="52" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ (November 2009). &quot;Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions&quot;. <em>Human Pathology</em>. <strong>40</strong> (11): 1534â€“42. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.humpath.2009.01.029" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.humpath.2009.01.029</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/19695681" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">19695681</a>.</span></div></li><li id="53" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Wani M, Afroze D, Makhdoomi M, Hamid I, Wani B, Bhat G, Wani R, Wani K (2012). <a href="http://ocean.kisti.re.kr/downfile/volume/apocp/POCPA9/2012/v13n8/POCPA9_2012_v13n8_4177.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Promoter methylation status of DNA repair gene (hMLH1) in gastric carcinoma patients of the Kashmir valley&quot;</a> (PDF). <em>Asian Pacific Journal of Cancer Prevention</em>. <strong>13</strong> (8): 4177â€“81. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.7314%2FAPJCP.2012.13.8.4177" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.7314/APJCP.2012.13.8.4177</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/23098428" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23098428</a>.</span></div></li><li id="54" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Agarwal A, Polineni R, Hussein Z, Vigoda I, Bhagat TD, Bhattacharyya S, Maitra A, Verma A (2012). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396065" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Role of epigenetic alterations in the pathogenesis of Barrett&#x27;s esophagus and esophageal adenocarcinoma&quot;</a>. <em>International Journal of Clinical and Experimental Pathology</em>. <strong>5</strong> (5): 382â€“96. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396065" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3396065</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22808291" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22808291</a>. Review.</span></div></li><li id="55" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Hofstad B, Vatn MH, Andersen SN, Huitfeldt HS, Rognum T, Larsen S, Osnes M (September 1996). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1383355" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years&quot;</a>. <em>Gut</em>. <strong>39</strong> (3): 449â€“56. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1136%2Fgut.39.3.449" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1136/gut.39.3.449</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1383355" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1383355</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/8949653" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8949653</a>.</span></div></li><li id="56" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Schmitt MW, Prindle MJ, Loeb LA (September 2012). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674777" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Implications of genetic heterogeneity in cancer&quot;</a>. <em>Annals of the New York Academy of Sciences</em>. <strong>1267</strong> (1): 110â€“6. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2012NYASA1267..110S" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2012NYASA1267..110S</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fj.1749-6632.2012.06590.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/j.1749-6632.2012.06590.x</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674777" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3674777</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22954224" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22954224</a>.</span></div></li><li id="57" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. (February 2001). <a href="https://doi.org/10.1038%2F35057062" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Initial sequencing and analysis of the human genome&quot;</a>. <em>Nature</em>. <strong>409</strong> (6822): 860â€“921. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2001Natur.409..860L" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2001Natur.409..860L</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2F35057062" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/35057062</a>. <span class="inline text-[1em] leading-7">hdl</span>:<a href="https://hdl.handle.net/2027.42%2F62798" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2027.42/62798</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11237011" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11237011</a>.</span></div></li><li id="58" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Yost SE, Smith EN, Schwab RB, Bao L, Jung H, Wang X, Voest E, Pierce JP, Messer K, Parker BA, Harismendy O, Frazer KA (August 2012). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413110" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens&quot;</a>. <em>Nucleic Acids Research</em>. <strong>40</strong> (14): e107. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1093%2Fnar%2Fgks299" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1093/nar/gks299</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413110" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3413110</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22492626" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22492626</a>.</span></div></li><li id="59" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Berger MF, Hodis E, Heffernan TP, Deribe YL, Lawrence MS, Protopopov A, et al. (May 2012). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367798" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Melanoma genome sequencing reveals frequent PREX2 mutations&quot;</a>. <em>Nature</em>. <strong>485</strong> (7399): 502â€“6. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2012Natur.485..502B" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2012Natur.485..502B</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fnature11071" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/nature11071</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367798" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3367798</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22622578" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22622578</a>.</span></div></li><li id="60" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Rasnick D, Duesberg PH (June 1999). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1220292" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;How aneuploidy affects metabolic control and causes cancer&quot;</a>. <em>The Biochemical Journal</em>. <strong>340</strong> (3): 621â€“30. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1042%2F0264-6021%3A3400621" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1042/0264-6021:3400621</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1220292" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1220292</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/10359645" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10359645</a>.</span></div></li><li id="61" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">LÃ³pez-LÃ¡zaro M (March 2010). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802554" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;A new view of carcinogenesis and an alternative approach to cancer therapy&quot;</a>. <em>Molecular Medicine</em>. <strong>16</strong> (3â€“4): 144â€“53. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.2119%2Fmolmed.2009.00162" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.2119/molmed.2009.00162</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802554" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2802554</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/20062820" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20062820</a>.</span></div></li><li id="62" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Juutilainen J, Herrala M, Luukkonen J, Naarala J, Hore PJ (May 2018). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998098" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Magnetocarcinogenesis: is there a mechanism for carcinogenic effects of weak magnetic fields?&quot;</a>. <em>Proceedings. Biological Sciences</em>. <strong>285</strong> (1879): 20180590. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1098%2Frspb.2018.0590" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1098/rspb.2018.0590</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998098" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5998098</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/29794049" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">29794049</a>.</span></div></li><li id="63" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Soto AM, Sonnenschein C (October 2004). &quot;The somatic mutation theory of cancer: growing problems with the paradigm?&quot;. <em>BioEssays</em>. <strong>26</strong> (10): 1097â€“107. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Fbies.20087" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/bies.20087</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15382143" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15382143</a>.</span></div></li><li id="64" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Davies PC, Lineweaver CH (February 2011). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148211" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cancer tumors as Metazoa 1.0: tapping genes of ancient ancestors&quot;</a>. <em>Physical Biology</em>. <strong>8</strong> (1): 015001. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2011PhBio...8a5001D" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2011PhBio...8a5001D</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1088%2F1478-3975%2F8%2F1%2F015001" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1088/1478-3975/8/1/015001</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148211" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3148211</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/21301065" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21301065</a>.</span></div></li><li id="65" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Dean, Tim. <a href="http://lifescientist.com.au/content/health-medical/news/cancer-resembles-life-1-billion-years-ago-say-astrobiologists-65321653" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cancer resembles life 1 billion years ago, say astrobiologists&quot;</a>, <em>Australian Life Scientist</em> , 8 February 2011. Retrieved 15 February 2011.</span></div></li><li id="66" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Sterrer, W (August 2016). <a href="https://web.archive.org/web/20220303085903/http://www.cancerhypotheses.org.uk/app/download/6246775/SterrerFV.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cancer - Mutational Resurrection of Prokaryote Endofossils&quot;</a> (PDF). <em>Cancer Hypotheses</em>. <strong>1</strong> (1): 1â€“15. Archived from <a href="http://www.cancerhypotheses.org.uk/app/download/6246775/SterrerFV.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> (PDF) on 3 March 2022. Retrieved 8 May 2019.</span></div></li><li id="https://www.science.org/doi/10.1126/science.959840" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.science.org/doi/10.1126/science.959840" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.science.org/doi/10.1126/science.959840</a></span></div></li><li id="https://www.nature.com/articles/nrc2013" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/nrc2013" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/nrc2013</a></span></div></li><li id="https://doi.org/10.1016%2FS0092-8674%2800%2981683-9" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://doi.org/10.1016%2FS0092-8674%2800%2981683-9" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://doi.org/10.1016%2FS0092-8674%2800%2981683-9</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/35022204/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/35022204/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/35022204/</a></span></div></li><li id="https://phys.org/news/2024-05-stiffness-viscosity-cells-differ-cancer.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://phys.org/news/2024-05-stiffness-viscosity-cells-differ-cancer.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://phys.org/news/2024-05-stiffness-viscosity-cells-differ-cancer.html</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0959437X07002512" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0959437X07002512" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0959437X07002512</a></span></div></li><li id="https://aacrjournals.org/cancerdiscovery/article/14/4/674/741959/Cancer-Hallmarks-Piecing-the-Puzzle-Together" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://aacrjournals.org/cancerdiscovery/article/14/4/674/741959/Cancer-Hallmarks-Piecing-the-Puzzle-Together" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://aacrjournals.org/cancerdiscovery/article/14/4/674/741959/Cancer-Hallmarks-Piecing-the-Puzzle-Together</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447318/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447318/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447318/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942331/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942331/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942331/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207479/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207479/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207479/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658206/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658206/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658206/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605511/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605511/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605511/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S193459091400219X" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S193459091400219X" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S193459091400219X</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605453/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605453/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605453/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703146/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703146/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703146/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724264/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724264/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724264/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S135961011200140X" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S135961011200140X" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S135961011200140X</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597209/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597209/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597209/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526340/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526340/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526340/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643398/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643398/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643398/</a></span></div></li><li id="https://onlinelibrary.wiley.com/doi/10.1002/hep.27353" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://onlinelibrary.wiley.com/doi/10.1002/hep.27353" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://onlinelibrary.wiley.com/doi/10.1002/hep.27353</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653079/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653079/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653079/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478943/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478943/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478943/</a></span></div></li><li id="https://jitc.bmj.com/content/9/9/e002647" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jitc.bmj.com/content/9/9/e002647" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jitc.bmj.com/content/9/9/e002647</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834864/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834864/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834864/</a></span></div></li><li id="https://onlinelibrary.wiley.com/doi/10.1002/cbf.3086" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://onlinelibrary.wiley.com/doi/10.1002/cbf.3086" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://onlinelibrary.wiley.com/doi/10.1002/cbf.3086</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S1359610114001584" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S1359610114001584" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S1359610114001584</a></span></div></li><li id="https://link.springer.com/article/10.1007/s12307-014-0147-5" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://link.springer.com/article/10.1007/s12307-014-0147-5" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://link.springer.com/article/10.1007/s12307-014-0147-5</a></span></div></li><li id="97" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Vogelstein B, Kinzler KW (August 2004). &quot;Cancer genes and the pathways they control&quot;. <em>Nature Medicine</em>. <strong>10</strong> (8): 789â€“99. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fnm1087" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/nm1087</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15286780" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15286780</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:205383514" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">205383514</a>.</span></div></li><li id="98" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Brand KA, Hermfisse U (April 1997). <a href="https://doi.org/10.1096%2Ffasebj.11.5.9141507" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species&quot;</a>. <em>FASEB Journal</em>. <strong>11</strong> (5): 388â€“95. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1096%2Ffasebj.11.5.9141507" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1096/fasebj.11.5.9141507</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9141507" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9141507</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:16745745" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16745745</a>.</span></div></li><li id="99" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Bos JL (September 1989). <a href="http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&amp;pmid=2547513" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;ras oncogenes in human cancer: a review&quot;</a>. <em>Cancer Research</em>. <strong>49</strong> (17): 4682â€“9. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/2547513" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2547513</a>.</span></div></li><li id="100" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Chang EH, Furth ME, Scolnick EM, Lowy DR (June 1982). &quot;Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus&quot;. <em>Nature</em>. <strong>297</strong> (5866): 479â€“83. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/1982Natur.297..479C" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1982Natur.297..479C</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2F297479a0" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/297479a0</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/6283358" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6283358</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:4234621" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4234621</a>.</span></div></li><li id="101" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Zhan H, Bhattacharya S, Cai H, Iglesias PA, Huang CH, Devreotes PN (September 2020). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505206" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;An excitable Ras/PI3K/ERK signaling network controls migration and oncogenic transformation in epithelial cells&quot;</a>. <em>Developmental Cell</em>. <strong>54</strong> (5): 608â€“623. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.devcel.2020.08.001" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.devcel.2020.08.001</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505206" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">7505206</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/32877650" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">32877650</a>.</span></div></li><li id="102" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Vlahopoulos SA, Logotheti S, Mikas D, Giarika A, Gorgoulis V, Zoumpourlis V (April 2008). &quot;The role of ATF-2 in oncogenesis&quot;. <em>BioEssays</em>. <strong>30</strong> (4): 314â€“27. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Fbies.20734" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/bies.20734</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18348191" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18348191</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:678541" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">678541</a>.</span></div></li><li id="103" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM (June 2006). &quot;p53 regulates mitochondrial respiration&quot;. <em>Science</em>. <strong>312</strong> (5780): 1650â€“3. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2006Sci...312.1650M" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2006Sci...312.1650M</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1126%2Fscience.1126863" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1126/science.1126863</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16728594" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16728594</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:36668814" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">36668814</a>.</span></div></li><li id="104" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Knudson AG (April 1971). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC389051" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Mutation and cancer: statistical study of retinoblastoma&quot;</a>. <em>Proceedings of the National Academy of Sciences of the United States of America</em>. <strong>68</strong> (4): 820â€“3. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/1971PNAS...68..820K" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1971PNAS...68..820K</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1073%2Fpnas.68.4.820" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1073/pnas.68.4.820</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC389051" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">389051</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/5279523" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5279523</a>.</span></div></li><li id="105" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Fodde R, Smits R (October 2002). &quot;Cancer biology. A matter of dosage&quot;. <em>Science</em>. <strong>298</strong> (5594): 761â€“3. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1126%2Fscience.1077707" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1126/science.1077707</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12399571" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12399571</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:50724" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">50724</a>.</span></div></li><li id="106" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, et al. (January 2011). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065307" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Massive genomic rearrangement acquired in a single catastrophic event during cancer development&quot;</a>. <em>Cell</em>. <strong>144</strong> (1): 27â€“40. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.cell.2010.11.055" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.cell.2010.11.055</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065307" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3065307</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/21215367" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21215367</a>.</span></div></li><li id="107" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kuipers EJ (March 1999). <a href="https://doi.org/10.1046%2Fj.1365-2036.1999.00002.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Review article: exploring the link between Helicobacter pylori and gastric cancer&quot;</a>. <em>Alimentary Pharmacology &amp; Therapeutics</em>. <strong>13</strong> (Suppl 1): 3â€“11. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1046%2Fj.1365-2036.1999.00002.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1046/j.1365-2036.1999.00002.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/10209681" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10209681</a>.</span></div></li><li id="108" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kusters JG, van Vliet AH, Kuipers EJ (July 2006). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1539101" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Pathogenesis of Helicobacter pylori infection&quot;</a>. <em>Clin. Microbiol. Rev</em>. <strong>19</strong> (3): 449â€“90. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1128%2FCMR.00054-05" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1128/CMR.00054-05</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1539101" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1539101</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16847081" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16847081</a>.</span></div></li><li id="109" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Parkin DM (June 2006). <a href="https://doi.org/10.1002%2Fijc.21731" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The global health burden of infection-associated cancers in the year 2002&quot;</a>. <em>Int. J. Cancer</em>. <strong>118</strong> (12): 3030â€“44. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Fijc.21731" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/ijc.21731</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16404738" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16404738</a>.</span></div></li><li id="110" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Wroblewski LE, Peek RM, Wilson KT (October 2010). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952980" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Helicobacter pylori and gastric cancer: factors that modulate disease risk&quot;</a>. <em>Clin. Microbiol. Rev</em>. <strong>23</strong> (4): 713â€“39. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1128%2FCMR.00011-10" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1128/CMR.00011-10</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952980" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2952980</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/20930071" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20930071</a>.</span></div></li><li id="111" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, PiÃ±eros M, Znaor A, Bray F (April 2019). <a href="https://doi.org/10.1002%2Fijc.31937" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods&quot;</a>. <em>Int. J. Cancer</em>. <strong>144</strong> (8): 1941â€“1953. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Fijc.31937" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/ijc.31937</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/30350310" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">30350310</a>.</span></div></li><li id="112" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Meurer LN, Bower DJ (April 2002). &quot;Management of Helicobacter pylori infection&quot;. <em>Am Fam Physician</em>. <strong>65</strong> (7): 1327â€“36. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11996414" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11996414</a>.</span></div></li><li id="113" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Prabhu SR, Ranganathan S, Amarapurkar DN (November 1994). &quot;Helicobacter pylori in normal gastric mucosa&quot;. <em>J Assoc Physicians India</em>. <strong>42</strong> (11): 863â€“4. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/7868485" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">7868485</a>.</span></div></li><li id="114" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">White JR, Winter JA, Robinson K (2015). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540215" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Differential inflammatory response to Helicobacter pylori infection: etiology and clinical outcomes&quot;</a>. <em>J Inflamm Res</em>. <strong>8</strong> : 137â€“47. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.2147%2FJIR.S64888" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.2147/JIR.S64888</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540215" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4540215</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/26316793" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">26316793</a>.</span></div></li><li id="115" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Deng JY, Liang H (April 2014). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983452" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Clinical significance of lymph node metastasis in gastric cancer&quot;</a>. <em>World J. Gastroenterol</em>. <strong>20</strong> (14): 3967â€“75. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3748%2Fwjg.v20.i14.3967" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3748/wjg.v20.i14.3967</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983452" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3983452</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/24744586" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">24744586</a>.</span></div></li><li id="116" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Valenzuela MA, Canales J, CorvalÃ¡n AH, Quest AF (December 2015). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671030" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis&quot;</a>. <em>World J. Gastroenterol</em>. <strong>21</strong> (45): 12742â€“56. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3748%2Fwjg.v21.i45.12742" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3748/wjg.v21.i45.12742</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671030" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4671030</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/26668499" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">26668499</a>.</span></div></li><li id="117" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Raza Y, Khan A, Farooqui A, Mubarak M, Facista A, Akhtar SS, Khan S, Kazi JI, Bernstein C, Kazmi SU (2014). &quot;Oxidative DNA damage as a potential early biomarker of Helicobacter pylori associated carcinogenesis&quot;. <em>Pathol. Oncol. Res</em>. <strong>20</strong> (4): 839â€“46. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1007%2Fs12253-014-9762-1" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1007/s12253-014-9762-1</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/24664859" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">24664859</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:18727504" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18727504</a>.</span></div></li><li id="118" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Koeppel M, Garcia-Alcalde F, Glowinski F, Schlaermann P, Meyer TF (June 2015). <a href="https://doi.org/10.1016%2Fj.celrep.2015.05.030" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Helicobacter pylori Infection Causes Characteristic DNA Damage Patterns in Human Cells&quot;</a>. <em>Cell Rep</em>. <strong>11</strong> (11): 1703â€“13. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.celrep.2015.05.030" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.celrep.2015.05.030</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/26074077" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">26074077</a>.</span></div></li><li id="119" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Muhammad JS, Eladl MA, Khoder G (February 2019). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471032" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Helicobacter pylori-induced DNA Methylation as an Epigenetic Modulator of Gastric Cancer: Recent Outcomes and Future Direction&quot;</a>. <em>Pathogens</em>. <strong>8</strong> (1): 23. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3390%2Fpathogens8010023" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3390/pathogens8010023</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471032" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6471032</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/30781778" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">30781778</a>.</span></div></li><li id="120" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Noto JM, Peek RM (2011). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417373" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis&quot;</a>. <em>Front Cell Infect Microbiol</em>. <strong>1</strong> : 21. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3389%2Ffcimb.2011.00021" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3389/fcimb.2011.00021</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417373" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3417373</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22919587" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22919587</a>.</span></div></li><li id="121" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Santos JC, Ribeiro ML (August 2015). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533035" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Epigenetic regulation of DNA repair machinery in Helicobacter pylori-induced gastric carcinogenesis&quot;</a>. <em>World J. Gastroenterol</em>. <strong>21</strong> (30): 9021â€“37. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3748%2Fwjg.v21.i30.9021" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3748/wjg.v21.i30.9021</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533035" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4533035</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/26290630" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">26290630</a>.</span></div></li><li id="122" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Raza Y, Ahmed A, Khan A, Chishti AA, Akhter SS, Mubarak M, Bernstein C, Zaitlin B, Kazmi SU (February 2020). <a href="https://doi.org/10.1016%2Fj.dnarep.2020.102836" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Helicobacter pylori severely reduces expression of DNA repair proteins PMS2 and ERCC1 in gastritis and gastric cancer&quot;</a>. <em>DNA Repair (Amst.)</em>. <strong>89</strong> 102836. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.dnarep.2020.102836" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.dnarep.2020.102836</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/32143126" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">32143126</a>.</span></div></li><li id="123" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Dore MP, Pes GM, Bassotti G, Usai-Satta P (2016). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864555" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Dyspepsia: When and How to Test for Helicobacter pylori Infection&quot;</a>. <em>Gastroenterol Res Pract</em>. <strong>2016</strong> : 8463614. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1155%2F2016%2F8463614" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1155/2016/8463614</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864555" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4864555</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/27239194" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">27239194</a>.</span></div></li><li id="124" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Borchsenius, SN; Daks, A; Fedorova, O; Chernova, O; Barlev, NA (2018). &quot;Effects of mycoplasma infection on the host organism response via p53/NF-ÎºB signaling&quot;. <em>Journal of Cellular Physiology</em>. <strong>234</strong> (1): 171â€“180. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Fjcp.26781" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/jcp.26781</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/30146800" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">30146800</a>.</span></div></li><li id="125" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Carrillo-Infante C, Abbadessa G, Bagella L, Giordano A (June 2007). <a href="https://doi.org/10.3892%2Fijo.30.6.1521" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Viral infections as a cause of cancer (review)&quot;</a>. <em>International Journal of Oncology</em>. <strong>30</strong> (6): 1521â€“8. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3892%2Fijo.30.6.1521" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3892/ijo.30.6.1521</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17487374" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17487374</a>.</span></div></li><li id="126" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Safdar A (2011). <a href="https://books.google.com/books?id=TpWhwLCDWWsC&amp;pg=PA478" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Management of Infections in Cancer Patients</em></a>. Springer. p. 478. <span class="inline text-[1em] leading-7">ISBN</span> 978-1-60761-643-6.</span></div></li><li id="https://monographs.iarc.who.int/wp-content/uploads/2018/06/mono100B.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://monographs.iarc.who.int/wp-content/uploads/2018/06/mono100B.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://monographs.iarc.who.int/wp-content/uploads/2018/06/mono100B.pdf</a></span></div></li><li id="128" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Daniel FI, Cherubini K, Yurgel LS, de Figueiredo MA, Salum FG (February 2011). <a href="https://doi.org/10.1002%2Fcncr.25482" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The role of epigenetic transcription repression and DNA methyltransferases in cancer&quot;</a>. <em>Cancer</em>. <strong>117</strong> (4): 677â€“87. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Fcncr.25482" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/cncr.25482</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/20945317" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20945317</a>. Review.</span></div></li><li id="129" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kanwal R, Gupta S (April 2012). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590802" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Epigenetic modifications in cancer&quot;</a>. <em>Clinical Genetics</em>. <strong>81</strong> (4): 303â€“11. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fj.1399-0004.2011.01809.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/j.1399-0004.2011.01809.x</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590802" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3590802</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22082348" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22082348</a>.</span></div></li><li id="130" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Pattani KM, Soudry E, Glazer CA, Ochs MF, Wang H, Schussel J, Sun W, Hennessey P, Mydlarz W, Loyo M, Demokan S, Smith IM, Califano JA (2012). Tao Q (ed.). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454438" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinoma&quot;</a>. <em>PLOS ONE</em>. <strong>7</strong> (9): e45534. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2012PLoSO...745534P" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2012PLoSO...745534P</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1371%2Fjournal.pone.0045534" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1371/journal.pone.0045534</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454438" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3454438</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/23029077" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23029077</a>.</span></div></li><li id="131" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Sampath D, Liu C, Vasan K, Sulda M, Puduvalli VK, Wierda WG, Keating MJ (February 2012). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277352" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia&quot;</a>. <em>Blood</em>. <strong>119</strong> (5): 1162â€“72. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1182%2Fblood-2011-05-351510" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1182/blood-2011-05-351510</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277352" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3277352</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22096249" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22096249</a>.</span></div></li><li id="132" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Hitchler MJ, Oberley LW, Domann FE (December 2008). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633123" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells&quot;</a>. <em>Free Radical Biology &amp; Medicine</em>. <strong>45</strong> (11): 1573â€“80. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.freeradbiomed.2008.09.005" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.freeradbiomed.2008.09.005</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633123" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2633123</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18845242" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18845242</a>.</span></div></li><li id="133" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Baldassarre G, Battista S, Belletti B, Thakur S, Pentimalli F, Trapasso F, Fedele M, Pierantoni G, Croce CM, Fusco A (April 2003). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC150734" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma&quot;</a>. <em>Molecular and Cellular Biology</em>. <strong>23</strong> (7): 2225â€“38. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1128%2FMCB.23.7.2225-2238.2003" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1128/MCB.23.7.2225-2238.2003</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC150734" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">150734</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12640109" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12640109</a>.</span></div></li><li id="134" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Dalerba P, Cho RW, Clarke MF (2007). &quot;Cancer stem cells: models and concepts&quot;. <em>Annual Review of Medicine</em>. <strong>58</strong> : 267â€“84. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1146%2Fannurev.med.58.062105.204854" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1146/annurev.med.58.062105.204854</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17002552" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17002552</a>.</span></div></li><li id="67" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Nowell PC (October 1976). &quot;The clonal evolution of tumor cell populations&quot;. <em>Science</em>. <strong>194</strong> (4260): 23â€“8. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/1976Sci...194...23N" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1976Sci...194...23N</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1126%2Fscience.959840" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1126/science.959840</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/959840" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">959840</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:38445059" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">38445059</a>.</span></div></li><li id="135" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Zhang W, Hanks AN, Boucher K, Florell SR, Allen SM, Alexander A, Brash DE, Grossman D (January 2005). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292404" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;UVB-induced apoptosis drives clonal expansion during skin tumor development&quot;</a>. <em>Carcinogenesis</em>. <strong>26</strong> (1): 249â€“57. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1093%2Fcarcin%2Fbgh300" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1093/carcin/bgh300</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292404" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2292404</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15498793" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15498793</a>.</span></div></li><li id="68" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Merlo LM, Pepper JW, Reid BJ, Maley CC (December 2006). &quot;Cancer as an evolutionary and ecological process&quot;. <em>Nature Reviews. Cancer</em>. <strong>6</strong> (12): 924â€“35. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fnrc2013" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/nrc2013</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17109012" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17109012</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:8040576" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8040576</a>.</span></div></li></ol></div><div class="text-fg-secondary text-xs [&amp;_*]:mb-2"><hr class="border-border-l1 my-8 rounded-sm border-t"/>
<span class="mb-4 block break-words text-[1em] leading-7">The content is adapted from <a href="https://en.wikipedia.org/wiki/Carcinogenesis" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Wikipedia</a>, licensed under Creative Commons Attribution-ShareAlike 4.0 License.</span></div></div></div><div class="hidden min-[1400px]:block"></div></div></div><!--$--><!--/$--><div role="region" aria-label="Notifications (F8)" tabindex="-1" style="pointer-events:none"><ol tabindex="-1" class="pointer-events-none fixed top-0 z-[100] flex max-h-screen w-full flex-col-reverse p-4 max-sm:left-0 sm:bottom-0 sm:right-0 sm:top-auto sm:max-w-[420px] sm:flex-col pl-16 pr-2 pt-16 sm:px-4"></ol></div><script type="application/json" id="server-client-data-experimentation">{"status":"uninitialized"}</script><script src="/_next/static/chunks/webpack-e121ed42680f327e.js" nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm" id="_R_" async=""></script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">(self.__next_f=self.__next_f||[]).push([0])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"1:\"$Sreact.fragment\"\n3:I[91363,[],\"\"]\n4:I[23775,[],\"\"]\n5:I[57654,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"PageHeaderProvider\"]\n6:I[17618,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"HeaderContent\"]\n7:I[25529,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"6751\",\"static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js\"],\"default\"]\n9:I[6666,[],\"OutletBoundary\"]\nb:I[80415,[],\"AsyncMetadataOutlet\"]\nd:I[6666,[],\"ViewportBoundary\"]\nf:I[6666,[],\"MetadataBoundary\"]\n10:\"$Sreact.suspense\"\n12:I[95909,[\"4219\",\"static/chunks/app/global-error-4d07d20223cd4b4c.js\"],\"default\"]\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"13:I[51498,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"ConstantsProvider\"]\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"14:I[91073,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"15:I[38642,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"16:I[99648,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"17:I[78825,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"18:I[8550,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MixpanelProvider\"]\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"19:I[12290,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MobileTocProvider\"]\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"1a:I[53947,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"NuqsAdapter\"]\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"1b:I[91873,[\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8039\",\"static/chunks/app/error-4a29e9399afba038.js\"],\"default\"]\n1c:I[5091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"4345\",\"static/chunks/app/not-found-dd95690acf732f18.js\"],\"default\"]\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"1d:I[16091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,":HL[\"/_next/static/media/1f2316909698f815.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/3d4419af2cf8609b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/4dec29efcaeb336c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/74452ea3ef0f9101.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/904ef0a86fe32a00.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/d886a03bcda7ad8f.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/e1447589d6f59c4b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/f5a90156f8995c8c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/css/62c4caba71dfda84.css\",\"style\",{\"nonce\":\"ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm\"}]\n:HL[\"/_next/static/css/eb3d87f98fe1565f.css\",\"style\",{\"nonce\":\"ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm\"}]\n:HL[\"/_next/static/css/1b5e561215938d4d.css\",\"style\",{\"nonce\":\"ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm\"}]\n:HL[\"/_next/static/css/0227d069a630d414.css\",\"style\",{\"nonce\":\"ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm\"}]\n:HL[\"/_next/static/css/f87fff2ab93d05a7.css\",\"style\",{\"nonce\":\"ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm\"}]\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"0:{\"P\":null,\"b\":\"BpM29AX4fmgcUxZ_6t0le\",\"p\":\"\",\"c\":[\"\",\"page\",\"Carcinogenesis\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"page\",{\"children\":[[\"slug\",\"Carcinogenesis\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/62c4caba71dfda84.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/eb3d87f98fe1565f.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm\"}],[\"$\",\"link\",\"2\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/1b5e561215938d4d.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm\"}],[\"$\",\"link\",\"3\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/0227d069a630d414.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm\"}]],\"$L2\"]}],{\"children\":[\"page\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"Carcinogenesis\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L5\",null,{\"children\":[[\"$\",\"$L6\",null,{\"maxWidth\":\"full\",\"mobileOptions\":{\"right\":{\"showFixedIssues\":true,\"showThemeSwitcher\":true,\"showSearch\":true,\"showTableOfContents\":true}}}],[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L7\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$L8\",[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/f87fff2ab93d05a7.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm\"}]],[\"$\",\"$L9\",null,{\"children\":[\"$La\",[\"$\",\"$Lb\",null,{\"promise\":\"$@c\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$Ld\",null,{\"children\":\"$Le\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$Lf\",null,{\"children\":[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$10\",null,{\"fallback\":null,\"children\":\"$L11\"}]}]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$12\",[]],\"s\":false,\"S\":false}\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"2:[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"bg-surface-base antialiased\",\"suppressHydrationWarning\":true,\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"title\",null,{\"children\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"type\":\"image/x-icon\",\"href\":\"/favicon.ico\",\"sizes\":\"48x48\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-dark.png\",\"media\":\"(prefers-color-scheme: light)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-light.png\",\"media\":\"(prefers-color-scheme: dark)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"apple-touch-icon\",\"href\":\"/icon-192x192.png\"}],[\"$\",\"link\",null,{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\"}],[\"$\",\"meta\",null,{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",null,{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"meta\",null,{\"property\":\"og:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"property\":\"og:url\",\"content\":\"https://grokipedia.com\"}],[\"$\",\"meta\",null,{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:locale\",\"content\":\"en_US\"}],[\"$\",\"meta\",null,{\"property\":\"og:type\",\"content\":\"website\"}],[\"$\",\"meta\",null,{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:alt\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}]]}],[\"$\",\"body\",null,{\"className\":\"flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b\",\"children\":[[\"$\",\"$L13\",null,{\"children\":[\"$\",\"$L14\",null,{\"children\":[\"$\",\"$L15\",null,{\"defaultTheme\":\"dark\",\"nonce\":\"ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm\",\"children\":[\"$\",\"$L16\",null,{\"children\":[\"$\",\"$L17\",null,{\"children\":[\"$\",\"$L18\",null,{\"children\":[\"$\",\"$L19\",null,{\"children\":[\"$\",\"$L1a\",null,{\"children\":[[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$1b\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L1c\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}],[\"$\",\"$L1d\",null,{}]]}]}]}]}]}]}]}]}],[\"$\",\"script\",null,{\"type\":\"application/json\",\"id\":\"server-client-data-experimentation\",\"children\":\"{\\\"status\\\":\\\"uninitialized\\\"}\"}]]}]]}]\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"e:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1, interactive-widget=resizes-content\"}]]\na:null\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"1e:I[42712,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"HydrationBoundary\"]\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"21:I[6367,[],\"IconMark\"]\n1f:T106ab,"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"# Carcinogenesis\n\nCancers and tumors are caused by a series of mutations. Each mutation alters the behavior of the cell somewhat.\n\n**Carcinogenesis**, also called **oncogenesis** or **tumorigenesis**, is the formation of a cancer, whereby normal cells are transformed into cancer cells. The process is characterized by changes at the cellular, genetic, and epigenetic levels and abnormal cell division. Cell division is a physiological process that occurs in almost all tissues and under a variety of circumstances. Normally, the balance between proliferation and programmed cell death, in the form of apoptosis, is maintained to ensure the integrity of tissues and organs. According to the prevailing accepted theory of carcinogenesis, the somatic mutation theory, mutations in DNA and epimutations that lead to cancer disrupt these orderly processes by interfering with the programming regulating the processes, upsetting the normal balance between proliferation and cell death.[2][3][4][5] This results in uncontrolled cell division and the evolution of those cells by natural selection in the body. Only certain mutations lead to cancer whereas the majority of mutations do not. \n\nVariants of inherited genes may predispose individuals to cancer. In addition, environmental factors such as carcinogens and radiation cause mutations that may contribute to the development of cancer. Finally random mistakes in normal DNA replication may result in cancer-causing mutations.[6] A series of several mutations to certain classes of genes is usually required before a normal cell will transform into a cancer cell.[7][8][9][10][11] Recent comprehensive patient-level classification and quantification of driver events in TCGA cohorts revealed that there are on average 12 driver events per tumor, of which 0.6 are point mutations in oncogenes, 1.5 are amplifications of oncogenes, 1.2 are point mutations in tumor suppressors, 2.1 are deletions of tumor suppressors, 1.5 are driver chromosome losses, 1 is a driver chromosome gain, 2 are driver chromosome arm losses, and 1.5 are driver chromosome arm gains.[12] Mutations in genes that regulate cell division, apoptosis (cell death), and DNA repair may result in uncontrolled cell proliferation and cancer. \n\nCancer is fundamentally a disease of regulation of tissue growth. In order for a normal cell to transform into a cancer cell, genes that regulate cell growth and differentiation must be altered.[13] Genetic and epigenetic changes can occur at many levels, from gain or loss of entire chromosomes, to a mutation affecting a single DNA nucleotide, or to silencing or activating a microRNA that controls expression of 100 to 500 genes.[14][15] There are two broad categories of genes that are affected by these changes. Oncogenes may be normal genes that are expressed at inappropriately high levels, or altered genes that have novel properties. In either case, expression of these genes promotes the malignant phenotype of cancer cells. Tumor suppressor genes are genes that inhibit cell division, survival, or other properties of cancer cells. Tumor suppressor genes are often disabled by cancer-promoting genetic changes. Certain viruses, known as oncoviruses, can contribute to cancer by introducing or activating oncogenes or through other mechanisms, leading to viral transformation. It is also believed that cancer is caused due to chromosomal abnormalities as explained in chromosome theory of cancer.[16]\n# Causes\n\n## Genetic and epigenetic\n\nThere is a diverse classification scheme for the various genomic changes that may contribute to the generation of [cancer cells](Cancer_cell \"Cancer cell\"). Many of these changes are [mutations](Mutation \"Mutation\"), or changes in the [nucleotide](Nucleotide \"Nucleotide\") sequence of genomic DNA. There are also many epigenetic changes that alter whether genes are expressed or not expressed. [Aneuploidy](Aneuploidy \"Aneuploidy\"), the presence of an abnormal number of chromosomes, is one genomic change that is not a mutation, and may involve either gain or loss of one or more [chromosomes](Chromosomes \"Chromosomes\") through errors in [mitosis](Mitosis \"Mitosis\"). Large-scale mutations involve either the [deletion](Deletion_\\(genetics\\) \"Deletion \\(genetics\\)\") or [duplication](Gene_duplication \"Gene duplication\") of a portion of a chromosome. [Genomic amplification](Gene_duplication \"Gene duplication\") occurs when a cell gains many copies (often 20 or more) of a small chromosomal region, usually containing one or more oncogenes and adjacent genetic material. [Translocation](Chromosomal_translocation \"Chromosomal translocation\") occurs when two separate chromosomal regions become abnormally fused, often at a characteristic location. A well-known example of this is the [Philadelphia chromosome](Philadelphia_chromosome \"Philadelphia chromosome\"), or translocation of chromosomes 9 and 22, which occurs in [chronic myelogenous leukemia](Chronic_myelogenous_leukemia \"Chronic myelogenous leukemia\"), and results in production of the [BCR](BCR_gene \"BCR gene\")-[abl](Abl_gene \"Abl gene\") [fusion protein](Fusion_protein \"Fusion protein\"), an oncogenic [tyrosine kinase](Tyrosine_kinase \"Tyrosine kinase\"). Small-scale mutations include [point mutations](Point_mutations \"Point mutations\"), [deletions](Deletion_\\(genetics\\) \"Deletion \\(genetics\\)\"), and [insertions](Insertion_\\(genetics\\) \"Insertion \\(genetics\\)\"), which may occur in the [promoter](Promoter_\\(biology\\) \"Promoter \\(biology\\)\") of a gene and affect its [expression](Gene_expression \"Gene expression\"), or may occur in the gene's [coding sequence](Coding_sequence \"Coding sequence\") and alter the function or stability of its [protein](Protein \"Protein\") product. Disruption of a single gene may also result from [integration of genomic material](Provirus \"Provirus\") from a [DNA virus](DNA_virus \"DNA virus\") or [retrovirus](Retrovirus \"Retrovirus\"), and such an event may also result in the expression of viral oncogenes in the affected cell and its descendants. \n\n## DNA damage\n\nThe central role of DNA damage and epigenetic defects in DNA repair genes in carcinogenesis\n\nDNA damage is considered to be the primary cause of cancer.[17] More than 60,000 new naturally occurring instances of DNA damage arise, on average, per human cell, per day, due to endogenous cellular processes (see article [DNA damage (naturally occurring)](DNA_damage_\\(naturally_occurring\\) \"DNA damage \\(naturally occurring\\)\")). \n\nAdditional DNA damage can arise from exposure to [exogenous](Exogeny \"Exogeny\") agents. As one example of an [exogenous](Exogeny \"Exogeny\") carcinogenic agent, tobacco smoke causes increased DNA damage, and this DNA damage likely cause the increase of lung cancer due to smoking.[18] In other examples, UV light from solar radiation causes DNA damage that is important in [melanoma](Melanoma \"Melanoma\"),[19] *Helicobacter pylori* infection produces high levels of [reactive oxygen species](Reactive_oxygen_species \"Reactive oxygen species\") that damage DNA and contribute to [gastric cancer](Gastric_cancer \"Gastric cancer\"),[20] and the *Aspergillus flavus* metabolite [aflatoxin](Aflatoxin \"Aflatoxin\") is a DNA damaging agent that is causative in liver cancer.[21]\n\nDNA damage can also be caused by [substances produced in the body](Endogeny_\\(biology\\)#endogenous_substances \"Endogeny \\(biology\\)\"). Macrophages and neutrophils in an inflamed colonic epithelium are the source of reactive oxygen species causing the DNA damage that initiates colonic [tumorigenesis](Tumorigenesis \"Tumorigenesis\"),[22] and bile acids, at high levels in the colons of humans eating a high-fat diet, also cause DNA damage and contribute to colon cancer.[23]\n\nA deficiency in DNA repair would cause more DNA damage to accumulate, and increase the risk for cancer. For example, individuals with an inherited impairment in any of 34 [DNA repair genes](DNA_repair_genes \"DNA repair genes\") (see article [DNA repair-deficiency disorder](DNA_repair-deficiency_disorder \"DNA repair-deficiency disorder\")) are at increased risk of cancer, with some defects causing an up to 100% lifetime chance of cancer (e.g. [p53](P53 \"P53\") mutations).[24] Such [germline mutations](Germline_mutation \"Germline mutation\") are shown in a box at the left of the figure, with an indication of their contribution to DNA repair deficiency. However, such germline mutations (which cause highly [penetrant](Genetic_penetrance \"Genetic penetrance\") cancer syndromes) are the cause of only about *one percent* of cancers.[25]\n\nThe majority of cancers are called non-hereditary or \"sporadic cancers\". About 30% of sporadic cancers do have some hereditary component that is currently undefined, while the majority, or 70% of sporadic cancers, have no hereditary component.[26]\n\nIn sporadic cancers, a deficiency in DNA repair is occasionally due to a mutation in a DNA repair gene; much more frequently, reduced or absent expression of DNA repair genes is due to [epigenetic alterations](Epigenetic_alteration \"Epigenetic alteration\") that reduce or [silence gene expression](Gene_silencing \"Gene silencing\"). This is indicated in the figure at the 3rd level from the top. For example, for 113 colorectal cancers examined in sequence, only four had a [missense mutation](Missense_mutation \"Missense mutation\") in the DNA repair gene [MGMT](O-6-methylguanine-DNA_methyltransferase \"O-6-methylguanine-DNA methyltransferase\"), while the majority had reduced MGMT expression due to [methylation](DNA \"DNA\") of the MGMT [promoter region](Promoter_region \"Promoter region\") (an epigenetic alteration).[27]\n\nWhen expression of DNA repair genes is reduced, this causes a DNA repair deficiency. This is shown in the figure at the 4th level from the top. With a DNA repair deficiency, DNA damage persists in cells at a higher than typical level (5th level from the top in figure); this excess damage causes an increased frequency of mutation and/or [epimutation](Epimutation \"Epimutation\") (6th level from top of figure). Experimentally, mutation rates increase substantially in cells defective in [DNA mismatch repair](DNA_mismatch_repair \"DNA mismatch repair\")[28][29] or in [Homologous recombinational](Homologous_recombination \"Homologous recombination\") repair (HRR).[30] [Chromosomal rearrangements](Chromosomal_rearrangement \"Chromosomal rearrangement\") and [aneuploidy](Aneuploidy \"Aneuploidy\") also increase in HRR-defective cells[31] During repair of DNA double-strand breaks, or repair of other DNA damage, incompletely cleared repair sites can cause epigenetic gene silencing.[32][33]\n\nThe somatic mutations and epigenetic alterations caused by DNA damage and deficiencies in DNA repair accumulate in [field defects](Field_cancerization \"Field cancerization\"). Field defects are normal-appearing tissues with multiple alterations (discussed in the section below), and are common precursors to development of the disordered and over-proliferating clone of tissue in a cancer. Such field defects (second level from bottom of figure) may have numerous mutations and epigenetic alterations. \n\nIt is impossible to determine the initial cause for most specific cancers. In a few cases, only one cause exists: for example, the virus [HHV-8](HHV-8 \"HHV-8\") causes all [Kaposi's sarcomas](Kaposi's_sarcoma \"Kaposi's sarcoma\"). However, with the help of [cancer epidemiology](Cancer_epidemiology \"Cancer epidemiology\") techniques and information, it is possible to produce an estimate of a likely cause in many more situations. For example, [lung cancer](Lung_cancer \"Lung cancer\") has several causes, including tobacco use and [radon gas](Radon_gas \"Radon gas\"). Men who currently smoke tobacco develop lung cancer at a rate 14 times that of men who have never smoked tobacco: the chance of lung cancer in a current smoker being caused by smoking is about 93%; there is a 7% chance that the smoker's lung cancer was caused by radon gas or some other, non-tobacco cause.[34] These statistical correlations have made it possible for researchers to infer that certain substances or behaviors are carcinogenic. Tobacco smoke causes increased [exogenous](Exogeny \"Exogeny\") DNA damage, and this DNA damage is the likely cause of lung cancer due to smoking. Among the more than 5,000 compounds in tobacco smoke, the [genotoxic](Genotoxicity \"Genotoxicity\") DNA-damaging agents that occur both at the highest concentrations, and which have the strongest mutagenic effects are [acrolein](Acrolein \"Acrolein\"), [formaldehyde](Formaldehyde \"Formaldehyde\"), [acrylonitrile](Acrylonitrile \"Acrylonitrile\"), [1,3-butadiene](1%2C3-butadiene \"1,3-butadiene\"), [acetaldehyde](Acetaldehyde \"Acetaldehyde\"), [ethylene oxide](Ethylene_oxide \"Ethylene oxide\") and [isoprene](Isoprene \"Isoprene\").[18]\n\nUsing [molecular biological](Molecular_biology \"Molecular biology\") techniques, it is possible to characterize the mutations, epimutations or chromosomal aberrations within a tumor, and rapid progress is being made in the field of predicting certain cancer patients' [prognosis](Prognosis \"Prognosis\") based on the spectrum of mutations. For example, up to half of all tumors have a defective p53 gene. This mutation is associated with poor prognosis, since those tumor cells are less likely to go into [apoptosis](Apoptosis \"Apoptosis\") or [programmed cell death](Programmed_cell_death \"Programmed cell death\") when damaged by therapy. [Telomerase](Telomerase \"Telomerase\") mutations remove additional barriers, extending the number of times a cell can divide. Other mutations enable the tumor to [grow new blood vessels](Angiogenesis \"Angiogenesis\") to provide more nutrients, or to [metastasize](Metastasis \"Metastasis\"), spreading to other parts of the body. However, once a cancer is formed it continues to evolve and to produce sub-clones. It was reported in 2012 that a single renal cancer specimen, sampled in nine different areas, had 40 \"ubiquitous\" mutations, found in all nine areas, 59 mutations shared by some, but not all nine areas, and 29 \"private\" mutations only present in one area.[35]\n\nThe lineages of cells in which all these DNA alterations accumulate are difficult to trace, but two recent lines of evidence suggest that normal [stem cells](Stem_cell \"Stem cell\") may be the cells of origin in cancers.[36][37] First, there exists a highly positive correlation (Spearman's rho = 0.81; P \u003c 3.5 Ã— 10âˆ’8) between the risk of developing cancer in a tissue and the number of normal stem cell divisions taking place in that same tissue. The correlation applied to 31 cancer types and extended across five [orders of magnitude](Orders_of_magnitude \"Orders of magnitude\").[38] This correlation means that if normal stem cells from a tissue divide once, the cancer risk in that tissue is approximately 1X. If they divide 1,000 times, the cancer risk is 1,000X. And if the normal stem cells from a tissue divide 100,000 times, the cancer risk in that tissue is approximately 100,000X. This strongly suggests that the main factor in cancer initiation is the fact that \"normal\" stem cells divide, which implies that cancer originates in normal, healthy stem cells.[37]\n\nSecond, statistics show that most human cancers are diagnosed in older people. A possible explanation is that cancers occur because cells accumulate damage through time. DNA is the only cellular component that can accumulate damage over the entire course of a life, and stem cells are the only cells that can transmit DNA from the zygote to cells late in life. Other cells, derived from stem cells, do not keep DNA from the beginning of life until a possible cancer occurs. This implies that most cancers arise from normal stem cells.[36][37]\n\n## Contribution of field defects\n\nThe term \"[field cancerization](Field_cancerization \"Field cancerization\")\" was first used in 1953 to describe an area or \"field\" of epithelium that has been preconditioned by (at that time) largely unknown processes so as to predispose it towards development of cancer.[39] Since then, the terms \"field cancerization\" and \"field defect\" have been used to describe pre-malignant tissue in which new cancers are likely to arise. \n\nField defects have been identified in association with cancers and are important in progression to cancer.[40][41] However, it was pointed out by Rubin[42] that \"the vast majority of studies in cancer research has been done on well-defined tumors in vivo, or on discrete neoplastic foci in vitro. Yet there is evidence that more than 80% of the somatic mutations found in [mutator phenotype](Genomic_instability \"Genomic instability\") human colorectal tumors occur before the onset of terminal clonal expansionâ€¦\"[43] More than half of somatic mutations identified in tumors occurred in a pre-neoplastic phase (in a field defect), during growth of apparently normal cells. It would also be expected that many of the epigenetic alterations present in tumors may have occurred in pre-neoplastic field defects.[44]\n\nIn the colon, a field defect probably arises by natural selection of a mutant or epigenetically altered cell among the stem cells at the base of one of the [intestinal crypts](Intestinal_gland \"Intestinal gland\") on the inside surface of the colon. A mutant or epigenetically altered stem cell may replace the other nearby stem cells by natural selection. This may cause a patch of abnormal tissue to arise. Within this first large patch in the diagram (a large clone of cells), a second such mutation or epigenetic alteration may occur, so that a given stem cell acquires an advantage compared to its neighbors, and this altered stem cell may expand clonally, forming a secondary patch, or sub-clone, within the original patch. This is indicated in the diagram by four smaller patches of different colors within the large yellow original area. Within these new patches (sub-clones), the process may be repeated multiple times, indicated by the still smaller patches within the four secondary patches (with still different colors in the diagram) which clonally expand, until stem cells arise that generate either small polyps or else a malignant neoplasm (cancer). These neoplasms are also indicated (in the diagram below the photo) by 4 small tan circles (polyps) and a larger red area (cancer). The cancer in the photo occurred in the cecal area of the colon, where the colon joins the small intestine (labeled) and where the appendix occurs (labeled). The fat in the photo is external to the outer wall of the colon. In the segment of colon shown here, the colon was cut open lengthwise to expose its inner surface and to display the cancer and polyps occurring within the inner epithelial lining of the colon. \n\nIf the general process by which sporadic colon cancers arise is the formation of a pre-neoplastic clone that spreads by natural selection, followed by formation of internal sub-clones within the initial clone, and sub-sub-clones inside those, then colon cancers generally should be associated with, and be preceded by, fields of increasing abnormality, reflecting the succession of premalignant events. The most extensive region of abnormality (the outermost yellow irregular area in the diagram) would reflect the earliest event in formation of a malignant neoplasm. \n\nIn experimental evaluation of specific DNA repair deficiencies in cancers, many specific DNA repair deficiencies were also shown to occur in the field defects surrounding those cancers. The table below gives examples for which the DNA repair deficiency in a cancer was shown to be caused by an epigenetic alteration, and the somewhat lower frequencies with which the same epigenetically caused DNA repair deficiency was found in the surrounding field defect. \n\n**Frequency of epigenetic changes in DNA repair genes in sporadic cancers and in adjacent field defects**\n\n| Cancer       | Gene   | Frequency in Cancer | Frequency in Field Defect | Reference |\n|--------------|--------|---------------------|---------------------------|-----------|\n| Colorectal  | MGMT  | 46%                | 34%                      | [45]     |\n| Colorectal  | MGMT  | 47%                | 11%                      | [46]     |\n| Colorectal  | MGMT  | 70%                | 60%                      | [47]     |\n| Colorectal  | MSH2  | 13%                | 5%                       | [46]     |\n| Colorectal  | ERCC1 | 100%               | 40%                      | [48]     |\n| Colorectal  | PMS2  | 88%                | 50%                      | [48]     |\n| Colorectal  | XPF   | 55%                | 40%                      | [48]     |\n| Head and Neck | MGMT | 54%                | 38%                      | [49]     |\n| Head and Neck | MLH1 | 33%                | 25%                      | [50]     |\n| Head and Neck | MLH1 | 31%                | 20%                      | [51]     |\n| Stomach     | MGMT  | 88%                | 78%                      | [52]     |\n| Stomach     | MLH1  | 73%                | 20%                      | [53]     |\n| Esophagus   | MLH1  | 77%â€“100%           | 23%â€“79%                  | [54]     |\n\nSome of the small polyps in the field defect shown in the photo of the opened colon segment may be relatively benign neoplasms. In a 1996 study of polyps less than 10mm in size found during colonoscopy and followed with repeat colonoscopies for 3 years, 25% remained unchanged in size, 35% regressed or shrank in size and 40% grew in size.[55]\n\n## Genome instability\n\nCancers are known to exhibit [genome instability](Genome_instability \"Genome instability\") or a \"mutator phenotype\".[56] The protein-coding DNA within the nucleus is about 1.5% of the total genomic DNA.[57] Within this protein-coding DNA (called the [exome](Exome \"Exome\")), an average cancer of the breast or colon can have about 60 to 70 protein altering mutations, of which about 3 or 4 may be \"driver\" mutations, and the remaining ones may be \"passenger\" mutations.[44] However, the average number of DNA sequence mutations in the entire genome (including [non-protein-coding regions](Noncoding_DNA \"Noncoding DNA\")) within a breast cancer tissue sample is about 20,000.[58] In an average melanoma tissue sample (melanomas have a higher [exome](Exome \"Exome\") mutation frequency),[44]) the total number of DNA sequence mutations is about 80,000.[59] These high frequencies of mutations in the total nucleotide sequences within cancers suggest that often an early alteration in the field defect giving rise to a cancer (e.g. yellow area in the diagram in the preceding section) is a deficiency in DNA repair. Large field defects surrounding colon cancers (extending to about 10 cm on each side of a cancer) are found[48] to frequently have epigenetic defects in two or three DNA repair proteins ([ERCC1](ERCC1 \"ERCC1\"), [ERCC4](ERCC4 \"ERCC4\") (XPF) and/or [PMS2](PMS2 \"PMS2\")) in the entire area of the field defect. When expression of DNA repair genes is reduced, DNA damage accumulates in cells at a higher than normal rate, and this excess damage causes an increased frequency of mutation and/or epimutation. Mutation rates strongly increase in cells defective in [DNA mismatch repair](DNA_mismatch_repair \"DNA mismatch repair\")[28][29] or in [homologous recombinational](Homologous_recombination \"Homologous recombination\") repair (HRR).[30] A deficiency in DNA repair, itself, can allow DNA damage to accumulate, and error-prone [translesion synthesis](DNA_repair \"DNA repair\") of some of the damaged areas may give rise to mutations. In addition, faulty repair of this accumulated DNA damage may give rise to epimutations. These new mutations and/or epimutations may provide a proliferative advantage, generating a field defect. Although the mutations/epimutations in DNA repair genes do not, themselves, confer a selective advantage, they may be carried along as passengers in cells when the cell acquires an additional mutation/epimutation that does provide a proliferative advantage. \n\n## Non-mainstream theories\n\nThere are a number of theories of carcinogenesis and cancer treatment that fall outside the mainstream of scientific opinion, due to lack of scientific rationale, logic, or evidence base. These theories may be used to justify various alternative cancer treatments. They should be distinguished from those theories of carcinogenesis that have a logical basis within mainstream cancer biology, and from which conventionally testable hypotheses can be made. \n\nSeveral alternative theories of carcinogenesis, however, are based on scientific evidence and are increasingly being acknowledged. Some researchers believe that cancer may be caused by [aneuploidy](Aneuploidy \"Aneuploidy\") (numerical and structural abnormalities in chromosomes)[60] rather than by mutations or epimutations. Cancer has also been considered as a metabolic disease, in which the cellular metabolism of oxygen is diverted from the pathway that generates energy ([oxidative phosphorylation](Oxidative_phosphorylation \"Oxidative phosphorylation\")) to the pathway that generates [reactive oxygen species](Reactive_oxygen_species \"Reactive oxygen species\").[61] This causes an energy switch from oxidative phosphorylation to aerobic glycolysis ([Warburg effect](Warburg_effect_\\(oncology\\) \"Warburg effect \\(oncology\\)\")), and the accumulation of [reactive oxygen species](Reactive_oxygen_species \"Reactive oxygen species\") leading to [oxidative stress](Oxidative_stress \"Oxidative stress\") (\"oxidative stress theory of cancer\").[61] Another concept of cancer development is based on exposure to weak [magnetic](Magnetic_field \"Magnetic field\") and [electromagnetic fields](Electromagnetic_fields \"Electromagnetic fields\") and their effects on [oxidative stress](Oxidative_stress \"Oxidative stress\"), known as magnetocarcinogenesis.[62]\n\nA number of authors have questioned the assumption that cancers result from sequential random mutations as oversimplistic, suggesting instead that cancer results from a failure of the body to inhibit an innate, programmed proliferative tendency.[63] A related theory suggests that cancer is an [atavism](Atavism \"Atavism\"), an evolutionary throwback to an earlier form of [multicellular life](Multicellular_organism \"Multicellular organism\").[64] The genes responsible for uncontrolled cell growth and cooperation between [cancer cells](Cancer_cell \"Cancer cell\") are very similar to those that enabled the first multicellular life forms to group together and flourish. These genes still exist within the genomes of more complex [metazoans](Animal \"Animal\"), such as humans, although more recently evolved genes keep them in check. When the newer controlling genes fail for whatever reason, the cell can revert to its more primitive programming and reproduce out of control. The theory is an alternative to the notion that cancers begin with rogue cells that undergo evolution within the body. Instead, they possess a fixed number of primitive genes that are progressively activated, giving them finite variability.[65] Another evolutionary theory puts the roots of cancer back to the origin of the [eukaryote](Eukaryote \"Eukaryote\") (nucleated) cell by massive [horizontal gene transfer](Horizontal_gene_transfer \"Horizontal gene transfer\"), when the genomes of infecting viruses were cleaved (and thereby attenuated) by the host, but their fragments integrated into the host genome as immune protection. Cancer thus originates when a rare somatic mutation recombines such fragments into a functional driver of cell proliferation.[66]\n# Cancer cell biology\n\nTissue can be organized in a continuous spectrum from normal to cancer.\n\nOften, the multiple genetic changes that result in cancer may take many years to accumulate. During this time, the biological behavior of the pre-malignant cells slowly changes from the properties of normal cells to cancer-like properties. Pre-malignant tissue can have a distinctive appearance under the microscope. Among the distinguishing traits of a pre-malignant lesion are an increased number of dividing cells, variation in nuclear size and shape, variation in cell size and shape, loss of specialized cell features, and loss of normal tissue organization. Dysplasia is an abnormal type of excessive cell proliferation characterized by loss of normal tissue arrangement and cell structure in pre-malignant cells. These early neoplastic changes must be distinguished from hyperplasia, a reversible increase in cell division caused by an external stimulus, such as a hormonal imbalance or chronic irritation. \n\nThe most severe cases of dysplasia are referred to as _carcinoma in situ_. In Latin, the term _in situ_ means \"in place\"; _carcinoma in situ_ refers to an uncontrolled growth of dysplastic cells that remains in its original location and has not shown invasion into other tissues. Carcinoma in situ may develop into an invasive malignancy and is usually removed surgically when detected. \n\n## Clonal evolution\n\nJust as a population of animals undergoes [evolution](Evolution \"Evolution\"), an unchecked population of cells also can undergo \"evolution\". This undesirable process is called [somatic evolution](Somatic_evolution_in_cancer \"Somatic evolution in cancer\"), and is how cancer arises and becomes more malignant over time.[](https://www.science.org/doi/10.1126/science.959840)\n\nMost changes in cellular metabolism that allow cells to grow in a disorderly fashion lead to cell death. However, once cancer begins, [cancer cells](Cancer_cell \"Cancer cell\") undergo a process of [natural selection](Natural_selection \"Natural selection\"): the few cells with new genetic changes that enhance their survival or reproduction multiply faster, and soon come to dominate the growing tumor as cells with less favorable genetic change are out-competed.[](https://www.nature.com/articles/nrc2013) This is the same mechanism by which [pathogenic](Pathogen \"Pathogen\") species such as [MRSA](Methicillin-resistant_Staphylococcus_aureus \"Methicillin-resistant Staphylococcus aureus\") can become [antibiotic-resistant](Antibiotic_resistance \"Antibiotic resistance\") and by which [HIV](HIV \"HIV\") can become [drug-resistant](Drug_resistance \"Drug resistance\"), and by which plant diseases and insects can become [pesticide-resistant](Pesticide_resistance \"Pesticide resistance\"). This evolution explains why a cancer [relapse](Relapse \"Relapse\") often involves cells that have acquired [cancer-drug resistance](Somatic_evolution_in_cancer#Somatic_evolution_in_therapeutic_resistance \"Somatic evolution in cancer\") or resistance to [radiotherapy](Radiotherapy \"Radiotherapy\"). \n\n## Biological properties of cancer cells\n\nIn a 2000 article by [Hanahan](Douglas_Hanahan \"Douglas Hanahan\") and [Weinberg](Robert_Weinberg_\\(biologist\\) \"Robert Weinberg \\(biologist\\)\"), the biological properties of malignant tumor cells were summarized as follows:[](https://doi.org/10.1016%2FS0092-8674%2800%2981683-9)\n\n* Acquisition of self-sufficiency in [growth signals](Growth_factor \"Growth factor\"), leading to unchecked growth.\n* Loss of sensitivity to anti-growth signals, also leading to unchecked growth.\n* Loss of capacity for [apoptosis](Apoptosis \"Apoptosis\"), allowing growth despite genetic errors and external anti-growth signals.\n* Loss of capacity for [senescence](Senescence \"Senescence\"), leading to limitless replicative potential (immortality)\n* Acquisition of [sustained angiogenesis](The_Hallmarks_of_Cancer#Sustained_angiogenesis \"The Hallmarks of Cancer\"), allowing the tumor to grow beyond the limitations of passive nutrient diffusion.\n* Acquisition of the ability to invade tissue and metastasize to distant sites, the defining property of invasive carcinoma and a late-appearing property of some malignant tumors.\n\nSubsequent updates to the hallmarks framework in 2011 and 2022 have expanded this list to include additional capabilities such as evading immune destruction, enabling replicative immortality through genomic instability, and interactions with the tumor microenvironment including the microbiome.[](https://pubmed.ncbi.nlm.nih.gov/35022204/)\n\nThe completion of these multiple steps would be a very rare event without: \n\n* Loss of capacity to repair genetic errors, leading to an increased [mutation](Mutation \"Mutation\") rate (genomic instability), thus accelerating all the other changes.\n* Dramatic changes to [cell mechanics](Mechanobiology \"Mechanobiology\"), enabling metastatic dissemination.[](https://phys.org/news/2024-05-stiffness-viscosity-cells-differ-cancer.html)\n\nThese biological changes are classical in [carcinomas](Carcinoma \"Carcinoma\"); other malignant tumors may not need to achieve them all. For example, given that tissue invasion and displacement to distant sites are normal properties of [leukocytes](Leukocytes \"Leukocytes\"), these steps are not needed in the development of [leukemia](Leukemia \"Leukemia\"). Nor do the different steps necessarily represent individual mutations. For example, inactivation of a single gene, coding for the [p53](P53 \"P53\") protein, will cause genomic instability, evasion of apoptosis and increased angiogenesis. Further, not all the [cancer cells](Cancer_cell \"Cancer cell\") are dividing. Rather, a subset of the cells in a tumor, called [cancer stem cells](Cancer_stem_cell \"Cancer stem cell\"), replicate themselves as they generate differentiated cells.[](https://www.sciencedirect.com/science/article/pii/S0959437X07002512) Recent studies highlight the heterogeneity within cancer stem cell populations, contributing to tumor adaptability and resistance to therapies.[](https://aacrjournals.org/cancerdiscovery/article/14/4/674/741959/Cancer-Hallmarks-Piecing-the-Puzzle-Together)\n\n## Cancer as a defect in cell interactions\n\nNormally, once a tissue is injured or infected, damaged cells elicit inflammation by stimulating specific patterns of enzyme activity and cytokine gene expression in surrounding cells.[](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447318/)[](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942331/) Discrete clusters (\"cytokine clusters\") of molecules are secreted, which act as mediators, inducing the activity of subsequent cascades of biochemical changes.[](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207479/) Each cytokine binds to specific receptors on various cell types, and each cell type responds in turn by altering the activity of intracellular signal transduction pathways, depending on the receptors that the cell expresses and the signaling molecules present inside the cell.[](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658206/)[](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605511/) Collectively, this reprogramming process induces a stepwise change in cell phenotypes, which will ultimately lead to restoration of tissue function and toward regaining essential structural integrity.[](https://www.sciencedirect.com/science/article/pii/S193459091400219X)[](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605453/) A tissue can thereby heal, depending on the productive communication between the cells present at the site of damage and the immune system.[](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703146/) One key factor in healing is the regulation of cytokine gene expression, which enables complementary groups of cells to respond to inflammatory mediators in a manner that gradually produces essential changes in tissue physiology.[](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724264/)[](https://www.sciencedirect.com/science/article/pii/S135961011200140X)[](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597209/) Cancer cells have either permanent (genetic) or reversible (epigenetic) changes to their genome, which partly inhibit their communication with surrounding cells and with the immune system.[](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526340/)[](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643398/) Cancer cells do not communicate with their tissue microenvironment in a manner that protects tissue integrity; instead, the movement and the survival of cancer cells become possible in locations where they can impair tissue function.[](https://onlinelibrary.wiley.com/doi/10.1002/hep.27353)[](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653079/) Cancer cells survive by \"rewiring\" signal pathways that normally protect the tissue from the immune system. This alteration of the immune response is evident in early stages of malignancy too.[](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478943/)[](https://jitc.bmj.com/content/9/9/e002647)\n\nOne example of tissue function rewiring in cancer is the activity of transcription factor [NF-ÎºB](NF-%CE%BAB \"NF-ÎºB\").[](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526340/) NF-ÎºB activates the expression of numerous genes involved in the transition between inflammation and regeneration, which encode cytokines, adhesion factors, and other molecules that can change cell fate.[](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834864/) This reprogramming of cellular phenotypes normally allows the development of a fully functional intact tissue.[](https://onlinelibrary.wiley.com/doi/10.1002/cbf.3086) NF-ÎºB activity is tightly controlled by multiple proteins, which collectively ensure that only discrete clusters of genes are induced by NF-ÎºB in a given cell and at a given time.[](https://www.sciencedirect.com/science/article/pii/S1359610114001584) This tight regulation of signal exchange between cells protects the tissue from excessive inflammation, and ensures that different cell types gradually acquire complementary functions and specific positions. Failure of this mutual regulation between genetic reprogramming and cell interactions allows cancer cells to give rise to metastasis. Cancer cells respond aberrantly to cytokines, and activate signal cascades that can protect them from the immune system.[](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526340/)[](https://link.springer.com/article/10.1007/s12307-014-0147-5)\n# Mechanisms\n\nIn order for cells to start dividing uncontrollably, genes that regulate cell growth must be dysregulated.[97] [Proto-oncogenes](Proto-oncogene \"Proto-oncogene\") are genes that promote cell growth and [mitosis](Mitosis \"Mitosis\"), whereas [tumor suppressor genes](Tumor_suppressor_gene \"Tumor suppressor gene\") discourage cell growth, or temporarily halt cell division to carry out [DNA repair](DNA_repair \"DNA repair\"). Typically, a series of several [mutations](Mutation \"Mutation\") to these genes is required before a normal cell transforms into a [cancer cell](Cancer_cell \"Cancer cell\").[10] This concept is sometimes termed \"oncoevolution.\" Mutations to these genes provide the signals for tumor cells to start dividing uncontrollably. But the uncontrolled cell division that characterizes cancer also requires that the dividing cell duplicates all its cellular components to create two daughter cells. The activation of aerobic glycolysis (the [Warburg effect](Warburg_effect_\\(oncology\\) \"Warburg effect \\(oncology\\)\")), which is not necessarily induced by mutations in proto-oncogenes and tumor suppressor genes,[98] provides most of the building blocks required to duplicate the cellular components of a dividing cell and, therefore, is also essential for carcinogenesis.[61]\n\n### Oncogenes\n\n[Oncogenes](Oncogene \"Oncogene\") promote cell growth in a variety of ways. Many can produce [hormones](Hormone \"Hormone\"), a \"chemical messenger\" between cells that encourage [mitosis](Mitosis \"Mitosis\"), the effect of which depends on the [signal transduction](Signal_transduction \"Signal transduction\") of the receiving tissue or cells. In other words, when a hormone receptor on a recipient cell is stimulated, the signal is conducted from the surface of the cell to the [cell nucleus](Cell_nucleus \"Cell nucleus\") to affect some change in gene transcription regulation at the nuclear level. Some oncogenes are part of the signal transduction system itself, or the signal [receptors](Receptor_\\(biochemistry\\) \"Receptor \\(biochemistry\\)\") in cells and tissues themselves, thus controlling the sensitivity to such hormones. Oncogenes often produce [mitogens](Mitogen \"Mitogen\"), or are involved in [transcription](Transcription_\\(genetics\\) \"Transcription \\(genetics\\)\") of DNA in [protein synthesis](Protein_biosynthesis \"Protein biosynthesis\"), which creates the [proteins](Protein \"Protein\") and [enzymes](Enzyme \"Enzyme\") responsible for producing the products and [biochemicals](Biochemistry \"Biochemistry\") cells use and interact with. \n\nMutations in proto-oncogenes, which are the normally quiescent counterparts of [oncogenes](Oncogenes \"Oncogenes\"), can modify their [expression](Gene_expression \"Gene expression\") and function, increasing the amount or activity of the product protein. When this happens, the proto-oncogenes become [oncogenes](Oncogene \"Oncogene\"), and this transition upsets the normal balance of [cell cycle](Cell_cycle \"Cell cycle\") regulation in the cell, making uncontrolled growth possible. The chance of cancer cannot be reduced by removing proto-oncogenes from the [genome](Genome \"Genome\"), even if this were possible, as they are critical for the growth, repair, and [homeostasis](Homeostasis \"Homeostasis\") of the organism. It is only when they become mutated that the signals for growth become excessive. \n\nOne of the first [oncogenes](Oncogenes \"Oncogenes\") to be defined in [cancer research](Cancer_research \"Cancer research\") is the [ras oncogene](Ras_oncogene \"Ras oncogene\"). Mutations in the Ras family of [proto-oncogenes](Proto-oncogene \"Proto-oncogene\") (comprising H-Ras, N-Ras, and K-Ras) are very common, being found in 20% to 30% of all human tumors.[99] Ras was originally identified in the Harvey sarcoma virus genome, and researchers were surprised that not only is this gene present in the human genome but also when ligated to a stimulating control element, it could induce cancers in cell line cultures.[100] New mechanisms were proposed recently that the cell transformation during carcinogenesis was decided by the overall threshold of the oncogene networks (such as Ras signaling) but not by the status of the individual oncogene.[101]\n\n### Proto-oncogenes\n\nProto-oncogenes promote cell growth in a variety of ways. Many can produce [hormones](Hormone \"Hormone\"), \"chemical messengers\" between cells that encourage mitosis, the effect of which depends on the [signal transduction](Signal_transduction \"Signal transduction\") of the receiving tissue or cells. Some are responsible for the signal transduction system and signal [receptors](Receptor_\\(biochemistry\\) \"Receptor \\(biochemistry\\)\") in cells and tissues themselves, thus controlling the sensitivity to such hormones. They often produce [mitogens](Mitogen \"Mitogen\"), or are involved in [transcription](Transcription_\\(genetics\\) \"Transcription \\(genetics\\)\") of DNA in [protein synthesis](Protein_synthesis \"Protein synthesis\"), which create the [proteins](Protein \"Protein\") and [enzymes](Enzyme \"Enzyme\") responsible for producing the products and [biochemicals](Biochemistry \"Biochemistry\") cells use and interact with. \n\nMutations in proto-oncogenes can modify their [expression](Gene_expression \"Gene expression\") and function, increasing the amount or activity of the product protein. When this happens, they become [oncogenes](Oncogene \"Oncogene\"), and, thus, cells have a higher chance of dividing excessively and uncontrollably. The chance of cancer cannot be reduced by removing proto-oncogenes from the [genome](Genome \"Genome\"), as they are critical for growth, repair and [homeostasis](Homeostasis \"Homeostasis\") of the body. It is only when they become mutated that the signals for growth become excessive. It is important to note that a gene possessing a growth-promoting role may increase the carcinogenic potential of a cell, under the condition that all necessary cellular mechanisms that permit growth are activated.[102] This condition also includes the inactivation of specific tumor suppressor genes (see below). If the condition is not fulfilled, the cell may cease to grow and can proceed to die. This makes identification of the stage and type of [cancer cell](Cancer_cell \"Cancer cell\") that grows under the control of a given oncogene crucial for the development of treatment strategies. \n\n### Tumor suppressor genes\n\nMany tumor suppressor genes effect signal transduction pathways that regulate [apoptosis](Apoptosis \"Apoptosis\"), also known as \"programmed cell death\".\n\n[Tumor suppressor genes](Tumor_suppressor_gene \"Tumor suppressor gene\") code for anti-proliferation signals and proteins that suppress mitosis and cell growth. Generally, tumor suppressors are [transcription factors](Transcription_factor \"Transcription factor\") that are activated by cellular [stress](Stress_\\(medicine\\) \"Stress \\(medicine\\)\") or DNA damage. Often DNA damage will cause the presence of free-floating genetic material as well as other signs, and will trigger enzymes and pathways that lead to the activation of [tumor suppressor genes](Tumor_suppressor_genes \"Tumor suppressor genes\"). The functions of such genes is to arrest the progression of the cell cycle in order to carry out DNA repair, preventing mutations from being passed on to daughter cells. The [p53](P53 \"P53\") protein, one of the most important studied tumor suppressor genes, is a transcription factor activated by many cellular stressors including [hypoxia](Hypoxia_\\(medical\\) \"Hypoxia \\(medical\\)\") and [ultraviolet radiation](Ultraviolet_radiation \"Ultraviolet radiation\") damage. \n\nDespite nearly half of all cancers possibly involving alterations in p53, its tumor suppressor function is poorly understood. p53 clearly has two functions: one a nuclear role as a transcription factor, and the other a cytoplasmic role in regulating the cell cycle, cell division, and apoptosis. \n\nThe [Warburg effect](Warburg_effect_\\(oncology\\) \"Warburg effect \\(oncology\\)\") is the preferential use of glycolysis for energy to sustain cancer growth. p53 has been shown to regulate the shift from the respiratory to the glycolytic pathway.[103]\n\nHowever, a mutation can damage the tumor suppressor gene itself, or the signal pathway that activates it, \"switching it off\". The invariable consequence of this is that DNA repair is hindered or inhibited: DNA damage accumulates without repair, inevitably leading to cancer. \n\nMutations of tumor suppressor genes that occur in [germline](Germline \"Germline\") cells are passed along to [offspring](Offspring \"Offspring\"), and increase the likelihood for cancer diagnoses in subsequent generations. Members of these families have increased incidence and decreased latency of multiple tumors. The tumor types are typical for each type of tumor suppressor gene mutation, with some mutations causing particular cancers, and other mutations causing others. The mode of inheritance of mutant tumor suppressors is that an affected member inherits a defective copy from one parent, and a normal copy from the other. For instance, individuals who inherit one mutant _[p53](P53 \"P53\")_ allele (and are therefore [heterozygous](Heterozygote \"Heterozygote\") for mutated _p53_) can develop [melanomas](Melanomas \"Melanomas\") and [pancreatic cancer](Pancreatic_cancer \"Pancreatic cancer\"), known as [Li-Fraumeni syndrome](Li-Fraumeni_syndrome \"Li-Fraumeni syndrome\"). Other inherited tumor suppressor gene syndromes include _[Rb](Retinoblastoma_protein \"Retinoblastoma protein\")_ mutations, linked to [retinoblastoma](Retinoblastoma \"Retinoblastoma\"), and _[APC](Familial_adenomatous_polyposis#Genetics \"Familial adenomatous polyposis\")_ gene mutations, linked to [adenopolyposis colon cancer](Familial_adenomatous_polyposis \"Familial adenomatous polyposis\"). Adenopolyposis colon cancer is associated with thousands of polyps in colon while young, leading to [colon cancer](Colorectal_cancer \"Colorectal cancer\") at a relatively early age. Finally, inherited mutations in _[BRCA1](BRCA1 \"BRCA1\")_ and _[BRCA2](BRCA2 \"BRCA2\")_ lead to early onset of [breast cancer](Breast_cancer \"Breast cancer\"). \n\nDevelopment of cancer was proposed in 1971 to depend on at least two mutational events. In what became known as the [Knudson](Alfred_G._Knudson \"Alfred G. Knudson\") [two-hit hypothesis](Knudson_hypothesis \"Knudson hypothesis\"), an inherited, germ-line mutation in a [tumor suppressor gene](Tumor_suppressor_gene \"Tumor suppressor gene\") would cause cancer only if another mutation event occurred later in the organism's life, inactivating the other [allele](Allele \"Allele\") of that [tumor suppressor gene](Tumor_suppressor_gene \"Tumor suppressor gene\").[104]\n\nUsually, oncogenes are [dominant](Dominant_gene \"Dominant gene\"), as they contain [gain-of-function mutations](Gain-of-function_mutation \"Gain-of-function mutation\"), while mutated tumor suppressors are [recessive](Recessive_gene \"Recessive gene\"), as they contain [loss-of-function mutations](Loss-of-function_mutation \"Loss-of-function mutation\"). Each cell has two copies of the same gene, one from each parent, and under most cases gain of function mutations in just one copy of a particular proto-oncogene is enough to make that gene a true oncogene. On the other hand, loss of function mutations need to happen in both copies of a tumor suppressor gene to render that gene completely non-functional. However, cases exist in which one mutated copy of a [tumor suppressor gene](Tumor_suppressor_gene \"Tumor suppressor gene\") can render the other, [wild-type](Wild-type \"Wild-type\") copy non-functional. This phenomenon is called the _dominant negative effect_ and is observed in many p53 mutations. \n\nKnudson's two hit model has recently been challenged by several investigators. Inactivation of one allele of some tumor suppressor genes is sufficient to cause tumors. This phenomenon is called [haploinsufficiency](Haploinsufficiency \"Haploinsufficiency\") and has been demonstrated by a number of experimental approaches. Tumors caused by [haploinsufficiency](Haploinsufficiency \"Haploinsufficiency\") usually have a later age of onset when compared with those by a two hit process.[105]\n\n### Multiple mutations\n\nMultiple mutations in [cancer cells](Cancer_cell \"Cancer cell\")\n\nIn general, mutations in both types of genes are required for cancer to occur. For example, a mutation limited to one oncogene would be suppressed by normal mitosis control and tumor suppressor genes, first [hypothesised](Hypothesis \"Hypothesis\") by the [Knudson hypothesis](Knudson_hypothesis \"Knudson hypothesis\").[8] A mutation to only one tumor suppressor gene would not cause cancer either, due to the presence of many \"[backup](Backup \"Backup\")\" genes that duplicate its functions. It is only when enough proto-oncogenes have mutated into oncogenes, and enough tumor suppressor genes deactivated or damaged, that the signals for cell growth overwhelm the signals to regulate it, that cell growth quickly spirals out of control.[10] Often, because these genes regulate the processes that prevent most damage to genes themselves, the rate of mutations increases as one gets older, because DNA damage forms a [feedback](Feedback \"Feedback\") loop. \n\nMutation of tumor suppressor genes that are passed on to the next generation of not merely cells, but their [offspring](Offspring \"Offspring\"), can cause increased likelihoods for cancers to be inherited. Members within these families have increased incidence and decreased latency of multiple tumors. The mode of inheritance of mutant tumor suppressors is that affected member inherits a defective copy from one parent, and a normal copy from another. Because mutations in tumor suppressors act in a recessive manner (note, however, there are exceptions), the loss of the normal copy creates the cancer [phenotype](Phenotype \"Phenotype\"). For instance, individuals that are [heterozygous](Heterozygote \"Heterozygote\") for p53 mutations are often victims of [Li-Fraumeni syndrome](Li-Fraumeni_syndrome \"Li-Fraumeni syndrome\"), and that are heterozygous for [Rb](Retinoblastoma_protein \"Retinoblastoma protein\") mutations develop [retinoblastoma](Retinoblastoma \"Retinoblastoma\"). In similar fashion, mutations in the [adenomatous polyposis coli](Familial_adenomatous_polyposis#Genetics \"Familial adenomatous polyposis\") gene are linked to [adenopolyposis colon cancer](Familial_adenomatous_polyposis \"Familial adenomatous polyposis\"), with thousands of polyps in the colon while young, whereas mutations in [BRCA1](BRCA1 \"BRCA1\") and [BRCA2](BRCA2 \"BRCA2\") lead to early onset of [breast cancer](Breast_cancer \"Breast cancer\"). \n\nA new idea announced in 2011 is an extreme version of multiple mutations, called _[chromothripsis](Chromothripsis \"Chromothripsis\")_ by its proponents. This idea, affecting only 2â€“3% of cases of cancer, although up to 25% of bone cancers, involves the catastrophic shattering of a chromosome into tens or hundreds of pieces and then being patched back together incorrectly. This shattering probably takes place when the chromosomes are compacted during [normal cell division](Mitosis \"Mitosis\"), but the trigger for the shattering is unknown. Under this model, cancer arises as the result of a single, isolated event, rather than the slow accumulation of multiple mutations. [106]\n\n### Non-mutagenic carcinogens\n\nMany [mutagens](Mutagen \"Mutagen\") are also [carcinogens](Carcinogen \"Carcinogen\"), but some carcinogens are not mutagens. Examples of carcinogens that are not mutagens include [alcohol](Alcohol_\\(drug\\) \"Alcohol \\(drug\\)\") and [estrogen](Estrogen \"Estrogen\"). These are thought to promote cancers through their stimulating effect on the rate of cell [mitosis](Mitosis \"Mitosis\"). Faster rates of mitosis increasingly leave fewer opportunities for repair enzymes to repair damaged DNA during [DNA replication](DNA_replication \"DNA replication\"), increasing the likelihood of a genetic mistake. A mistake made during mitosis can lead to the daughter cells' receiving the wrong number of [chromosomes](Chromosomes \"Chromosomes\"), which leads to [aneuploidy](Aneuploidy \"Aneuploidy\") and may lead to cancer. \n\n### Role of infections\n\n#### Bacterial\n\n_Helicobacter pylori_ can cause [gastric cancer](Stomach_cancer \"Stomach cancer\"). Although the data varies between different countries, overall about 1% to 3% of people infected with _Helicobacter pylori_ develop gastric cancer in their lifetime compared to 0.13% of individuals who have had no _H. pylori_ infection.[107][108] _H. pylori_ infection is very prevalent. As evaluated in 2002, it is present in the gastric tissues of 74% of middle-aged adults in developing countries and 58% in developed countries.[109] Since 1% to 3% of infected individuals are likely to develop gastric cancer,[110] _H. pylori_ -induced gastric cancer is the third highest cause of worldwide cancer mortality as of 2018.[111]\n\nInfection by _H. pylori_ causes no symptoms in about 80% of those infected.[112] About 75% of individuals infected with _H. pylori_ develop [gastritis](Gastritis \"Gastritis\").[113] Thus, the usual consequence of _H. pylori_ infection is chronic asymptomatic gastritis.[114] Because of the usual lack of symptoms, when gastric cancer is finally diagnosed it is often fairly advanced. More than half of gastric cancer patients have lymph node metastasis when they are initially diagnosed.[115]\n\nThe gastritis caused by _H. pylori_ is accompanied by [inflammation](Inflammation \"Inflammation\"), characterized by infiltration of [neutrophils](Neutrophil \"Neutrophil\") and [macrophages](Macrophage \"Macrophage\") to the gastric epithelium, which favors the accumulation of [pro-inflammatory cytokines](Inflammatory_cytokine \"Inflammatory cytokine\") and [reactive oxygen species](Reactive_oxygen_species \"Reactive oxygen species\")/[reactive nitrogen species](Reactive_nitrogen_species \"Reactive nitrogen species\") (ROS/RNS).[116] The substantial presence of ROS/RNS causes DNA damage including [8-oxo-2'-deoxyguanosine](8-oxo-2'-deoxyguanosine \"8-oxo-2'-deoxyguanosine\") (8-OHdG).[116] If the infecting _H. pylori_ carry the cytotoxic [cagA](CagA \"CagA\") gene (present in about 60% of Western isolates and a higher percentage of Asian isolates), they can increase the level of 8-OHdG in gastric cells by 8-fold, while if the _H. pylori_ do not carry the cagA gene, the increase in 8-OHdG is about 4-fold.[117] In addition to the [oxidative DNA damage](DNA_oxidation \"DNA oxidation\") 8-OHdG, _H. pylori_ infection causes other characteristic DNA damages including DNA double-strand breaks.[118]\n\n_H. pylori_ also causes many [epigenetic](Cancer_epigenetics \"Cancer epigenetics\") alterations linked to cancer development.[119][120] These [epigenetic](Cancer_epigenetics \"Cancer epigenetics\") alterations are due to _H. pylori_ -induced [methylation of CpG sites in promoters of genes](CpG_site#Promoter_CpG_hyper/hypo-methylation_in_cancer \"CpG site\")[119] and _H. pylori_ -induced altered expression of multiple [microRNAs](MicroRNA \"MicroRNA\").[120]\n\nAs reviewed by Santos and Ribeiro[121] _H. pylori_ infection is associated with epigenetically reduced efficiency of the DNA repair machinery, which favors the accumulation of mutations and genomic instability as well as gastric carcinogenesis. In particular, Raza et al.[122] showed that expression of two DNA repair proteins, [ERCC1](ERCC1 \"ERCC1\") and [PMS2](PMS2 \"PMS2\"), was severely reduced once _H. pylori_ infection had progressed to cause [dyspepsia](Indigestion \"Indigestion\"). Dyspepsia occurs in about 20% of infected individuals.[123] In addition, as reviewed by Raza et al.,[122] human gastric infection with _H. pylori_ causes epigenetically reduced protein expression of DNA repair proteins [MLH1](MLH1 \"MLH1\"), [MGMT](O-6-methylguanine-DNA_methyltransferase \"O-6-methylguanine-DNA methyltransferase\") and [MRE11](MRE11A \"MRE11A\"). Reduced DNA repair in the presence of increased DNA damage increases carcinogenic mutations and is likely a significant cause of _H. pylori_ carcinogenesis. \n\nOther bacteria might also play a role in carcinogenesis. Checkpoint control of the [cell cycle](Cell_cycle \"Cell cycle\") and [apoptosis](Apoptosis \"Apoptosis\") by [p53](P53 \"P53\") is inhibited by the [mycoplasma](Mycoplasma \"Mycoplasma\") bacterium,[124] allowing cells with [DNA damage](DNA_damage_\\(naturally_occurring\\) \"DNA damage \\(naturally occurring\\)\") to \"run an apoptotic red light\" and proceed through the cell cycle. \n\n#### Viral\n\nFurthermore, many cancers originate from a [viral](Virus \"Virus\") [infection](Infection \"Infection\"); this is especially true in animals such as [birds](Bird \"Bird\"), but less so in [humans](Human \"Human\"). 12% of human cancers can be attributed to a viral infection.[125] The mode of virally induced tumors can be divided into two, _acutely transforming_ or _slowly transforming_. In acutely transforming viruses, the viral particles carry a gene that encodes for an overactive oncogene called viral-oncogene (v-onc), and the infected cell is transformed as soon as v-onc is expressed. In contrast, in slowly transforming viruses, the virus genome is inserted, especially as viral genome insertion is an obligatory part of [retroviruses](Retrovirus \"Retrovirus\"), near a proto-oncogene in the host genome. The viral [promoter](Promoter_\\(biology\\) \"Promoter \\(biology\\)\") or other transcription regulation elements, in turn, cause over-expression of that proto-oncogene, which, in turn, induces uncontrolled cellular proliferation. Because viral genome insertion is not specific to proto-oncogenes and the chance of insertion near that proto-oncogene is low, slowly transforming viruses have very long tumor latency compared to acutely transforming virus, which already carries the viral-oncogene. \n\nViruses that are known to cause cancer such as [HPV](HPV \"HPV\") ([cervical cancer](Cervical_cancer \"Cervical cancer\")), [Hepatitis B](Hepatitis_B \"Hepatitis B\") ([liver cancer](Liver_cancer \"Liver cancer\")), and [EBV](Epstein-Barr_virus \"Epstein-Barr virus\") (a type of [lymphoma](Lymphoma \"Lymphoma\")), are all DNA viruses. It is thought that when the virus infects a cell, it inserts a part of its own DNA near the cell growth genes, causing cell division. The group of changed cells that are formed from the first cell dividing all have the same viral DNA near the cell growth genes. The group of changed cells are now special because one of the normal controls on growth has been lost. \n\nDepending on their location, cells can be damaged through radiation, chemicals from cigarette smoke, and inflammation from bacterial infection or other viruses. Each cell has a chance of damage. Cells often die if they are damaged, through failure of a vital process or the immune system, however, sometimes damage will knock out a single cancer gene. In an old person, there are thousands, tens of thousands, or hundreds of thousands of knocked-out cells. The chance that any one would form a cancer is very low. \n\nWhen the damage occurs in any area of changed cells, something different occurs. Each of the cells has the potential for growth. The changed cells will divide quicker when the area is damaged by physical, chemical, or viral agents. A [vicious circle](Vicious_circle \"Vicious circle\") has been set up: Damaging the area will cause the changed cells to divide, causing a greater likelihood that they will experience knock-outs. \n\nThis model of carcinogenesis is popular because it explains why cancers grow. It would be expected that cells that are damaged through radiation would die or at least be worse off because they have fewer genes working; viruses increase the number of genes working. \n\nOne thought is that we may end up with thousands of vaccines to prevent every virus that can change our cells. Viruses can have different effects on different parts of the body. It may be possible to prevent a number of different cancers by immunizing against one viral agent. It is likely that HPV, for instance, has a role in cancers of the mucous membranes of the mouth. \n\n#### Helminthiasis\n\nCertain parasitic worms are known to be carcinogenic.[126] These include: \n\n* _[Clonorchis sinensis](Clonorchis_sinensis \"Clonorchis sinensis\")_ (the organism causing [Clonorchiasis](Clonorchiasis \"Clonorchiasis\")) and _[Opisthorchis viverrini](Opisthorchis_viverrini \"Opisthorchis viverrini\")_ (causing [Opisthorchiasis](Opisthorchiasis \"Opisthorchiasis\")) are associated with [cholangiocarcinoma](Cholangiocarcinoma \"Cholangiocarcinoma\").[](https://monographs.iarc.who.int/wp-content/uploads/2018/06/mono100B.pdf)\n* _[Schistosoma](Schistosoma \"Schistosoma\") species_ (the organisms causing [Schistosomiasis](Schistosomiasis \"Schistosomiasis\")) is associated with [bladder cancer](Bladder_cancer \"Bladder cancer\").[](https://monographs.iarc.who.int/wp-content/uploads/2018/06/mono100B.pdf)\n\n### Epigenetics\n\n[Epigenetics](Epigenetic \"Epigenetic\") is the study of the regulation of gene expression through chemical, non-mutational changes in DNA structure. The theory of [epigenetics](Epigenetics \"Epigenetics\") in cancer pathogenesis is that non-mutational changes to DNA can lead to alterations in gene expression. Normally, [oncogenes](Oncogenes \"Oncogenes\") are silent, for example, because of [DNA methylation](DNA_methylation \"DNA methylation\"). Loss of that methylation can induce the aberrant expression of [oncogenes](Oncogenes \"Oncogenes\"), leading to cancer pathogenesis. Known mechanisms of epigenetic change include [DNA methylation](DNA_methylation \"DNA methylation\"), and methylation or acetylation of [histone](Histone \"Histone\") proteins bound to chromosomal DNA at specific locations. Classes of medications, known as [HDAC inhibitors](Histone_deacetylase_inhibitor \"Histone deacetylase inhibitor\") and [DNA methyltransferase](DNA_methyltransferase \"DNA methyltransferase\") inhibitors, can re-regulate the epigenetic signaling in the [cancer cell](Cancer_cell \"Cancer cell\"). \n\n[Epimutations](Epigenetics \"Epigenetics\") include methylations or demethylations of the [CpG islands](CpG_island \"CpG island\") of the [promoter](Promoter_\\(genetics\\) \"Promoter \\(genetics\\)\") regions of genes, which result in repression or de-repression, respectively of gene expression.[128][129][130] Epimutations can also occur by acetylation, methylation, phosphorylation or other alterations to histones, creating a [histone code](Histone_code \"Histone code\") that represses or activates gene expression, and such histone epimutations can be important epigenetic factors in cancer.[131][132] In addition, carcinogenic epimutation can occur through alterations of chromosome architecture caused by proteins such as [HMGA2](HMGA2 \"HMGA2\").[133] A further source of epimutation is due to increased or decreased expression of [microRNAs](MicroRNA \"MicroRNA\") (miRNAs). For example, extra expression of miR-137 can cause downregulation of expression of 491 genes, and miR-137 is epigenetically silenced in 32% of colorectal cancers\u003e[15]\n\n### Cancer stem cells\n\nA new way of looking at carcinogenesis comes from integrating the ideas of [developmental biology](Developmental_biology \"Developmental biology\") into [oncology](Oncology \"Oncology\"). The [cancer stem cell](Cancer_stem_cell \"Cancer stem cell\") [hypothesis](Hypothesis \"Hypothesis\") proposes that the different kinds of cells in a [heterogeneous](Heterogeneous \"Heterogeneous\") tumor arise from a single cell, termed Cancer Stem Cell. Cancer stem cells may arise from transformation of [adult stem cells](Adult_stem_cell \"Adult stem cell\") or [differentiated](Cellular_differentiation \"Cellular differentiation\") cells within a body. These cells persist as a subcomponent of the tumor and retain key stem cell properties. They give rise to a variety of cells, are capable of self-renewal and [homeostatic](Homeostatic \"Homeostatic\") control.[134] Furthermore, the [relapse](Relapse \"Relapse\") of cancer and the emergence of [metastasis](Metastasis \"Metastasis\") are also attributed to these cells. The [cancer stem cell](Cancer_stem_cell \"Cancer stem cell\") [hypothesis](Hypothesis \"Hypothesis\") does not contradict earlier concepts of carcinogenesis. The cancer stem cell hypothesis has been a proposed mechanism that contributes to [tumour heterogeneity](Tumour_heterogeneity \"Tumour heterogeneity\"). \n\n### Clonal evolution\n\nWhile genetic and [epigenetic](Epigenetic \"Epigenetic\") alterations in tumor suppressor genes and oncogenes change the behavior of cells, those alterations, in the end, result in cancer through their effects on the population of [neoplastic](Neoplasm \"Neoplasm\") cells and their microenvironment.[67] Mutant cells in neoplasms compete for space and resources. Thus, a clone with a mutation in a tumor suppressor gene or oncogene will expand only in a neoplasm if that mutation gives the clone a competitive advantage over the other clones and normal cells in its microenvironment.[135] Thus, the process of carcinogenesis is formally a process of Darwinian [evolution](Evolution \"Evolution\"), known as [somatic or clonal evolution](Somatic_evolution_in_cancer \"Somatic evolution in cancer\").[68]"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"8:[\"$\",\"$L1e\",null,{\"state\":{\"mutations\":[],\"queries\":[{\"dehydratedAt\":1761884116576,\"state\":{\"data\":{\"page\":{\"citations\":[{\"id\":\"1\",\"title\":\"** MajÃ©rus, Marie-Ange (1 July 2022). [\\\"The cause of cancer: The unifying theory\\\"](https://doi.org/10.1016%2Fj.adcanc.2022.100034). _Advances in Cancer Biology - Metastasis_. **4** 100034\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.adcanc.2022.100034](https://doi.org/10.1016%2Fj.adcanc.2022.100034). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [2667-3940](https://search.worldcat.org/issn/2667-3940). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [247145082](https://api.semanticscholar.org/CorpusID:247145082).\",\"description\":\"1. **^** MajÃ©rus, Marie-Ange (1 July 2022). [\\\"The cause of cancer: The unifying theory\\\"](https://doi.org/10.1016%2Fj.adcanc.2022.100034). _Advances in Cancer Biology - Metastasis_. **4** 100034\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.adcanc.2022.100034](https://doi.org/10.1016%2Fj.adcanc.2022.100034). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [2667-3940](https://search.worldcat.org/issn/2667-3940). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [247145082](https://api.semanticscholar.org/CorpusID:247145082).\",\"url\":\"https://doi.org/10.1016%2Fj.adcanc.2022.100034\",\"favicon\":\"\"},{\"id\":\"2\",\"title\":\"** Nowell, Peter C. (1 October 1976). [\\\"The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression\\\"](https://www.science.org/doi/10.1126/science.959840). _Science_. **194** (4260): 23â€“28\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1976Sci...194...23N](https://ui.adsabs.harvard.edu/abs/1976Sci...194...23N). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.959840](https://doi.org/10.1126%2Fscience.959840). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0036-8075](https://search.worldcat.org/issn/0036-8075). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [959840](https://pubmed.ncbi.nlm.nih.gov/959840). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [38445059](https://api.semanticscholar.org/CorpusID:38445059).\",\"description\":\"2. **^** Nowell, Peter C. (1 October 1976). [\\\"The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression\\\"](https://www.science.org/doi/10.1126/science.959840). _Science_. **194** (4260): 23â€“28\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1976Sci...194...23N](https://ui.adsabs.harvard.edu/abs/1976Sci...194...23N). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.959840](https://doi.org/10.1126%2Fscience.959840). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0036-8075](https://search.worldcat.org/issn/0036-8075). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [959840](https://pubmed.ncbi.nlm.nih.gov/959840). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [38445059](https://api.semanticscholar.org/CorpusID:38445059).\",\"url\":\"https://www.science.org/doi/10.1126/science.959840\",\"favicon\":\"\"},{\"id\":\"3\",\"title\":\"** Hanahan, Douglas; Weinberg, Robert A (7 January 2000). [\\\"The Hallmarks of Cancer\\\"](https://doi.org/10.1016%2Fs0092-8674%2800%2981683-9). _Cell_. **100** (1): 57â€“70\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/s0092-8674(00)81683-9](https://doi.org/10.1016%2Fs0092-8674%2800%2981683-9). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0092-8674](https://search.worldcat.org/issn/0092-8674). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10647931](https://pubmed.ncbi.nlm.nih.gov/10647931). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [1478778](https://api.semanticscholar.org/CorpusID:1478778).\",\"description\":\"3. **^** Hanahan, Douglas; Weinberg, Robert A (7 January 2000). [\\\"The Hallmarks of Cancer\\\"](https://doi.org/10.1016%2Fs0092-8674%2800%2981683-9). _Cell_. **100** (1): 57â€“70\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/s0092-8674(00)81683-9](https://doi.org/10.1016%2Fs0092-8674%2800%2981683-9). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0092-8674](https://search.worldcat.org/issn/0092-8674). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10647931](https://pubmed.ncbi.nlm.nih.gov/10647931). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [1478778](https://api.semanticscholar.org/CorpusID:1478778).\",\"url\":\"https://doi.org/10.1016%2Fs0092-8674%2800%2981683-9\",\"favicon\":\"\"},{\"id\":\"4\",\"title\":\"** Hahn, William C.; Weinberg, Robert A. (14 November 2002). [\\\"Rules for Making Human Tumor Cells\\\"](http://www.nejm.org/doi/abs/10.1056/NEJMra021902). _New England Journal of Medicine_. **347** (20): 1593â€“1603\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMra021902](https://doi.org/10.1056%2FNEJMra021902). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0028-4793](https://search.worldcat.org/issn/0028-4793). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12432047](https://pubmed.ncbi.nlm.nih.gov/12432047).\",\"description\":\"4. **^** Hahn, William C.; Weinberg, Robert A. (14 November 2002). [\\\"Rules for Making Human Tumor Cells\\\"](http://www.nejm.org/doi/abs/10.1056/NEJMra021902). _New England Journal of Medicine_. **347** (20): 1593â€“1603\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMra021902](https://doi.org/10.1056%2FNEJMra021902). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0028-4793](https://search.worldcat.org/issn/0028-4793). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12432047](https://pubmed.ncbi.nlm.nih.gov/12432047).\",\"url\":\"http://www.nejm.org/doi/abs/10.1056/NEJMra021902\",\"favicon\":\"\"},{\"id\":\"5\",\"title\":\"** Calkins, Gary N. (11 December 1914). [\\\"Zur Frage der Entstehung maligner Tumoren. By Th. Boveri. Jena, Gustav Fischer. 1914. 64 pages\\\"](https://www.science.org/doi/10.1126/science.40.1041.857). _Science_. **40** (1041): 857â€“859\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.40.1041.857](https://doi.org/10.1126%2Fscience.40.1041.857). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0036-8075](https://search.worldcat.org/issn/0036-8075).\",\"description\":\"5. **^** Calkins, Gary N. (11 December 1914). [\\\"Zur Frage der Entstehung maligner Tumoren. By Th. Boveri. Jena, Gustav Fischer. 1914. 64 pages\\\"](https://www.science.org/doi/10.1126/science.40.1041.857). _Science_. **40** (1041): 857â€“859\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.40.1041.857](https://doi.org/10.1126%2Fscience.40.1041.857). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0036-8075](https://search.worldcat.org/issn/0036-8075).\",\"url\":\"https://www.science.org/doi/10.1126/science.40.1041.857\",\"favicon\":\"\"},{\"id\":\"6\",\"title\":\"** Tomasetti C, Li L, Vogelstein B (23 March 2017). [\\\"Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852673). _Science_. **355** (6331): 1330â€“1334\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2017Sci...355.1330T](https://ui.adsabs.harvard.edu/abs/2017Sci...355.1330T). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.aaf9011](https://doi.org/10.1126%2Fscience.aaf9011). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5852673](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852673). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28336671](https://pubmed.ncbi.nlm.nih.gov/28336671).\",\"description\":\"6. **^** Tomasetti C, Li L, Vogelstein B (23 March 2017). [\\\"Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852673). _Science_. **355** (6331): 1330â€“1334\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2017Sci...355.1330T](https://ui.adsabs.harvard.edu/abs/2017Sci...355.1330T). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.aaf9011](https://doi.org/10.1126%2Fscience.aaf9011). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5852673](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852673). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28336671](https://pubmed.ncbi.nlm.nih.gov/28336671).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852673\",\"favicon\":\"\"},{\"id\":\"7\",\"title\":\"** Wood LD, Parsons DW, Jones S, Lin J, SjÃ¶blom T, Leary RJ, et al. (November 2007). \\\"The genomic landscapes of human breast and colorectal cancers\\\". _Science_. **318** (5853): 1108â€“13\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2007Sci...318.1108W](https://ui.adsabs.harvard.edu/abs/2007Sci...318.1108W). [CiteSeerX](CiteSeerX_\\\\(identifier\\\\) \\\"CiteSeerX \\\\(identifier\\\\)\\\") [10.1.1.218.5477](https://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.218.5477). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.1145720](https://doi.org/10.1126%2Fscience.1145720). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17932254](https://pubmed.ncbi.nlm.nih.gov/17932254). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [7586573](https://api.semanticscholar.org/CorpusID:7586573).\",\"description\":\"7. **^** Wood LD, Parsons DW, Jones S, Lin J, SjÃ¶blom T, Leary RJ, et al. (November 2007). \\\"The genomic landscapes of human breast and colorectal cancers\\\". _Science_. **318** (5853): 1108â€“13\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2007Sci...318.1108W](https://ui.adsabs.harvard.edu/abs/2007Sci...318.1108W). [CiteSeerX](CiteSeerX_\\\\(identifier\\\\) \\\"CiteSeerX \\\\(identifier\\\\)\\\") [10.1.1.218.5477](https://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.218.5477). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.1145720](https://doi.org/10.1126%2Fscience.1145720). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17932254](https://pubmed.ncbi.nlm.nih.gov/17932254). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [7586573](https://api.semanticscholar.org/CorpusID:7586573).\",\"url\":\"Bibcode_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"8\",\"title\":\"_**a**_ _**b**_ Knudson AG (November 2001). \\\"Two genetic hits (more or less) to cancer\\\". _Nature Reviews. Cancer_. **1** (2): 157â€“62\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/35101031](https://doi.org/10.1038%2F35101031). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11905807](https://pubmed.ncbi.nlm.nih.gov/11905807). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [20201610](https://api.semanticscholar.org/CorpusID:20201610).\",\"description\":\"8. ^ _**a**_ _**b**_ Knudson AG (November 2001). \\\"Two genetic hits (more or less) to cancer\\\". _Nature Reviews. Cancer_. **1** (2): 157â€“62\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/35101031](https://doi.org/10.1038%2F35101031). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11905807](https://pubmed.ncbi.nlm.nih.gov/11905807). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [20201610](https://api.semanticscholar.org/CorpusID:20201610).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"9\",\"title\":\"** Fearon ER, Vogelstein B (June 1990). [\\\"A genetic model for colorectal tumorigenesis\\\"](https://doi.org/10.1016%2F0092-8674%2890%2990186-I). _Cell_. **61** (5): 759â€“67\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/0092-8674(90)90186-I](https://doi.org/10.1016%2F0092-8674%2890%2990186-I). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [2188735](https://pubmed.ncbi.nlm.nih.gov/2188735). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [22975880](https://api.semanticscholar.org/CorpusID:22975880).\",\"description\":\"9. **^** Fearon ER, Vogelstein B (June 1990). [\\\"A genetic model for colorectal tumorigenesis\\\"](https://doi.org/10.1016%2F0092-8674%2890%2990186-I). _Cell_. **61** (5): 759â€“67\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/0092-8674(90)90186-I](https://doi.org/10.1016%2F0092-8674%2890%2990186-I). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [2188735](https://pubmed.ncbi.nlm.nih.gov/2188735). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [22975880](https://api.semanticscholar.org/CorpusID:22975880).\",\"url\":\"https://doi.org/10.1016%2F0092-8674%2890%2990186-I\",\"favicon\":\"\"},{\"id\":\"10\",\"title\":\"_**a**_ _**b**_ _**c**_ Belikov AV (September 2017). [\\\"The number of key carcinogenic events can be predicted from cancer incidence\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610194). _Scientific Reports_. **7** (1) 12170. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2017NatSR...712170B](https://ui.adsabs.harvard.edu/abs/2017NatSR...712170B). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/s41598-017-12448-7](https://doi.org/10.1038%2Fs41598-017-12448-7). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5610194](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610194). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28939880](https://pubmed.ncbi.nlm.nih.gov/28939880).\",\"description\":\"10. ^ _**a**_ _**b**_ _**c**_ Belikov AV (September 2017). [\\\"The number of key carcinogenic events can be predicted from cancer incidence\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610194). _Scientific Reports_. **7** (1) 12170. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2017NatSR...712170B](https://ui.adsabs.harvard.edu/abs/2017NatSR...712170B). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/s41598-017-12448-7](https://doi.org/10.1038%2Fs41598-017-12448-7). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5610194](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610194). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28939880](https://pubmed.ncbi.nlm.nih.gov/28939880).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610194\",\"favicon\":\"\"},{\"id\":\"11\",\"title\":\"** Belikov AV, Vyatkin A, Leonov SV (6 August 2021). [\\\"The Erlang distribution approximates the age distribution of incidence of childhood and young adulthood cancers\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351573). _PeerJ_. **9** e11976. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7717/peerj.11976](https://doi.org/10.7717%2Fpeerj.11976). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [8351573](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351573). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [34434669](https://pubmed.ncbi.nlm.nih.gov/34434669).\",\"description\":\"11. **^** Belikov AV, Vyatkin A, Leonov SV (6 August 2021). [\\\"The Erlang distribution approximates the age distribution of incidence of childhood and young adulthood cancers\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351573). _PeerJ_. **9** e11976. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7717/peerj.11976](https://doi.org/10.7717%2Fpeerj.11976). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [8351573](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351573). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [34434669](https://pubmed.ncbi.nlm.nih.gov/34434669).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351573\",\"favicon\":\"\"},{\"id\":\"12\",\"title\":\"** Vyatkin, Alexey D.; Otnyukov, Danila V.; Leonov, Sergey V.; Belikov, Aleksey V. (14 January 2022). [\\\"Comprehensive patient-level classification and quantification of driver events in TCGA PanCanAtlas cohorts\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759692). _PLOS Genetics_. **18** (1): e1009996. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1371/journal.pgen.1009996](https://doi.org/10.1371%2Fjournal.pgen.1009996). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [8759692](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759692). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [35030162](https://pubmed.ncbi.nlm.nih.gov/35030162).\",\"description\":\"12. **^** Vyatkin, Alexey D.; Otnyukov, Danila V.; Leonov, Sergey V.; Belikov, Aleksey V. (14 January 2022). [\\\"Comprehensive patient-level classification and quantification of driver events in TCGA PanCanAtlas cohorts\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759692). _PLOS Genetics_. **18** (1): e1009996. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1371/journal.pgen.1009996](https://doi.org/10.1371%2Fjournal.pgen.1009996). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [8759692](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759692). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [35030162](https://pubmed.ncbi.nlm.nih.gov/35030162).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759692\",\"favicon\":\"\"},{\"id\":\"13\",\"title\":\"** Croce CM (January 2008). \\\"Oncogenes and cancer\\\". _The New England Journal of Medicine_. **358** (5): 502â€“11\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMra072367](https://doi.org/10.1056%2FNEJMra072367). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18234754](https://pubmed.ncbi.nlm.nih.gov/18234754).\",\"description\":\"13. **^** Croce CM (January 2008). \\\"Oncogenes and cancer\\\". _The New England Journal of Medicine_. **358** (5): 502â€“11\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMra072367](https://doi.org/10.1056%2FNEJMra072367). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18234754](https://pubmed.ncbi.nlm.nih.gov/18234754).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"14\",\"title\":\"** Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM (February 2005). \\\"Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs\\\". _Nature_. **433** (7027): 769â€“73\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2005Natur.433..769L](https://ui.adsabs.harvard.edu/abs/2005Natur.433..769L). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/nature03315](https://doi.org/10.1038%2Fnature03315). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15685193](https://pubmed.ncbi.nlm.nih.gov/15685193). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [4430576](https://api.semanticscholar.org/CorpusID:4430576).\",\"description\":\"14. **^** Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM (February 2005). \\\"Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs\\\". _Nature_. **433** (7027): 769â€“73\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2005Natur.433..769L](https://ui.adsabs.harvard.edu/abs/2005Natur.433..769L). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/nature03315](https://doi.org/10.1038%2Fnature03315). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15685193](https://pubmed.ncbi.nlm.nih.gov/15685193). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [4430576](https://api.semanticscholar.org/CorpusID:4430576).\",\"url\":\"Bibcode_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"15\",\"title\":\"_**a**_ _**b**_ Balaguer F, Link A, Lozano JJ, Cuatrecasas M, Nagasaka T, Boland CR, Goel A (August 2010). [\\\"Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922409). _Cancer Research_. **70** (16): 6609â€“18\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1158/0008-5472.CAN-10-0622](https://doi.org/10.1158%2F0008-5472.CAN-10-0622). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2922409](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922409). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20682795](https://pubmed.ncbi.nlm.nih.gov/20682795).\",\"description\":\"15. ^ _**a**_ _**b**_ Balaguer F, Link A, Lozano JJ, Cuatrecasas M, Nagasaka T, Boland CR, Goel A (August 2010). [\\\"Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922409). _Cancer Research_. **70** (16): 6609â€“18\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1158/0008-5472.CAN-10-0622](https://doi.org/10.1158%2F0008-5472.CAN-10-0622). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2922409](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922409). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20682795](https://pubmed.ncbi.nlm.nih.gov/20682795).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922409\",\"favicon\":\"\"},{\"id\":\"16\",\"title\":\"** [\\\"How Chromosome Imbalances Can Drive Cancer | Harvard Medical School\\\"](https://hms.harvard.edu/news/how-chromosome-imbalances-can-drive-cancer). _hms.harvard.edu_. 6 July 2023. Retrieved 2 April 2024.\",\"description\":\"16. **^** [\\\"How Chromosome Imbalances Can Drive Cancer | Harvard Medical School\\\"](https://hms.harvard.edu/news/how-chromosome-imbalances-can-drive-cancer). _hms.harvard.edu_. 6 July 2023. Retrieved 2 April 2024.\",\"url\":\"https://hms.harvard.edu/news/how-chromosome-imbalances-can-drive-cancer\",\"favicon\":\"\"},{\"id\":\"17\",\"title\":\"** Kastan MB (April 2008). [\\\"DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture\\\"](https://doi.org/10.1158%2F1541-7786.MCR-08-0020). _Molecular Cancer Research_. **6** (4): 517â€“24\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1158/1541-7786.MCR-08-0020](https://doi.org/10.1158%2F1541-7786.MCR-08-0020). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18403632](https://pubmed.ncbi.nlm.nih.gov/18403632).\",\"description\":\"17. **^** Kastan MB (April 2008). [\\\"DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture\\\"](https://doi.org/10.1158%2F1541-7786.MCR-08-0020). _Molecular Cancer Research_. **6** (4): 517â€“24\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1158/1541-7786.MCR-08-0020](https://doi.org/10.1158%2F1541-7786.MCR-08-0020). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18403632](https://pubmed.ncbi.nlm.nih.gov/18403632).\",\"url\":\"https://doi.org/10.1158%2F1541-7786.MCR-08-0020\",\"favicon\":\"\"},{\"id\":\"18\",\"title\":\"_**a**_ _**b**_ Cunningham FH, Fiebelkorn S, Johnson M, Meredith C (November 2011). \\\"A novel application of the Margin of Exposure approach: segregation of tobacco smoke toxicants\\\". _Food and Chemical Toxicology_. **49** (11): 2921â€“33\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.fct.2011.07.019](https://doi.org/10.1016%2Fj.fct.2011.07.019). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21802474](https://pubmed.ncbi.nlm.nih.gov/21802474).\",\"description\":\"18. ^ _**a**_ _**b**_ Cunningham FH, Fiebelkorn S, Johnson M, Meredith C (November 2011). \\\"A novel application of the Margin of Exposure approach: segregation of tobacco smoke toxicants\\\". _Food and Chemical Toxicology_. **49** (11): 2921â€“33\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.fct.2011.07.019](https://doi.org/10.1016%2Fj.fct.2011.07.019). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21802474](https://pubmed.ncbi.nlm.nih.gov/21802474).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"19\",\"title\":\"** Kanavy HE, Gerstenblith MR (December 2011). \\\"Ultraviolet radiation and melanoma\\\". _Seminars in Cutaneous Medicine and Surgery_. **30** (4): 222â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.sder.2011.08.003](https://doi.org/10.1016%2Fj.sder.2011.08.003) (inactive 11 July 2025). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22123420](https://pubmed.ncbi.nlm.nih.gov/22123420).`{{cite journal}}`: CS1 maint: DOI inactive as of July 2025 (link)\",\"description\":\"19. **^** Kanavy HE, Gerstenblith MR (December 2011). \\\"Ultraviolet radiation and melanoma\\\". _Seminars in Cutaneous Medicine and Surgery_. **30** (4): 222â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.sder.2011.08.003](https://doi.org/10.1016%2Fj.sder.2011.08.003) (inactive 11 July 2025). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22123420](https://pubmed.ncbi.nlm.nih.gov/22123420).`{{cite journal}}`: CS1 maint: DOI inactive as of July 2025 (link)\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"20\",\"title\":\"** Handa O, Naito Y, Yoshikawa T (2011). [\\\"Redox biology and gastric carcinogenesis: the role of Helicobacter pylori\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837368). _Redox Report_. **16** (1): 1â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1179/174329211X12968219310756](https://doi.org/10.1179%2F174329211X12968219310756). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6837368](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837368). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21605492](https://pubmed.ncbi.nlm.nih.gov/21605492).\",\"description\":\"20. **^** Handa O, Naito Y, Yoshikawa T (2011). [\\\"Redox biology and gastric carcinogenesis: the role of Helicobacter pylori\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837368). _Redox Report_. **16** (1): 1â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1179/174329211X12968219310756](https://doi.org/10.1179%2F174329211X12968219310756). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6837368](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837368). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21605492](https://pubmed.ncbi.nlm.nih.gov/21605492).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837368\",\"favicon\":\"\"},{\"id\":\"21\",\"title\":\"** Smela ME, Hamm ML, Henderson PT, Harris CM, Harris TM, Essigmann JM (May 2002). [\\\"The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC124458). _Proceedings of the National Academy of Sciences of the United States of America_. **99** (10): 6655â€“60\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2002PNAS...99.6655S](https://ui.adsabs.harvard.edu/abs/2002PNAS...99.6655S). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1073/pnas.102167699](https://doi.org/10.1073%2Fpnas.102167699). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [124458](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC124458). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12011430](https://pubmed.ncbi.nlm.nih.gov/12011430).\",\"description\":\"21. **^** Smela ME, Hamm ML, Henderson PT, Harris CM, Harris TM, Essigmann JM (May 2002). [\\\"The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC124458). _Proceedings of the National Academy of Sciences of the United States of America_. **99** (10): 6655â€“60\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2002PNAS...99.6655S](https://ui.adsabs.harvard.edu/abs/2002PNAS...99.6655S). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1073/pnas.102167699](https://doi.org/10.1073%2Fpnas.102167699). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [124458](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC124458). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12011430](https://pubmed.ncbi.nlm.nih.gov/12011430).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC124458\",\"favicon\":\"\"},{\"id\":\"22\",\"title\":\"** Katsurano M, Niwa T, Yasui Y, Shigematsu Y, Yamashita S, Takeshima H, Lee MS, Kim YJ, Tanaka T, Ushijima T (January 2012). [\\\"Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction\\\"](https://doi.org/10.1038%2Fonc.2011.241). _Oncogene_. **31** (3): 342â€“51\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/onc.2011.241](https://doi.org/10.1038%2Fonc.2011.241). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21685942](https://pubmed.ncbi.nlm.nih.gov/21685942).\",\"description\":\"22. **^** Katsurano M, Niwa T, Yasui Y, Shigematsu Y, Yamashita S, Takeshima H, Lee MS, Kim YJ, Tanaka T, Ushijima T (January 2012). [\\\"Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction\\\"](https://doi.org/10.1038%2Fonc.2011.241). _Oncogene_. **31** (3): 342â€“51\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/onc.2011.241](https://doi.org/10.1038%2Fonc.2011.241). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21685942](https://pubmed.ncbi.nlm.nih.gov/21685942).\",\"url\":\"https://doi.org/10.1038%2Fonc.2011.241\",\"favicon\":\"\"},{\"id\":\"23\",\"title\":\"** Bernstein C, Holubec H, Bhattacharyya AK, Nguyen H, Payne CM, Zaitlin B, Bernstein H (August 2011). [\\\"Carcinogenicity of deoxycholate, a secondary bile acid\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149672). _Archives of Toxicology_. **85** (8): 863â€“71\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s00204-011-0648-7](https://doi.org/10.1007%2Fs00204-011-0648-7). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3149672](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149672). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21267546](https://pubmed.ncbi.nlm.nih.gov/21267546).\",\"description\":\"23. **^** Bernstein C, Holubec H, Bhattacharyya AK, Nguyen H, Payne CM, Zaitlin B, Bernstein H (August 2011). [\\\"Carcinogenicity of deoxycholate, a secondary bile acid\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149672). _Archives of Toxicology_. **85** (8): 863â€“71\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s00204-011-0648-7](https://doi.org/10.1007%2Fs00204-011-0648-7). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3149672](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149672). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21267546](https://pubmed.ncbi.nlm.nih.gov/21267546).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149672\",\"favicon\":\"\"},{\"id\":\"24\",\"title\":\"** Malkin D (April 2011). [\\\"Li-fraumeni syndrome\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135649). _Genes \u0026 Cancer_. **2** (4): 475â€“84\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1177/1947601911413466](https://doi.org/10.1177%2F1947601911413466). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3135649](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135649). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21779515](https://pubmed.ncbi.nlm.nih.gov/21779515).\",\"description\":\"24. **^** Malkin D (April 2011). [\\\"Li-fraumeni syndrome\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135649). _Genes \u0026 Cancer_. **2** (4): 475â€“84\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1177/1947601911413466](https://doi.org/10.1177%2F1947601911413466). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3135649](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135649). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21779515](https://pubmed.ncbi.nlm.nih.gov/21779515).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135649\",\"favicon\":\"\"},{\"id\":\"25\",\"title\":\"** Fearon ER (November 1997). \\\"Human cancer syndromes: clues to the origin and nature of cancer\\\". _Science_. **278** (5340): 1043â€“50\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1997Sci...278.1043F](https://ui.adsabs.harvard.edu/abs/1997Sci...278.1043F). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.278.5340.1043](https://doi.org/10.1126%2Fscience.278.5340.1043). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9353177](https://pubmed.ncbi.nlm.nih.gov/9353177).\",\"description\":\"25. **^** Fearon ER (November 1997). \\\"Human cancer syndromes: clues to the origin and nature of cancer\\\". _Science_. **278** (5340): 1043â€“50\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1997Sci...278.1043F](https://ui.adsabs.harvard.edu/abs/1997Sci...278.1043F). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.278.5340.1043](https://doi.org/10.1126%2Fscience.278.5340.1043). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9353177](https://pubmed.ncbi.nlm.nih.gov/9353177).\",\"url\":\"Bibcode_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"26\",\"title\":\"** Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (July 2000). [\\\"Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland\\\"](https://doi.org/10.1056%2FNEJM200007133430201). _The New England Journal of Medicine_. **343** (2): 78â€“85\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJM200007133430201](https://doi.org/10.1056%2FNEJM200007133430201). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10891514](https://pubmed.ncbi.nlm.nih.gov/10891514).\",\"description\":\"26. **^** Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (July 2000). [\\\"Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland\\\"](https://doi.org/10.1056%2FNEJM200007133430201). _The New England Journal of Medicine_. **343** (2): 78â€“85\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJM200007133430201](https://doi.org/10.1056%2FNEJM200007133430201). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10891514](https://pubmed.ncbi.nlm.nih.gov/10891514).\",\"url\":\"https://doi.org/10.1056%2FNEJM200007133430201\",\"favicon\":\"\"},{\"id\":\"27\",\"title\":\"** Halford S, Rowan A, Sawyer E, Talbot I, Tomlinson I (June 2005). [\\\"O(6)-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C\u003eA:T transitions\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774551). _Gut_. **54** (6): 797â€“802\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/gut.2004.059535](https://doi.org/10.1136%2Fgut.2004.059535). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1774551](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774551). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15888787](https://pubmed.ncbi.nlm.nih.gov/15888787).\",\"description\":\"27. **^** Halford S, Rowan A, Sawyer E, Talbot I, Tomlinson I (June 2005). [\\\"O(6)-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C\u003eA:T transitions\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774551). _Gut_. **54** (6): 797â€“802\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/gut.2004.059535](https://doi.org/10.1136%2Fgut.2004.059535). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1774551](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774551). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15888787](https://pubmed.ncbi.nlm.nih.gov/15888787).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774551\",\"favicon\":\"\"},{\"id\":\"28\",\"title\":\"_**a**_ _**b**_ Narayanan L, Fritzell JA, Baker SM, Liskay RM, Glazer PM (April 1997). [\\\"Elevated levels of mutation in multiple tissues of mice deficient in the DNA mismatch repair gene Pms2\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20332). _Proceedings of the National Academy of Sciences of the United States of America_. **94** (7): 3122â€“7\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1997PNAS...94.3122N](https://ui.adsabs.harvard.edu/abs/1997PNAS...94.3122N). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1073/pnas.94.7.3122](https://doi.org/10.1073%2Fpnas.94.7.3122). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [20332](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20332). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9096356](https://pubmed.ncbi.nlm.nih.gov/9096356).\",\"description\":\"28. ^ _**a**_ _**b**_ Narayanan L, Fritzell JA, Baker SM, Liskay RM, Glazer PM (April 1997). [\\\"Elevated levels of mutation in multiple tissues of mice deficient in the DNA mismatch repair gene Pms2\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20332). _Proceedings of the National Academy of Sciences of the United States of America_. **94** (7): 3122â€“7\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1997PNAS...94.3122N](https://ui.adsabs.harvard.edu/abs/1997PNAS...94.3122N). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1073/pnas.94.7.3122](https://doi.org/10.1073%2Fpnas.94.7.3122). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [20332](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20332). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9096356](https://pubmed.ncbi.nlm.nih.gov/9096356).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20332\",\"favicon\":\"\"},{\"id\":\"29\",\"title\":\"_**a**_ _**b**_ Hegan DC, Narayanan L, Jirik FR, Edelmann W, Liskay RM, Glazer PM (December 2006). [\\\"Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612936). _Carcinogenesis_. **27** (12): 2402â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/carcin/bgl079](https://doi.org/10.1093%2Fcarcin%2Fbgl079). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2612936](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612936). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16728433](https://pubmed.ncbi.nlm.nih.gov/16728433).\",\"description\":\"29. ^ _**a**_ _**b**_ Hegan DC, Narayanan L, Jirik FR, Edelmann W, Liskay RM, Glazer PM (December 2006). [\\\"Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612936). _Carcinogenesis_. **27** (12): 2402â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/carcin/bgl079](https://doi.org/10.1093%2Fcarcin%2Fbgl079). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2612936](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612936). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16728433](https://pubmed.ncbi.nlm.nih.gov/16728433).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612936\",\"favicon\":\"\"},{\"id\":\"30\",\"title\":\"_**a**_ _**b**_ Tutt AN, van Oostrom CT, Ross GM, van Steeg H, Ashworth A (March 2002). [\\\"Disruption of Brca2 increases the spontaneous mutation rate in vivo: synergism with ionizing radiation\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1084010). _EMBO Reports_. **3** (3): 255â€“60\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/embo-reports/kvf037](https://doi.org/10.1093%2Fembo-reports%2Fkvf037). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1084010](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1084010). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11850397](https://pubmed.ncbi.nlm.nih.gov/11850397).\",\"description\":\"30. ^ _**a**_ _**b**_ Tutt AN, van Oostrom CT, Ross GM, van Steeg H, Ashworth A (March 2002). [\\\"Disruption of Brca2 increases the spontaneous mutation rate in vivo: synergism with ionizing radiation\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1084010). _EMBO Reports_. **3** (3): 255â€“60\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/embo-reports/kvf037](https://doi.org/10.1093%2Fembo-reports%2Fkvf037). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1084010](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1084010). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11850397](https://pubmed.ncbi.nlm.nih.gov/11850397).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1084010\",\"favicon\":\"\"},{\"id\":\"31\",\"title\":\"** German J (March 1969). [\\\"Bloom's syndrome. I. Genetical and clinical observations in the first twenty-seven patients\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1706430). _American Journal of Human Genetics_. **21** (2): 196â€“227\\\\. [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1706430](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1706430). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [5770175](https://pubmed.ncbi.nlm.nih.gov/5770175).\",\"description\":\"31. **^** German J (March 1969). [\\\"Bloom's syndrome. I. Genetical and clinical observations in the first twenty-seven patients\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1706430). _American Journal of Human Genetics_. **21** (2): 196â€“227\\\\. [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1706430](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1706430). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [5770175](https://pubmed.ncbi.nlm.nih.gov/5770175).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1706430\",\"favicon\":\"\"},{\"id\":\"32\",\"title\":\"** O'Hagan HM, Mohammad HP, Baylin SB (August 2008). Lee JT (ed.). [\\\"Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491723). _PLOS Genetics_. **4** (8): e1000155. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1371/journal.pgen.1000155](https://doi.org/10.1371%2Fjournal.pgen.1000155). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2491723](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491723). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18704159](https://pubmed.ncbi.nlm.nih.gov/18704159).\",\"description\":\"32. **^** O'Hagan HM, Mohammad HP, Baylin SB (August 2008). Lee JT (ed.). [\\\"Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491723). _PLOS Genetics_. **4** (8): e1000155. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1371/journal.pgen.1000155](https://doi.org/10.1371%2Fjournal.pgen.1000155). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2491723](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491723). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18704159](https://pubmed.ncbi.nlm.nih.gov/18704159).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491723\",\"favicon\":\"\"},{\"id\":\"33\",\"title\":\"** Cuozzo C, Porcellini A, Angrisano T, Morano A, Lee B, Di Pardo A, Messina S, Iuliano R, Fusco A, Santillo MR, Muller MT, Chiariotti L, Gottesman ME, Avvedimento EV (July 2007). [\\\"DNA damage, homology-directed repair, and DNA methylation\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913100). _PLOS Genetics_. **3** (7): e110. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1371/journal.pgen.0030110](https://doi.org/10.1371%2Fjournal.pgen.0030110). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1913100](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913100). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17616978](https://pubmed.ncbi.nlm.nih.gov/17616978).\",\"description\":\"33. **^** Cuozzo C, Porcellini A, Angrisano T, Morano A, Lee B, Di Pardo A, Messina S, Iuliano R, Fusco A, Santillo MR, Muller MT, Chiariotti L, Gottesman ME, Avvedimento EV (July 2007). [\\\"DNA damage, homology-directed repair, and DNA methylation\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913100). _PLOS Genetics_. **3** (7): e110. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1371/journal.pgen.0030110](https://doi.org/10.1371%2Fjournal.pgen.0030110). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1913100](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913100). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17616978](https://pubmed.ncbi.nlm.nih.gov/17616978).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913100\",\"favicon\":\"\"},{\"id\":\"34\",\"title\":\"** Villeneuve PJ, Mao Y (November 1994). \\\"Lifetime probability of developing lung cancer, by smoking status, Canada\\\". _Canadian Journal of Public Health_. **85** (6): 385â€“8\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [7895211](https://pubmed.ncbi.nlm.nih.gov/7895211).\",\"description\":\"34. **^** Villeneuve PJ, Mao Y (November 1994). \\\"Lifetime probability of developing lung cancer, by smoking status, Canada\\\". _Canadian Journal of Public Health_. **85** (6): 385â€“8\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [7895211](https://pubmed.ncbi.nlm.nih.gov/7895211).\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"35\",\"title\":\"** Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. (March 2012). [\\\"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878653). _The New England Journal of Medicine_. **366** (10): 883â€“92\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMoa1113205](https://doi.org/10.1056%2FNEJMoa1113205). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4878653](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878653). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22397650](https://pubmed.ncbi.nlm.nih.gov/22397650).\",\"description\":\"35. **^** Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. (March 2012). [\\\"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878653). _The New England Journal of Medicine_. **366** (10): 883â€“92\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMoa1113205](https://doi.org/10.1056%2FNEJMoa1113205). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4878653](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878653). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22397650](https://pubmed.ncbi.nlm.nih.gov/22397650).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878653\",\"favicon\":\"\"},{\"id\":\"36\",\"title\":\"_**a**_ _**b**_ LÃ³pez-LÃ¡zaro M (August 2015). [\\\"Stem cell division theory of cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242319). _Cell Cycle_. **14** (16): 2547â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1080/15384101.2015.1062330](https://doi.org/10.1080%2F15384101.2015.1062330). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5242319](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242319). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26090957](https://pubmed.ncbi.nlm.nih.gov/26090957).\",\"description\":\"36. ^ _**a**_ _**b**_ LÃ³pez-LÃ¡zaro M (August 2015). [\\\"Stem cell division theory of cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242319). _Cell Cycle_. **14** (16): 2547â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1080/15384101.2015.1062330](https://doi.org/10.1080%2F15384101.2015.1062330). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5242319](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242319). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26090957](https://pubmed.ncbi.nlm.nih.gov/26090957).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242319\",\"favicon\":\"\"},{\"id\":\"37\",\"title\":\"_**a**_ _**b**_ _**c**_ LÃ³pez-LÃ¡zaro M (May 2015). [\\\"The migration ability of stem cells can explain the existence of cancer of unknown primary site. Rethinking metastasis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468332). _Oncoscience_. **2** (5): 467â€“75\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.18632/oncoscience.159](https://doi.org/10.18632%2Foncoscience.159). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4468332](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468332). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26097879](https://pubmed.ncbi.nlm.nih.gov/26097879).\",\"description\":\"37. ^ _**a**_ _**b**_ _**c**_ LÃ³pez-LÃ¡zaro M (May 2015). [\\\"The migration ability of stem cells can explain the existence of cancer of unknown primary site. Rethinking metastasis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468332). _Oncoscience_. **2** (5): 467â€“75\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.18632/oncoscience.159](https://doi.org/10.18632%2Foncoscience.159). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4468332](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468332). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26097879](https://pubmed.ncbi.nlm.nih.gov/26097879).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468332\",\"favicon\":\"\"},{\"id\":\"38\",\"title\":\"** Tomasetti C, Vogelstein B (January 2015). [\\\"Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446723). _Science_. **347** (6217): 78â€“81\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.1260825](https://doi.org/10.1126%2Fscience.1260825). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4446723](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446723). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25554788](https://pubmed.ncbi.nlm.nih.gov/25554788).\",\"description\":\"38. **^** Tomasetti C, Vogelstein B (January 2015). [\\\"Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446723). _Science_. **347** (6217): 78â€“81\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.1260825](https://doi.org/10.1126%2Fscience.1260825). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4446723](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446723). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25554788](https://pubmed.ncbi.nlm.nih.gov/25554788).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446723\",\"favicon\":\"\"},{\"id\":\"39\",\"title\":\"** Slaughter DP, Southwick HW, Smejkal W (September 1953). [\\\"Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin\\\"](https://doi.org/10.1002%2F1097-0142%28195309%296%3A5%3C963%3A%3AAID-CNCR2820060515%3E3.0.CO%3B2-Q). _Cancer_. **6** (5): 963â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/1097-0142(195309)6:5\u003c963::AID-CNCR2820060515\u003e3.0.CO;2-Q](https://doi.org/10.1002%2F1097-0142%28195309%296%3A5%3C963%3A%3AAID-CNCR2820060515%3E3.0.CO%3B2-Q). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [13094644](https://pubmed.ncbi.nlm.nih.gov/13094644). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [6736946](https://api.semanticscholar.org/CorpusID:6736946).\",\"description\":\"39. **^** Slaughter DP, Southwick HW, Smejkal W (September 1953). [\\\"Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin\\\"](https://doi.org/10.1002%2F1097-0142%28195309%296%3A5%3C963%3A%3AAID-CNCR2820060515%3E3.0.CO%3B2-Q). _Cancer_. **6** (5): 963â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/1097-0142(195309)6:5\u003c963::AID-CNCR2820060515\u003e3.0.CO;2-Q](https://doi.org/10.1002%2F1097-0142%28195309%296%3A5%3C963%3A%3AAID-CNCR2820060515%3E3.0.CO%3B2-Q). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [13094644](https://pubmed.ncbi.nlm.nih.gov/13094644). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [6736946](https://api.semanticscholar.org/CorpusID:6736946).\",\"url\":\"https://doi.org/10.1002%2F1097-0142%28195309%296%3A5%3C963%3A%3AAID-CNCR2820060515%3E3.0.CO%3B2-Q\",\"favicon\":\"\"},{\"id\":\"40\",\"title\":\"** Bernstein C, Bernstein H, Payne CM, Dvorak K, Garewal H (February 2008). [\\\"Field defects in progression to gastrointestinal tract cancers\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744582). review. _Cancer Letters_. **260** (1â€“2): 1â€“10\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.canlet.2007.11.027](https://doi.org/10.1016%2Fj.canlet.2007.11.027). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2744582](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744582). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18164807](https://pubmed.ncbi.nlm.nih.gov/18164807).\",\"description\":\"40. **^** Bernstein C, Bernstein H, Payne CM, Dvorak K, Garewal H (February 2008). [\\\"Field defects in progression to gastrointestinal tract cancers\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744582). review. _Cancer Letters_. **260** (1â€“2): 1â€“10\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.canlet.2007.11.027](https://doi.org/10.1016%2Fj.canlet.2007.11.027). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2744582](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744582). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18164807](https://pubmed.ncbi.nlm.nih.gov/18164807).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744582\",\"favicon\":\"\"},{\"id\":\"41\",\"title\":\"** Nguyen H, Loustaunau C, Facista A, Ramsey L, Hassounah N, Taylor H, Krouse R, Payne CM, Tsikitis VL, Goldschmid S, Banerjee B, Perini RF, Bernstein C (2010). [\\\"Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149991). _Journal of Visualized Experiments_ (41): 1931. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3791/1931](https://doi.org/10.3791%2F1931). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3149991](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149991). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20689513](https://pubmed.ncbi.nlm.nih.gov/20689513).\",\"description\":\"41. **^** Nguyen H, Loustaunau C, Facista A, Ramsey L, Hassounah N, Taylor H, Krouse R, Payne CM, Tsikitis VL, Goldschmid S, Banerjee B, Perini RF, Bernstein C (2010). [\\\"Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149991). _Journal of Visualized Experiments_ (41): 1931. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3791/1931](https://doi.org/10.3791%2F1931). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3149991](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149991). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20689513](https://pubmed.ncbi.nlm.nih.gov/20689513).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149991\",\"favicon\":\"\"},{\"id\":\"42\",\"title\":\"** Rubin H (March 2011). \\\"Fields and field cancerization: the preneoplastic origins of cancer: asymptomatic hyperplastic fields are precursors of neoplasia, and their progression to tumors can be tracked by saturation density in culture\\\". _BioEssays_. **33** (3): 224â€“31\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/bies.201000067](https://doi.org/10.1002%2Fbies.201000067). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21254148](https://pubmed.ncbi.nlm.nih.gov/21254148). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [44981539](https://api.semanticscholar.org/CorpusID:44981539).\",\"description\":\"42. **^** Rubin H (March 2011). \\\"Fields and field cancerization: the preneoplastic origins of cancer: asymptomatic hyperplastic fields are precursors of neoplasia, and their progression to tumors can be tracked by saturation density in culture\\\". _BioEssays_. **33** (3): 224â€“31\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/bies.201000067](https://doi.org/10.1002%2Fbies.201000067). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21254148](https://pubmed.ncbi.nlm.nih.gov/21254148). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [44981539](https://api.semanticscholar.org/CorpusID:44981539).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"43\",\"title\":\"** Tsao JL, Yatabe Y, Salovaara R, JÃ¤rvinen HJ, Mecklin JP, Aaltonen LA, TavarÃ© S, Shibata D (February 2000). [\\\"Genetic reconstruction of individual colorectal tumor histories\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC15581). _Proceedings of the National Academy of Sciences of the United States of America_. **97** (3): 1236â€“41\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2000PNAS...97.1236T](https://ui.adsabs.harvard.edu/abs/2000PNAS...97.1236T). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1073/pnas.97.3.1236](https://doi.org/10.1073%2Fpnas.97.3.1236). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [15581](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC15581). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10655514](https://pubmed.ncbi.nlm.nih.gov/10655514).\",\"description\":\"43. **^** Tsao JL, Yatabe Y, Salovaara R, JÃ¤rvinen HJ, Mecklin JP, Aaltonen LA, TavarÃ© S, Shibata D (February 2000). [\\\"Genetic reconstruction of individual colorectal tumor histories\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC15581). _Proceedings of the National Academy of Sciences of the United States of America_. **97** (3): 1236â€“41\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2000PNAS...97.1236T](https://ui.adsabs.harvard.edu/abs/2000PNAS...97.1236T). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1073/pnas.97.3.1236](https://doi.org/10.1073%2Fpnas.97.3.1236). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [15581](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC15581). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10655514](https://pubmed.ncbi.nlm.nih.gov/10655514).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC15581\",\"favicon\":\"\"},{\"id\":\"44\",\"title\":\"_**a**_ _**b**_ _**c**_ Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW (March 2013). [\\\"Cancer genome landscapes\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749880). review. _Science_. **339** (6127): 1546â€“58\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2013Sci...339.1546V](https://ui.adsabs.harvard.edu/abs/2013Sci...339.1546V). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.1235122](https://doi.org/10.1126%2Fscience.1235122). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3749880](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749880). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23539594](https://pubmed.ncbi.nlm.nih.gov/23539594).\",\"description\":\"44. ^ _**a**_ _**b**_ _**c**_ Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW (March 2013). [\\\"Cancer genome landscapes\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749880). review. _Science_. **339** (6127): 1546â€“58\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2013Sci...339.1546V](https://ui.adsabs.harvard.edu/abs/2013Sci...339.1546V). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.1235122](https://doi.org/10.1126%2Fscience.1235122). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3749880](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749880). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23539594](https://pubmed.ncbi.nlm.nih.gov/23539594).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749880\",\"favicon\":\"\"},{\"id\":\"45\",\"title\":\"** Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR, Einspahr JG, Buckmeier J, Alberts DS, Hamilton SR, Issa JP (September 2005). [\\\"MGMT promoter methylation and field defect in sporadic colorectal cancer\\\"](https://doi.org/10.1093%2Fjnci%2Fdji275). _Journal of the National Cancer Institute_. **97** (18): 1330â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/jnci/dji275](https://doi.org/10.1093%2Fjnci%2Fdji275). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16174854](https://pubmed.ncbi.nlm.nih.gov/16174854).\",\"description\":\"45. **^** Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR, Einspahr JG, Buckmeier J, Alberts DS, Hamilton SR, Issa JP (September 2005). [\\\"MGMT promoter methylation and field defect in sporadic colorectal cancer\\\"](https://doi.org/10.1093%2Fjnci%2Fdji275). _Journal of the National Cancer Institute_. **97** (18): 1330â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/jnci/dji275](https://doi.org/10.1093%2Fjnci%2Fdji275). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16174854](https://pubmed.ncbi.nlm.nih.gov/16174854).\",\"url\":\"https://doi.org/10.1093%2Fjnci%2Fdji275\",\"favicon\":\"\"},{\"id\":\"46\",\"title\":\"_**a**_ _**b**_ Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH (October 2011). \\\"Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence\\\". _Langenbeck's Archives of Surgery_. **396** (7): 1017â€“26\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s00423-011-0812-9](https://doi.org/10.1007%2Fs00423-011-0812-9). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21706233](https://pubmed.ncbi.nlm.nih.gov/21706233). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [8069716](https://api.semanticscholar.org/CorpusID:8069716).\",\"description\":\"46. ^ _**a**_ _**b**_ Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH (October 2011). \\\"Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence\\\". _Langenbeck's Archives of Surgery_. **396** (7): 1017â€“26\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s00423-011-0812-9](https://doi.org/10.1007%2Fs00423-011-0812-9). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21706233](https://pubmed.ncbi.nlm.nih.gov/21706233). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [8069716](https://api.semanticscholar.org/CorpusID:8069716).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"47\",\"title\":\"** Svrcek M, Buhard O, Colas C, Coulet F, Dumont S, Massaoudi I, et al. (November 2010). \\\"Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers\\\". _Gut_. **59** (11): 1516â€“26\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/gut.2009.194787](https://doi.org/10.1136%2Fgut.2009.194787). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20947886](https://pubmed.ncbi.nlm.nih.gov/20947886). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [206950452](https://api.semanticscholar.org/CorpusID:206950452).\",\"description\":\"47. **^** Svrcek M, Buhard O, Colas C, Coulet F, Dumont S, Massaoudi I, et al. (November 2010). \\\"Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers\\\". _Gut_. **59** (11): 1516â€“26\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/gut.2009.194787](https://doi.org/10.1136%2Fgut.2009.194787). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20947886](https://pubmed.ncbi.nlm.nih.gov/20947886). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [206950452](https://api.semanticscholar.org/CorpusID:206950452).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"48\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ Facista A, Nguyen H, Lewis C, Prasad AR, Ramsey L, Zaitlin B, Nfonsam V, Krouse RS, Bernstein H, Payne CM, Stern S, Oatman N, Banerjee B, Bernstein C (April 2012). [\\\"Deficient expression of DNA repair enzymes in early progression to sporadic colon cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351028). _Genome Integrity_. **3** (1): 3. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1186/2041-9414-3-3](https://doi.org/10.1186%2F2041-9414-3-3). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3351028](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351028). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22494821](https://pubmed.ncbi.nlm.nih.gov/22494821).\",\"description\":\"48. ^ _**a**_ _**b**_ _**c**_ _**d**_ Facista A, Nguyen H, Lewis C, Prasad AR, Ramsey L, Zaitlin B, Nfonsam V, Krouse RS, Bernstein H, Payne CM, Stern S, Oatman N, Banerjee B, Bernstein C (April 2012). [\\\"Deficient expression of DNA repair enzymes in early progression to sporadic colon cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351028). _Genome Integrity_. **3** (1): 3. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1186/2041-9414-3-3](https://doi.org/10.1186%2F2041-9414-3-3). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3351028](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351028). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22494821](https://pubmed.ncbi.nlm.nih.gov/22494821).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351028\",\"favicon\":\"\"},{\"id\":\"49\",\"title\":\"** Paluszczak J, Misiak P, Wierzbicka M, WoÅºniak A, Baer-Dubowska W (February 2011). \\\"Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa\\\". _Oral Oncology_. **47** (2): 104â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.oraloncology.2010.11.006](https://doi.org/10.1016%2Fj.oraloncology.2010.11.006). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21147548](https://pubmed.ncbi.nlm.nih.gov/21147548).\",\"description\":\"49. **^** Paluszczak J, Misiak P, Wierzbicka M, WoÅºniak A, Baer-Dubowska W (February 2011). \\\"Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa\\\". _Oral Oncology_. **47** (2): 104â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.oraloncology.2010.11.006](https://doi.org/10.1016%2Fj.oraloncology.2010.11.006). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21147548](https://pubmed.ncbi.nlm.nih.gov/21147548).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"50\",\"title\":\"** Zuo C, Zhang H, Spencer HJ, Vural E, Suen JY, Schichman SA, Smoller BR, Kokoska MS, Fan CY (October 2009). \\\"Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma\\\". _Otolaryngologyâ€“Head and Neck Surgery_. **141** (4): 484â€“90\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.otohns.2009.07.007](https://doi.org/10.1016%2Fj.otohns.2009.07.007). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19786217](https://pubmed.ncbi.nlm.nih.gov/19786217). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [8357370](https://api.semanticscholar.org/CorpusID:8357370).\",\"description\":\"50. **^** Zuo C, Zhang H, Spencer HJ, Vural E, Suen JY, Schichman SA, Smoller BR, Kokoska MS, Fan CY (October 2009). \\\"Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma\\\". _Otolaryngologyâ€“Head and Neck Surgery_. **141** (4): 484â€“90\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.otohns.2009.07.007](https://doi.org/10.1016%2Fj.otohns.2009.07.007). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19786217](https://pubmed.ncbi.nlm.nih.gov/19786217). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [8357370](https://api.semanticscholar.org/CorpusID:8357370).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"51\",\"title\":\"** Tawfik HM, El-Maqsoud NM, Hak BH, El-Sherbiny YM (2011). \\\"Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene\\\". _American Journal of Otolaryngology_. **32** (6): 528â€“36\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.amjoto.2010.11.005](https://doi.org/10.1016%2Fj.amjoto.2010.11.005). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21353335](https://pubmed.ncbi.nlm.nih.gov/21353335).\",\"description\":\"51. **^** Tawfik HM, El-Maqsoud NM, Hak BH, El-Sherbiny YM (2011). \\\"Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene\\\". _American Journal of Otolaryngology_. **32** (6): 528â€“36\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.amjoto.2010.11.005](https://doi.org/10.1016%2Fj.amjoto.2010.11.005). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21353335](https://pubmed.ncbi.nlm.nih.gov/21353335).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"52\",\"title\":\"** Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ (November 2009). \\\"Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions\\\". _Human Pathology_. **40** (11): 1534â€“42\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.humpath.2009.01.029](https://doi.org/10.1016%2Fj.humpath.2009.01.029). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19695681](https://pubmed.ncbi.nlm.nih.gov/19695681).\",\"description\":\"52. **^** Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ (November 2009). \\\"Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions\\\". _Human Pathology_. **40** (11): 1534â€“42\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.humpath.2009.01.029](https://doi.org/10.1016%2Fj.humpath.2009.01.029). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19695681](https://pubmed.ncbi.nlm.nih.gov/19695681).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"53\",\"title\":\"** Wani M, Afroze D, Makhdoomi M, Hamid I, Wani B, Bhat G, Wani R, Wani K (2012). [\\\"Promoter methylation status of DNA repair gene (hMLH1) in gastric carcinoma patients of the Kashmir valley\\\"](http://ocean.kisti.re.kr/downfile/volume/apocp/POCPA9/2012/v13n8/POCPA9_2012_v13n8_4177.pdf) (PDF). _Asian Pacific Journal of Cancer Prevention_. **13** (8): 4177â€“81\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7314/APJCP.2012.13.8.4177](https://doi.org/10.7314%2FAPJCP.2012.13.8.4177). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23098428](https://pubmed.ncbi.nlm.nih.gov/23098428).\",\"description\":\"53. **^** Wani M, Afroze D, Makhdoomi M, Hamid I, Wani B, Bhat G, Wani R, Wani K (2012). [\\\"Promoter methylation status of DNA repair gene (hMLH1) in gastric carcinoma patients of the Kashmir valley\\\"](http://ocean.kisti.re.kr/downfile/volume/apocp/POCPA9/2012/v13n8/POCPA9_2012_v13n8_4177.pdf) (PDF). _Asian Pacific Journal of Cancer Prevention_. **13** (8): 4177â€“81\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.7314/APJCP.2012.13.8.4177](https://doi.org/10.7314%2FAPJCP.2012.13.8.4177). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23098428](https://pubmed.ncbi.nlm.nih.gov/23098428).\",\"url\":\"http://ocean.kisti.re.kr/downfile/volume/apocp/POCPA9/2012/v13n8/POCPA9_2012_v13n8_4177.pdf\",\"favicon\":\"\"},{\"id\":\"54\",\"title\":\"** Agarwal A, Polineni R, Hussein Z, Vigoda I, Bhagat TD, Bhattacharyya S, Maitra A, Verma A (2012). [\\\"Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396065). _International Journal of Clinical and Experimental Pathology_. **5** (5): 382â€“96\\\\. [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3396065](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396065). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22808291](https://pubmed.ncbi.nlm.nih.gov/22808291). Review.\",\"description\":\"54. **^** Agarwal A, Polineni R, Hussein Z, Vigoda I, Bhagat TD, Bhattacharyya S, Maitra A, Verma A (2012). [\\\"Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396065). _International Journal of Clinical and Experimental Pathology_. **5** (5): 382â€“96\\\\. [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3396065](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396065). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22808291](https://pubmed.ncbi.nlm.nih.gov/22808291). Review.\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396065\",\"favicon\":\"\"},{\"id\":\"55\",\"title\":\"** Hofstad B, Vatn MH, Andersen SN, Huitfeldt HS, Rognum T, Larsen S, Osnes M (September 1996). [\\\"Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1383355). _Gut_. **39** (3): 449â€“56\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/gut.39.3.449](https://doi.org/10.1136%2Fgut.39.3.449). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1383355](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1383355). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8949653](https://pubmed.ncbi.nlm.nih.gov/8949653).\",\"description\":\"55. **^** Hofstad B, Vatn MH, Andersen SN, Huitfeldt HS, Rognum T, Larsen S, Osnes M (September 1996). [\\\"Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1383355). _Gut_. **39** (3): 449â€“56\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/gut.39.3.449](https://doi.org/10.1136%2Fgut.39.3.449). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1383355](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1383355). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8949653](https://pubmed.ncbi.nlm.nih.gov/8949653).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1383355\",\"favicon\":\"\"},{\"id\":\"56\",\"title\":\"** Schmitt MW, Prindle MJ, Loeb LA (September 2012). [\\\"Implications of genetic heterogeneity in cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674777). _Annals of the New York Academy of Sciences_. **1267** (1): 110â€“6\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2012NYASA1267..110S](https://ui.adsabs.harvard.edu/abs/2012NYASA1267..110S). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1749-6632.2012.06590.x](https://doi.org/10.1111%2Fj.1749-6632.2012.06590.x). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3674777](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674777). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22954224](https://pubmed.ncbi.nlm.nih.gov/22954224).\",\"description\":\"56. **^** Schmitt MW, Prindle MJ, Loeb LA (September 2012). [\\\"Implications of genetic heterogeneity in cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674777). _Annals of the New York Academy of Sciences_. **1267** (1): 110â€“6\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2012NYASA1267..110S](https://ui.adsabs.harvard.edu/abs/2012NYASA1267..110S). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1749-6632.2012.06590.x](https://doi.org/10.1111%2Fj.1749-6632.2012.06590.x). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3674777](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674777). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22954224](https://pubmed.ncbi.nlm.nih.gov/22954224).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674777\",\"favicon\":\"\"},{\"id\":\"57\",\"title\":\"** Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. (February 2001). [\\\"Initial sequencing and analysis of the human genome\\\"](https://doi.org/10.1038%2F35057062). _Nature_. **409** (6822): 860â€“921\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2001Natur.409..860L](https://ui.adsabs.harvard.edu/abs/2001Natur.409..860L). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/35057062](https://doi.org/10.1038%2F35057062). [hdl](Hdl_\\\\(identifier\\\\) \\\"Hdl \\\\(identifier\\\\)\\\"):[2027.42/62798](https://hdl.handle.net/2027.42%2F62798). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11237011](https://pubmed.ncbi.nlm.nih.gov/11237011).\",\"description\":\"57. **^** Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. (February 2001). [\\\"Initial sequencing and analysis of the human genome\\\"](https://doi.org/10.1038%2F35057062). _Nature_. **409** (6822): 860â€“921\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2001Natur.409..860L](https://ui.adsabs.harvard.edu/abs/2001Natur.409..860L). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/35057062](https://doi.org/10.1038%2F35057062). [hdl](Hdl_\\\\(identifier\\\\) \\\"Hdl \\\\(identifier\\\\)\\\"):[2027.42/62798](https://hdl.handle.net/2027.42%2F62798). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11237011](https://pubmed.ncbi.nlm.nih.gov/11237011).\",\"url\":\"https://doi.org/10.1038%2F35057062\",\"favicon\":\"\"},{\"id\":\"58\",\"title\":\"** Yost SE, Smith EN, Schwab RB, Bao L, Jung H, Wang X, Voest E, Pierce JP, Messer K, Parker BA, Harismendy O, Frazer KA (August 2012). [\\\"Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413110). _Nucleic Acids Research_. **40** (14): e107. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/nar/gks299](https://doi.org/10.1093%2Fnar%2Fgks299). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3413110](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413110). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22492626](https://pubmed.ncbi.nlm.nih.gov/22492626).\",\"description\":\"58. **^** Yost SE, Smith EN, Schwab RB, Bao L, Jung H, Wang X, Voest E, Pierce JP, Messer K, Parker BA, Harismendy O, Frazer KA (August 2012). [\\\"Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413110). _Nucleic Acids Research_. **40** (14): e107. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/nar/gks299](https://doi.org/10.1093%2Fnar%2Fgks299). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3413110](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413110). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22492626](https://pubmed.ncbi.nlm.nih.gov/22492626).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413110\",\"favicon\":\"\"},{\"id\":\"59\",\"title\":\"** Berger MF, Hodis E, Heffernan TP, Deribe YL, Lawrence MS, Protopopov A, et al. (May 2012). [\\\"Melanoma genome sequencing reveals frequent PREX2 mutations\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367798). _Nature_. **485** (7399): 502â€“6\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2012Natur.485..502B](https://ui.adsabs.harvard.edu/abs/2012Natur.485..502B). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/nature11071](https://doi.org/10.1038%2Fnature11071). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3367798](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367798). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22622578](https://pubmed.ncbi.nlm.nih.gov/22622578).\",\"description\":\"59. **^** Berger MF, Hodis E, Heffernan TP, Deribe YL, Lawrence MS, Protopopov A, et al. (May 2012). [\\\"Melanoma genome sequencing reveals frequent PREX2 mutations\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367798). _Nature_. **485** (7399): 502â€“6\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2012Natur.485..502B](https://ui.adsabs.harvard.edu/abs/2012Natur.485..502B). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/nature11071](https://doi.org/10.1038%2Fnature11071). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3367798](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367798). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22622578](https://pubmed.ncbi.nlm.nih.gov/22622578).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367798\",\"favicon\":\"\"},{\"id\":\"60\",\"title\":\"** Rasnick D, Duesberg PH (June 1999). [\\\"How aneuploidy affects metabolic control and causes cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1220292). _The Biochemical Journal_. **340** (3): 621â€“30\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1042/0264-6021:3400621](https://doi.org/10.1042%2F0264-6021%3A3400621). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1220292](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1220292). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10359645](https://pubmed.ncbi.nlm.nih.gov/10359645).\",\"description\":\"60. **^** Rasnick D, Duesberg PH (June 1999). [\\\"How aneuploidy affects metabolic control and causes cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1220292). _The Biochemical Journal_. **340** (3): 621â€“30\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1042/0264-6021:3400621](https://doi.org/10.1042%2F0264-6021%3A3400621). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1220292](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1220292). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10359645](https://pubmed.ncbi.nlm.nih.gov/10359645).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1220292\",\"favicon\":\"\"},{\"id\":\"61\",\"title\":\"_**a**_ _**b**_ _**c**_ LÃ³pez-LÃ¡zaro M (March 2010). [\\\"A new view of carcinogenesis and an alternative approach to cancer therapy\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802554). _Molecular Medicine_. **16** (3â€“4): 144â€“53\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2119/molmed.2009.00162](https://doi.org/10.2119%2Fmolmed.2009.00162). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2802554](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802554). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20062820](https://pubmed.ncbi.nlm.nih.gov/20062820).\",\"description\":\"61. ^ _**a**_ _**b**_ _**c**_ LÃ³pez-LÃ¡zaro M (March 2010). [\\\"A new view of carcinogenesis and an alternative approach to cancer therapy\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802554). _Molecular Medicine_. **16** (3â€“4): 144â€“53\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2119/molmed.2009.00162](https://doi.org/10.2119%2Fmolmed.2009.00162). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2802554](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802554). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20062820](https://pubmed.ncbi.nlm.nih.gov/20062820).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802554\",\"favicon\":\"\"},{\"id\":\"62\",\"title\":\"** Juutilainen J, Herrala M, Luukkonen J, Naarala J, Hore PJ (May 2018). [\\\"Magnetocarcinogenesis: is there a mechanism for carcinogenic effects of weak magnetic fields?\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998098). _Proceedings. Biological Sciences_. **285** (1879): 20180590. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1098/rspb.2018.0590](https://doi.org/10.1098%2Frspb.2018.0590). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5998098](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998098). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29794049](https://pubmed.ncbi.nlm.nih.gov/29794049).\",\"description\":\"62. **^** Juutilainen J, Herrala M, Luukkonen J, Naarala J, Hore PJ (May 2018). [\\\"Magnetocarcinogenesis: is there a mechanism for carcinogenic effects of weak magnetic fields?\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998098). _Proceedings. Biological Sciences_. **285** (1879): 20180590. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1098/rspb.2018.0590](https://doi.org/10.1098%2Frspb.2018.0590). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5998098](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998098). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29794049](https://pubmed.ncbi.nlm.nih.gov/29794049).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998098\",\"favicon\":\"\"},{\"id\":\"63\",\"title\":\"** Soto AM, Sonnenschein C (October 2004). \\\"The somatic mutation theory of cancer: growing problems with the paradigm?\\\". _BioEssays_. **26** (10): 1097â€“107\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/bies.20087](https://doi.org/10.1002%2Fbies.20087). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15382143](https://pubmed.ncbi.nlm.nih.gov/15382143).\",\"description\":\"63. **^** Soto AM, Sonnenschein C (October 2004). \\\"The somatic mutation theory of cancer: growing problems with the paradigm?\\\". _BioEssays_. **26** (10): 1097â€“107\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/bies.20087](https://doi.org/10.1002%2Fbies.20087). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15382143](https://pubmed.ncbi.nlm.nih.gov/15382143).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"64\",\"title\":\"** Davies PC, Lineweaver CH (February 2011). [\\\"Cancer tumors as Metazoa 1.0: tapping genes of ancient ancestors\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148211). _Physical Biology_. **8** (1): 015001. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2011PhBio...8a5001D](https://ui.adsabs.harvard.edu/abs/2011PhBio...8a5001D). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1088/1478-3975/8/1/015001](https://doi.org/10.1088%2F1478-3975%2F8%2F1%2F015001). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3148211](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148211). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21301065](https://pubmed.ncbi.nlm.nih.gov/21301065).\",\"description\":\"64. **^** Davies PC, Lineweaver CH (February 2011). [\\\"Cancer tumors as Metazoa 1.0: tapping genes of ancient ancestors\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148211). _Physical Biology_. **8** (1): 015001. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2011PhBio...8a5001D](https://ui.adsabs.harvard.edu/abs/2011PhBio...8a5001D). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1088/1478-3975/8/1/015001](https://doi.org/10.1088%2F1478-3975%2F8%2F1%2F015001). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3148211](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148211). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21301065](https://pubmed.ncbi.nlm.nih.gov/21301065).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148211\",\"favicon\":\"\"},{\"id\":\"65\",\"title\":\"** Dean, Tim. [\\\"Cancer resembles life 1 billion years ago, say astrobiologists\\\"](http://lifescientist.com.au/content/health-medical/news/cancer-resembles-life-1-billion-years-ago-say-astrobiologists-65321653), _Australian Life Scientist_ , 8 February 2011. Retrieved 15 February 2011.\",\"description\":\"65. **^** Dean, Tim. [\\\"Cancer resembles life 1 billion years ago, say astrobiologists\\\"](http://lifescientist.com.au/content/health-medical/news/cancer-resembles-life-1-billion-years-ago-say-astrobiologists-65321653), _Australian Life Scientist_ , 8 February 2011. Retrieved 15 February 2011.\",\"url\":\"http://lifescientist.com.au/content/health-medical/news/cancer-resembles-life-1-billion-years-ago-say-astrobiologists-65321653\",\"favicon\":\"\"},{\"id\":\"66\",\"title\":\"** Sterrer, W (August 2016). [\\\"Cancer - Mutational Resurrection of Prokaryote Endofossils\\\"](https://web.archive.org/web/20220303085903/http://www.cancerhypotheses.org.uk/app/download/6246775/SterrerFV.pdf) (PDF). _Cancer Hypotheses_. **1** (1): 1â€“15\\\\. Archived from [the original](http://www.cancerhypotheses.org.uk/app/download/6246775/SterrerFV.pdf) (PDF) on 3 March 2022. Retrieved 8 May 2019.\",\"description\":\"66. **^** Sterrer, W (August 2016). [\\\"Cancer - Mutational Resurrection of Prokaryote Endofossils\\\"](https://web.archive.org/web/20220303085903/http://www.cancerhypotheses.org.uk/app/download/6246775/SterrerFV.pdf) (PDF). _Cancer Hypotheses_. **1** (1): 1â€“15\\\\. Archived from [the original](http://www.cancerhypotheses.org.uk/app/download/6246775/SterrerFV.pdf) (PDF) on 3 March 2022. Retrieved 8 May 2019.\",\"url\":\"https://web.archive.org/web/20220303085903/http://www.cancerhypotheses.org.uk/app/download/6246775/SterrerFV.pdf\",\"favicon\":\"\"},{\"id\":\"67\",\"title\":\"_**a**_ _**b**_ Nowell PC (October 1976). \\\"The clonal evolution of tumor cell populations\\\". _Science_. **194** (4260): 23â€“8\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1976Sci...194...23N](https://ui.adsabs.harvard.edu/abs/1976Sci...194...23N). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.959840](https://doi.org/10.1126%2Fscience.959840). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [959840](https://pubmed.ncbi.nlm.nih.gov/959840). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [38445059](https://api.semanticscholar.org/CorpusID:38445059).\",\"description\":\"67. ^ _**a**_ _**b**_ Nowell PC (October 1976). \\\"The clonal evolution of tumor cell populations\\\". _Science_. **194** (4260): 23â€“8\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1976Sci...194...23N](https://ui.adsabs.harvard.edu/abs/1976Sci...194...23N). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.959840](https://doi.org/10.1126%2Fscience.959840). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [959840](https://pubmed.ncbi.nlm.nih.gov/959840). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [38445059](https://api.semanticscholar.org/CorpusID:38445059).\",\"url\":\"Bibcode_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"68\",\"title\":\"_**a**_ _**b**_ Merlo LM, Pepper JW, Reid BJ, Maley CC (December 2006). \\\"Cancer as an evolutionary and ecological process\\\". _Nature Reviews. Cancer_. **6** (12): 924â€“35\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/nrc2013](https://doi.org/10.1038%2Fnrc2013). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17109012](https://pubmed.ncbi.nlm.nih.gov/17109012). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [8040576](https://api.semanticscholar.org/CorpusID:8040576).\",\"description\":\"68. ^ _**a**_ _**b**_ Merlo LM, Pepper JW, Reid BJ, Maley CC (December 2006). \\\"Cancer as an evolutionary and ecological process\\\". _Nature Reviews. Cancer_. **6** (12): 924â€“35\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/nrc2013](https://doi.org/10.1038%2Fnrc2013). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17109012](https://pubmed.ncbi.nlm.nih.gov/17109012). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [8040576](https://api.semanticscholar.org/CorpusID:8040576).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"69\",\"title\":\"** Hanahan D, Weinberg RA (January 2000). [\\\"The hallmarks of cancer\\\"](https://doi.org/10.1016%2FS0092-8674%2800%2981683-9). _Cell_. **100** (1): 57â€“70\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0092-8674(00)81683-9](https://doi.org/10.1016%2FS0092-8674%2800%2981683-9). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10647931](https://pubmed.ncbi.nlm.nih.gov/10647931).\",\"description\":\"69. **^** Hanahan D, Weinberg RA (January 2000). [\\\"The hallmarks of cancer\\\"](https://doi.org/10.1016%2FS0092-8674%2800%2981683-9). _Cell_. **100** (1): 57â€“70\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0092-8674(00)81683-9](https://doi.org/10.1016%2FS0092-8674%2800%2981683-9). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10647931](https://pubmed.ncbi.nlm.nih.gov/10647931).\",\"url\":\"https://doi.org/10.1016%2FS0092-8674%2800%2981683-9\",\"favicon\":\"\"},{\"id\":\"70\",\"title\":\"** Lindhout, Rianne; University, Leiden. [\\\"Stiffness and viscosity of cells found to differ in cancer and other diseases\\\"](https://phys.org/news/2024-05-stiffness-viscosity-cells-differ-cancer.html#google_vignette). _phys.org_.\",\"description\":\"70. **^** Lindhout, Rianne; University, Leiden. [\\\"Stiffness and viscosity of cells found to differ in cancer and other diseases\\\"](https://phys.org/news/2024-05-stiffness-viscosity-cells-differ-cancer.html#google_vignette). _phys.org_.\",\"url\":\"https://phys.org/news/2024-05-stiffness-viscosity-cells-differ-cancer.html#google_vignette\",\"favicon\":\"\"},{\"id\":\"71\",\"title\":\"** Cho RW, Clarke MF (February 2008). \\\"Recent advances in cancer stem cells\\\". _Current Opinion in Genetics \u0026 Development_. **18** (1): 48â€“53\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.gde.2008.01.017](https://doi.org/10.1016%2Fj.gde.2008.01.017). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18356041](https://pubmed.ncbi.nlm.nih.gov/18356041).\",\"description\":\"71. **^** Cho RW, Clarke MF (February 2008). \\\"Recent advances in cancer stem cells\\\". _Current Opinion in Genetics \u0026 Development_. **18** (1): 48â€“53\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.gde.2008.01.017](https://doi.org/10.1016%2Fj.gde.2008.01.017). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18356041](https://pubmed.ncbi.nlm.nih.gov/18356041).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"72\",\"title\":\"** Taniguchi K, Wu LW, Grivennikov SI, de Jong PR, Lian I, Yu FX, Wang K, Ho SB, Boland BS, Chang JT, Sandborn WJ, Hardiman G, Raz E, Maehara Y, Yoshimura A, Zucman-Rossi J, Guan KL, Karin M (March 2015). [\\\"A gp130-Src-YAP module links inflammation to epithelial regeneration\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447318). _Nature_. **519** (7541): 57â€“62\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2015Natur.519...57T](https://ui.adsabs.harvard.edu/abs/2015Natur.519...57T). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/nature14228](https://doi.org/10.1038%2Fnature14228). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4447318](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447318). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25731159](https://pubmed.ncbi.nlm.nih.gov/25731159).\",\"description\":\"72. **^** Taniguchi K, Wu LW, Grivennikov SI, de Jong PR, Lian I, Yu FX, Wang K, Ho SB, Boland BS, Chang JT, Sandborn WJ, Hardiman G, Raz E, Maehara Y, Yoshimura A, Zucman-Rossi J, Guan KL, Karin M (March 2015). [\\\"A gp130-Src-YAP module links inflammation to epithelial regeneration\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447318). _Nature_. **519** (7541): 57â€“62\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2015Natur.519...57T](https://ui.adsabs.harvard.edu/abs/2015Natur.519...57T). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/nature14228](https://doi.org/10.1038%2Fnature14228). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4447318](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447318). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25731159](https://pubmed.ncbi.nlm.nih.gov/25731159).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447318\",\"favicon\":\"\"},{\"id\":\"73\",\"title\":\"** You H, Lei P, Andreadis ST (December 2013). [\\\"JNK is a novel regulator of intercellular adhesion\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942331). _Tissue Barriers_. **1** (5): e26845. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.4161/tisb.26845](https://doi.org/10.4161%2Ftisb.26845). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3942331](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942331). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24868495](https://pubmed.ncbi.nlm.nih.gov/24868495).\",\"description\":\"73. **^** You H, Lei P, Andreadis ST (December 2013). [\\\"JNK is a novel regulator of intercellular adhesion\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942331). _Tissue Barriers_. **1** (5): e26845. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.4161/tisb.26845](https://doi.org/10.4161%2Ftisb.26845). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3942331](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942331). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24868495](https://pubmed.ncbi.nlm.nih.gov/24868495).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942331\",\"favicon\":\"\"},{\"id\":\"74\",\"title\":\"** Busillo JM, Azzam KM, Cidlowski JA (November 2011). [\\\"Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207479). _The Journal of Biological Chemistry_. **286** (44): 38703â€“13\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.M111.275370](https://doi.org/10.1074%2Fjbc.M111.275370). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3207479](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207479). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21940629](https://pubmed.ncbi.nlm.nih.gov/21940629).\",\"description\":\"74. **^** Busillo JM, Azzam KM, Cidlowski JA (November 2011). [\\\"Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207479). _The Journal of Biological Chemistry_. **286** (44): 38703â€“13\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.M111.275370](https://doi.org/10.1074%2Fjbc.M111.275370). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3207479](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207479). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21940629](https://pubmed.ncbi.nlm.nih.gov/21940629).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207479\",\"favicon\":\"\"},{\"id\":\"75\",\"title\":\"** Wang Y, Bugatti M, Ulland TK, Vermi W, Gilfillan S, Colonna M (March 2016). [\\\"Nonredundant roles of keratinocyte-derived IL-34 and neutrophil-derived CSF1 in Langerhans cell renewal in the steady state and during inflammation\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658206). _European Journal of Immunology_. **46** (3): 552â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/eji.201545917](https://doi.org/10.1002%2Feji.201545917). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5658206](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658206). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26634935](https://pubmed.ncbi.nlm.nih.gov/26634935).\",\"description\":\"75. **^** Wang Y, Bugatti M, Ulland TK, Vermi W, Gilfillan S, Colonna M (March 2016). [\\\"Nonredundant roles of keratinocyte-derived IL-34 and neutrophil-derived CSF1 in Langerhans cell renewal in the steady state and during inflammation\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658206). _European Journal of Immunology_. **46** (3): 552â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/eji.201545917](https://doi.org/10.1002%2Feji.201545917). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5658206](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658206). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26634935](https://pubmed.ncbi.nlm.nih.gov/26634935).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658206\",\"favicon\":\"\"},{\"id\":\"76\",\"title\":\"** Siqueira Mietto B, Kroner A, Girolami EI, Santos-Nogueira E, Zhang J, David S (December 2015). [\\\"Role of IL-10 in Resolution of Inflammation and Functional Recovery after Peripheral Nerve Injury\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605511). _The Journal of Neuroscience_. **35** (50): 16431â€“42\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1523/JNEUROSCI.2119-15.2015](https://doi.org/10.1523%2FJNEUROSCI.2119-15.2015). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6605511](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605511). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26674868](https://pubmed.ncbi.nlm.nih.gov/26674868).\",\"description\":\"76. **^** Siqueira Mietto B, Kroner A, Girolami EI, Santos-Nogueira E, Zhang J, David S (December 2015). [\\\"Role of IL-10 in Resolution of Inflammation and Functional Recovery after Peripheral Nerve Injury\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605511). _The Journal of Neuroscience_. **35** (50): 16431â€“42\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1523/JNEUROSCI.2119-15.2015](https://doi.org/10.1523%2FJNEUROSCI.2119-15.2015). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6605511](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605511). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26674868](https://pubmed.ncbi.nlm.nih.gov/26674868).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605511\",\"favicon\":\"\"},{\"id\":\"77\",\"title\":\"** Seifert AW, Maden M (2014). \\\"New insights into vertebrate skin regeneration\\\". _International Review of Cell and Molecular Biology_. Vol. 310\\\\. pp. 129â€“69\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/B978-0-12-800180-6.00004-9](https://doi.org/10.1016%2FB978-0-12-800180-6.00004-9). [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-12-800180-6. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24725426](https://pubmed.ncbi.nlm.nih.gov/24725426). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [22554281](https://api.semanticscholar.org/CorpusID:22554281).\",\"description\":\"77. **^** Seifert AW, Maden M (2014). \\\"New insights into vertebrate skin regeneration\\\". _International Review of Cell and Molecular Biology_. Vol. 310\\\\. pp. 129â€“69\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/B978-0-12-800180-6.00004-9](https://doi.org/10.1016%2FB978-0-12-800180-6.00004-9). [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-12-800180-6. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24725426](https://pubmed.ncbi.nlm.nih.gov/24725426). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [22554281](https://api.semanticscholar.org/CorpusID:22554281).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"78\",\"title\":\"** Kwon MJ, Shin HY, Cui Y, Kim H, Thi AH, Choi JY, Kim EY, Hwang DH, Kim BG (December 2015). [\\\"CCL2 Mediates Neuron-Macrophage Interactions to Drive Proregenerative Macrophage Activation Following Preconditioning Injury\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605453). _The Journal of Neuroscience_. **35** (48): 15934â€“47\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1523/JNEUROSCI.1924-15.2015](https://doi.org/10.1523%2FJNEUROSCI.1924-15.2015). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6605453](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605453). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26631474](https://pubmed.ncbi.nlm.nih.gov/26631474).\",\"description\":\"78. **^** Kwon MJ, Shin HY, Cui Y, Kim H, Thi AH, Choi JY, Kim EY, Hwang DH, Kim BG (December 2015). [\\\"CCL2 Mediates Neuron-Macrophage Interactions to Drive Proregenerative Macrophage Activation Following Preconditioning Injury\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605453). _The Journal of Neuroscience_. **35** (48): 15934â€“47\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1523/JNEUROSCI.1924-15.2015](https://doi.org/10.1523%2FJNEUROSCI.1924-15.2015). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6605453](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605453). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26631474](https://pubmed.ncbi.nlm.nih.gov/26631474).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605453\",\"favicon\":\"\"},{\"id\":\"79\",\"title\":\"** Hajishengallis G, Chavakis T (January 2013). [\\\"Endogenous modulators of inflammatory cell recruitment\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703146). _Trends in Immunology_. **34** (1): 1â€“6\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.it.2012.08.003](https://doi.org/10.1016%2Fj.it.2012.08.003). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3703146](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703146). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22951309](https://pubmed.ncbi.nlm.nih.gov/22951309).\",\"description\":\"79. **^** Hajishengallis G, Chavakis T (January 2013). [\\\"Endogenous modulators of inflammatory cell recruitment\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703146). _Trends in Immunology_. **34** (1): 1â€“6\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.it.2012.08.003](https://doi.org/10.1016%2Fj.it.2012.08.003). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3703146](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703146). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22951309](https://pubmed.ncbi.nlm.nih.gov/22951309).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703146\",\"favicon\":\"\"},{\"id\":\"80\",\"title\":\"** Nelson AM, Katseff AS, Ratliff TS, Garza LA (February 2016). [\\\"Interleukin 6 and STAT3 regulate p63 isoform expression in keratinocytes during regeneration\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724264). _Experimental Dermatology_. **25** (2): 155â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/exd.12896](https://doi.org/10.1111%2Fexd.12896). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4724264](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724264). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26566817](https://pubmed.ncbi.nlm.nih.gov/26566817).\",\"description\":\"80. **^** Nelson AM, Katseff AS, Ratliff TS, Garza LA (February 2016). [\\\"Interleukin 6 and STAT3 regulate p63 isoform expression in keratinocytes during regeneration\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724264). _Experimental Dermatology_. **25** (2): 155â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/exd.12896](https://doi.org/10.1111%2Fexd.12896). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4724264](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724264). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26566817](https://pubmed.ncbi.nlm.nih.gov/26566817).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724264\",\"favicon\":\"\"},{\"id\":\"81\",\"title\":\"** Vidal PM, Lemmens E, Dooley D, Hendrix S (February 2013). \\\"The role of \\\"anti-inflammatory\\\" cytokines in axon regeneration\\\". _Cytokine \u0026 Growth Factor Reviews_. **24** (1): 1â€“12\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.cytogfr.2012.08.008](https://doi.org/10.1016%2Fj.cytogfr.2012.08.008). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22985997](https://pubmed.ncbi.nlm.nih.gov/22985997).\",\"description\":\"81. **^** Vidal PM, Lemmens E, Dooley D, Hendrix S (February 2013). \\\"The role of \\\"anti-inflammatory\\\" cytokines in axon regeneration\\\". _Cytokine \u0026 Growth Factor Reviews_. **24** (1): 1â€“12\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.cytogfr.2012.08.008](https://doi.org/10.1016%2Fj.cytogfr.2012.08.008). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22985997](https://pubmed.ncbi.nlm.nih.gov/22985997).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"82\",\"title\":\"** Hsueh YY, Chang YJ, Huang CW, Handayani F, Chiang YL, Fan SC, Ho CJ, Kuo YM, Yang SH, Chen YL, Lin SC, Huang CC, Wu CC (October 2015). [\\\"Synergy of endothelial and neural progenitor cells from adipose-derived stem cells to preserve neurovascular structures in rat hypoxic-ischemic brain injury\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597209). _Scientific Reports_. **5** 14985\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2015NatSR...514985H](https://ui.adsabs.harvard.edu/abs/2015NatSR...514985H). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/srep14985](https://doi.org/10.1038%2Fsrep14985). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4597209](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597209). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26447335](https://pubmed.ncbi.nlm.nih.gov/26447335).\",\"description\":\"82. **^** Hsueh YY, Chang YJ, Huang CW, Handayani F, Chiang YL, Fan SC, Ho CJ, Kuo YM, Yang SH, Chen YL, Lin SC, Huang CC, Wu CC (October 2015). [\\\"Synergy of endothelial and neural progenitor cells from adipose-derived stem cells to preserve neurovascular structures in rat hypoxic-ischemic brain injury\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597209). _Scientific Reports_. **5** 14985\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2015NatSR...514985H](https://ui.adsabs.harvard.edu/abs/2015NatSR...514985H). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/srep14985](https://doi.org/10.1038%2Fsrep14985). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4597209](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597209). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26447335](https://pubmed.ncbi.nlm.nih.gov/26447335).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597209\",\"favicon\":\"\"},{\"id\":\"83\",\"title\":\"** Yaniv M (September 2014). \\\"Chromatin remodeling: from transcription to cancer\\\". _Cancer Genetics_. **207** (9): 352â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.cancergen.2014.03.006](https://doi.org/10.1016%2Fj.cancergen.2014.03.006). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24825771](https://pubmed.ncbi.nlm.nih.gov/24825771).\",\"description\":\"83. **^** Yaniv M (September 2014). \\\"Chromatin remodeling: from transcription to cancer\\\". _Cancer Genetics_. **207** (9): 352â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.cancergen.2014.03.006](https://doi.org/10.1016%2Fj.cancergen.2014.03.006). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24825771](https://pubmed.ncbi.nlm.nih.gov/24825771).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"84\",\"title\":\"** Zhang X, He N, Gu D, Wickliffe J, Salazar J, Boldogh I, Xie J (October 2015). [\\\"Genetic Evidence for XPC-KRAS Interactions During Lung Cancer Development\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643398). _Journal of Genetics and Genomics = Yi Chuan Xue Bao_. **42** (10): 589â€“96\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.jgg.2015.09.006](https://doi.org/10.1016%2Fj.jgg.2015.09.006). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4643398](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643398). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26554912](https://pubmed.ncbi.nlm.nih.gov/26554912).\",\"description\":\"84. **^** Zhang X, He N, Gu D, Wickliffe J, Salazar J, Boldogh I, Xie J (October 2015). [\\\"Genetic Evidence for XPC-KRAS Interactions During Lung Cancer Development\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643398). _Journal of Genetics and Genomics = Yi Chuan Xue Bao_. **42** (10): 589â€“96\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.jgg.2015.09.006](https://doi.org/10.1016%2Fj.jgg.2015.09.006). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4643398](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643398). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26554912](https://pubmed.ncbi.nlm.nih.gov/26554912).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643398\",\"favicon\":\"\"},{\"id\":\"85\",\"title\":\"** Dubois-Pot-Schneider H, Fekir K, Coulouarn C, Glaise D, Aninat C, Jarnouen K, Le GuÃ©vel R, Kubo T, Ishida S, Morel F, Corlu A (December 2014). \\\"Inflammatory cytokines promote the retrodifferentiation of tumor-derived hepatocyte-like cells to progenitor cells\\\". _Hepatology_. **60** (6): 2077â€“90\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/hep.27353](https://doi.org/10.1002%2Fhep.27353). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25098666](https://pubmed.ncbi.nlm.nih.gov/25098666). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [11182192](https://api.semanticscholar.org/CorpusID:11182192).\",\"description\":\"85. **^** Dubois-Pot-Schneider H, Fekir K, Coulouarn C, Glaise D, Aninat C, Jarnouen K, Le GuÃ©vel R, Kubo T, Ishida S, Morel F, Corlu A (December 2014). \\\"Inflammatory cytokines promote the retrodifferentiation of tumor-derived hepatocyte-like cells to progenitor cells\\\". _Hepatology_. **60** (6): 2077â€“90\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/hep.27353](https://doi.org/10.1002%2Fhep.27353). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25098666](https://pubmed.ncbi.nlm.nih.gov/25098666). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [11182192](https://api.semanticscholar.org/CorpusID:11182192).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"86\",\"title\":\"** Finkin S, Yuan D, Stein I, Taniguchi K, Weber A, Unger K, et al. (December 2015). [\\\"Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653079). _Nature Immunology_. **16** (12): 1235â€“44\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/ni.3290](https://doi.org/10.1038%2Fni.3290). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4653079](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653079). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26502405](https://pubmed.ncbi.nlm.nih.gov/26502405).\",\"description\":\"86. **^** Finkin S, Yuan D, Stein I, Taniguchi K, Weber A, Unger K, et al. (December 2015). [\\\"Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653079). _Nature Immunology_. **16** (12): 1235â€“44\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/ni.3290](https://doi.org/10.1038%2Fni.3290). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4653079](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653079). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26502405](https://pubmed.ncbi.nlm.nih.gov/26502405).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653079\",\"favicon\":\"\"},{\"id\":\"87\",\"title\":\"** Beane JE, Mazzilli SA, Campbell JD, Duclos G, Krysan K, Moy C, et al. (April 2019). [\\\"Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478943). _Nature Communications_. **10** (1) 1856. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2019NatCo..10.1856B](https://ui.adsabs.harvard.edu/abs/2019NatCo..10.1856B). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/s41467-019-09834-2](https://doi.org/10.1038%2Fs41467-019-09834-2). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6478943](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478943). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [31015447](https://pubmed.ncbi.nlm.nih.gov/31015447).\",\"description\":\"87. **^** Beane JE, Mazzilli SA, Campbell JD, Duclos G, Krysan K, Moy C, et al. (April 2019). [\\\"Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478943). _Nature Communications_. **10** (1) 1856. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2019NatCo..10.1856B](https://ui.adsabs.harvard.edu/abs/2019NatCo..10.1856B). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/s41467-019-09834-2](https://doi.org/10.1038%2Fs41467-019-09834-2). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6478943](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478943). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [31015447](https://pubmed.ncbi.nlm.nih.gov/31015447).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478943\",\"favicon\":\"\"},{\"id\":\"88\",\"title\":\"** Maoz A, Merenstein C, Koga Y, Potter A, Gower AC, Liu G, et al. (September 2021). [\\\"Elevated T cell repertoire diversity is associated with progression of lung squamous cell premalignant lesions\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477334). _Journal for Immunotherapy of Cancer_. **9** (9): e002647. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/jitc-2021-002647](https://doi.org/10.1136%2Fjitc-2021-002647). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [8477334](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477334). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [34580161](https://pubmed.ncbi.nlm.nih.gov/34580161).\",\"description\":\"88. **^** Maoz A, Merenstein C, Koga Y, Potter A, Gower AC, Liu G, et al. (September 2021). [\\\"Elevated T cell repertoire diversity is associated with progression of lung squamous cell premalignant lesions\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477334). _Journal for Immunotherapy of Cancer_. **9** (9): e002647. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/jitc-2021-002647](https://doi.org/10.1136%2Fjitc-2021-002647). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [8477334](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477334). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [34580161](https://pubmed.ncbi.nlm.nih.gov/34580161).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477334\",\"favicon\":\"\"},{\"id\":\"89\",\"title\":\"_**a**_ _**b**_ Vlahopoulos SA, Cen O, Hengen N, Agan J, Moschovi M, Critselis E, Adamaki M, Bacopoulou F, Copland JA, Boldogh I, Karin M, Chrousos GP (August 2015). [\\\"Dynamic aberrant NF-ÎºB spurs tumorigenesis: a new model encompassing the microenvironment\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526340). _Cytokine \u0026 Growth Factor Reviews_. **26** (4): 389â€“403\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.cytogfr.2015.06.001](https://doi.org/10.1016%2Fj.cytogfr.2015.06.001). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4526340](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526340). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26119834](https://pubmed.ncbi.nlm.nih.gov/26119834).\",\"description\":\"89. ^ _**a**_ _**b**_ Vlahopoulos SA, Cen O, Hengen N, Agan J, Moschovi M, Critselis E, Adamaki M, Bacopoulou F, Copland JA, Boldogh I, Karin M, Chrousos GP (August 2015). [\\\"Dynamic aberrant NF-ÎºB spurs tumorigenesis: a new model encompassing the microenvironment\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526340). _Cytokine \u0026 Growth Factor Reviews_. **26** (4): 389â€“403\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.cytogfr.2015.06.001](https://doi.org/10.1016%2Fj.cytogfr.2015.06.001). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4526340](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526340). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26119834](https://pubmed.ncbi.nlm.nih.gov/26119834).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526340\",\"favicon\":\"\"},{\"id\":\"90\",\"title\":\"** Grivennikov SI, Karin M (February 2010). [\\\"Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834864). _Cytokine \u0026 Growth Factor Reviews_. **21** (1): 11â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.cytogfr.2009.11.005](https://doi.org/10.1016%2Fj.cytogfr.2009.11.005). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2834864](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834864). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20018552](https://pubmed.ncbi.nlm.nih.gov/20018552).\",\"description\":\"90. **^** Grivennikov SI, Karin M (February 2010). [\\\"Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834864). _Cytokine \u0026 Growth Factor Reviews_. **21** (1): 11â€“9\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.cytogfr.2009.11.005](https://doi.org/10.1016%2Fj.cytogfr.2009.11.005). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2834864](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834864). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20018552](https://pubmed.ncbi.nlm.nih.gov/20018552).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834864\",\"favicon\":\"\"},{\"id\":\"91\",\"title\":\"** Rieger S, Zhao H, Martin P, Abe K, Lisse TS (January 2015). [\\\"The role of nuclear hormone receptors in cutaneous wound repair\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357276). _Cell Biochemistry and Function_. **33** (1): 1â€“13\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/cbf.3086](https://doi.org/10.1002%2Fcbf.3086). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4357276](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357276). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25529612](https://pubmed.ncbi.nlm.nih.gov/25529612).\",\"description\":\"91. **^** Rieger S, Zhao H, Martin P, Abe K, Lisse TS (January 2015). [\\\"The role of nuclear hormone receptors in cutaneous wound repair\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357276). _Cell Biochemistry and Function_. **33** (1): 1â€“13\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/cbf.3086](https://doi.org/10.1002%2Fcbf.3086). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4357276](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357276). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25529612](https://pubmed.ncbi.nlm.nih.gov/25529612).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357276\",\"favicon\":\"\"},{\"id\":\"92\",\"title\":\"** Lu X, Yarbrough WG (February 2015). \\\"Negative regulation of RelA phosphorylation: emerging players and their roles in cancer\\\". _Cytokine \u0026 Growth Factor Reviews_. **26** (1): 7â€“13\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.cytogfr.2014.09.003](https://doi.org/10.1016%2Fj.cytogfr.2014.09.003). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25438737](https://pubmed.ncbi.nlm.nih.gov/25438737).\",\"description\":\"92. **^** Lu X, Yarbrough WG (February 2015). \\\"Negative regulation of RelA phosphorylation: emerging players and their roles in cancer\\\". _Cytokine \u0026 Growth Factor Reviews_. **26** (1): 7â€“13\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.cytogfr.2014.09.003](https://doi.org/10.1016%2Fj.cytogfr.2014.09.003). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25438737](https://pubmed.ncbi.nlm.nih.gov/25438737).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"93\",\"title\":\"** Sionov RV, Fridlender ZG, Granot Z (December 2015). [\\\"The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714999). _Cancer Microenvironment_. **8** (3): 125â€“58\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s12307-014-0147-5](https://doi.org/10.1007%2Fs12307-014-0147-5). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4714999](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714999). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24895166](https://pubmed.ncbi.nlm.nih.gov/24895166).\",\"description\":\"93. **^** Sionov RV, Fridlender ZG, Granot Z (December 2015). [\\\"The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714999). _Cancer Microenvironment_. **8** (3): 125â€“58\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s12307-014-0147-5](https://doi.org/10.1007%2Fs12307-014-0147-5). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4714999](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714999). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24895166](https://pubmed.ncbi.nlm.nih.gov/24895166).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714999\",\"favicon\":\"\"},{\"id\":\"94\",\"title\":\"** Venturi, Sebastiano (2011). \\\"Evolutionary Significance of Iodine\\\". _Current Chemical Biology_. **5** (3): 155â€“162\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2174/187231311796765012](https://doi.org/10.2174%2F187231311796765012) (inactive 11 July 2025). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [1872-3136](https://search.worldcat.org/issn/1872-3136).`{{cite journal}}`: CS1 maint: DOI inactive as of July 2025 (link)\",\"description\":\"94. **^** Venturi, Sebastiano (2011). \\\"Evolutionary Significance of Iodine\\\". _Current Chemical Biology_. **5** (3): 155â€“162\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2174/187231311796765012](https://doi.org/10.2174%2F187231311796765012) (inactive 11 July 2025). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [1872-3136](https://search.worldcat.org/issn/1872-3136).`{{cite journal}}`: CS1 maint: DOI inactive as of July 2025 (link)\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"95\",\"title\":\"** Venturi S (2014). \\\"Iodine, PUFAs and Iodolipids in Health and Disease: An Evolutionary Perspective\\\". _Human Evolution_. **29** (1â€“3): 185â€“205\\\\. [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0393-9375](https://search.worldcat.org/issn/0393-9375).\",\"description\":\"95. **^** Venturi S (2014). \\\"Iodine, PUFAs and Iodolipids in Health and Disease: An Evolutionary Perspective\\\". _Human Evolution_. **29** (1â€“3): 185â€“205\\\\. [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0393-9375](https://search.worldcat.org/issn/0393-9375).\",\"url\":\"ISSN_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"96\",\"title\":\"** Walsh CJ, Luer CA, Bodine AB, Smith CA, Cox HL, Noyes DR, Maura G (December 2006). [\\\"Elasmobranch immune cells as a source of novel tumor cell inhibitors: Implications for public health\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664222). _Integrative and Comparative Biology_. **46** (6): 1072â€“1081\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/icb/icl041](https://doi.org/10.1093%2Ficb%2Ficl041). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2664222](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664222). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19343108](https://pubmed.ncbi.nlm.nih.gov/19343108).\",\"description\":\"96. **^** Walsh CJ, Luer CA, Bodine AB, Smith CA, Cox HL, Noyes DR, Maura G (December 2006). [\\\"Elasmobranch immune cells as a source of novel tumor cell inhibitors: Implications for public health\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664222). _Integrative and Comparative Biology_. **46** (6): 1072â€“1081\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/icb/icl041](https://doi.org/10.1093%2Ficb%2Ficl041). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2664222](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664222). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19343108](https://pubmed.ncbi.nlm.nih.gov/19343108).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664222\",\"favicon\":\"\"},{\"id\":\"97\",\"title\":\"** Vogelstein B, Kinzler KW (August 2004). \\\"Cancer genes and the pathways they control\\\". _Nature Medicine_. **10** (8): 789â€“99\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/nm1087](https://doi.org/10.1038%2Fnm1087). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15286780](https://pubmed.ncbi.nlm.nih.gov/15286780). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [205383514](https://api.semanticscholar.org/CorpusID:205383514).\",\"description\":\"97. **^** Vogelstein B, Kinzler KW (August 2004). \\\"Cancer genes and the pathways they control\\\". _Nature Medicine_. **10** (8): 789â€“99\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/nm1087](https://doi.org/10.1038%2Fnm1087). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15286780](https://pubmed.ncbi.nlm.nih.gov/15286780). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [205383514](https://api.semanticscholar.org/CorpusID:205383514).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"98\",\"title\":\"** Brand KA, Hermfisse U (April 1997). [\\\"Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species\\\"](https://doi.org/10.1096%2Ffasebj.11.5.9141507). _FASEB Journal_. **11** (5): 388â€“95\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1096/fasebj.11.5.9141507](https://doi.org/10.1096%2Ffasebj.11.5.9141507). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9141507](https://pubmed.ncbi.nlm.nih.gov/9141507). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [16745745](https://api.semanticscholar.org/CorpusID:16745745).\",\"description\":\"98. **^** Brand KA, Hermfisse U (April 1997). [\\\"Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species\\\"](https://doi.org/10.1096%2Ffasebj.11.5.9141507). _FASEB Journal_. **11** (5): 388â€“95\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1096/fasebj.11.5.9141507](https://doi.org/10.1096%2Ffasebj.11.5.9141507). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9141507](https://pubmed.ncbi.nlm.nih.gov/9141507). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [16745745](https://api.semanticscholar.org/CorpusID:16745745).\",\"url\":\"https://doi.org/10.1096%2Ffasebj.11.5.9141507\",\"favicon\":\"\"},{\"id\":\"99\",\"title\":\"** Bos JL (September 1989). [\\\"ras oncogenes in human cancer: a review\\\"](http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long\u0026pmid=2547513). _Cancer Research_. **49** (17): 4682â€“9\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [2547513](https://pubmed.ncbi.nlm.nih.gov/2547513).\",\"description\":\"99. **^** Bos JL (September 1989). [\\\"ras oncogenes in human cancer: a review\\\"](http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long\u0026pmid=2547513). _Cancer Research_. **49** (17): 4682â€“9\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [2547513](https://pubmed.ncbi.nlm.nih.gov/2547513).\",\"url\":\"http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long\u0026pmid=2547513\",\"favicon\":\"\"},{\"id\":\"100\",\"title\":\"** Chang EH, Furth ME, Scolnick EM, Lowy DR (June 1982). \\\"Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus\\\". _Nature_. **297** (5866): 479â€“83\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1982Natur.297..479C](https://ui.adsabs.harvard.edu/abs/1982Natur.297..479C). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/297479a0](https://doi.org/10.1038%2F297479a0). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [6283358](https://pubmed.ncbi.nlm.nih.gov/6283358). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [4234621](https://api.semanticscholar.org/CorpusID:4234621).\",\"description\":\"100. **^** Chang EH, Furth ME, Scolnick EM, Lowy DR (June 1982). \\\"Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus\\\". _Nature_. **297** (5866): 479â€“83\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1982Natur.297..479C](https://ui.adsabs.harvard.edu/abs/1982Natur.297..479C). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/297479a0](https://doi.org/10.1038%2F297479a0). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [6283358](https://pubmed.ncbi.nlm.nih.gov/6283358). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [4234621](https://api.semanticscholar.org/CorpusID:4234621).\",\"url\":\"Bibcode_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"101\",\"title\":\"** Zhan H, Bhattacharya S, Cai H, Iglesias PA, Huang CH, Devreotes PN (September 2020). [\\\"An excitable Ras/PI3K/ERK signaling network controls migration and oncogenic transformation in epithelial cells\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505206). _Developmental Cell_. **54** (5): 608â€“623\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.devcel.2020.08.001](https://doi.org/10.1016%2Fj.devcel.2020.08.001). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [7505206](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505206). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [32877650](https://pubmed.ncbi.nlm.nih.gov/32877650).\",\"description\":\"101. **^** Zhan H, Bhattacharya S, Cai H, Iglesias PA, Huang CH, Devreotes PN (September 2020). [\\\"An excitable Ras/PI3K/ERK signaling network controls migration and oncogenic transformation in epithelial cells\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505206). _Developmental Cell_. **54** (5): 608â€“623\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.devcel.2020.08.001](https://doi.org/10.1016%2Fj.devcel.2020.08.001). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [7505206](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505206). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [32877650](https://pubmed.ncbi.nlm.nih.gov/32877650).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505206\",\"favicon\":\"\"},{\"id\":\"102\",\"title\":\"** Vlahopoulos SA, Logotheti S, Mikas D, Giarika A, Gorgoulis V, Zoumpourlis V (April 2008). \\\"The role of ATF-2 in oncogenesis\\\". _BioEssays_. **30** (4): 314â€“27\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/bies.20734](https://doi.org/10.1002%2Fbies.20734). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18348191](https://pubmed.ncbi.nlm.nih.gov/18348191). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [678541](https://api.semanticscholar.org/CorpusID:678541).\",\"description\":\"102. **^** Vlahopoulos SA, Logotheti S, Mikas D, Giarika A, Gorgoulis V, Zoumpourlis V (April 2008). \\\"The role of ATF-2 in oncogenesis\\\". _BioEssays_. **30** (4): 314â€“27\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/bies.20734](https://doi.org/10.1002%2Fbies.20734). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18348191](https://pubmed.ncbi.nlm.nih.gov/18348191). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [678541](https://api.semanticscholar.org/CorpusID:678541).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"103\",\"title\":\"** Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM (June 2006). \\\"p53 regulates mitochondrial respiration\\\". _Science_. **312** (5780): 1650â€“3\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2006Sci...312.1650M](https://ui.adsabs.harvard.edu/abs/2006Sci...312.1650M). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.1126863](https://doi.org/10.1126%2Fscience.1126863). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16728594](https://pubmed.ncbi.nlm.nih.gov/16728594). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [36668814](https://api.semanticscholar.org/CorpusID:36668814).\",\"description\":\"103. **^** Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM (June 2006). \\\"p53 regulates mitochondrial respiration\\\". _Science_. **312** (5780): 1650â€“3\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2006Sci...312.1650M](https://ui.adsabs.harvard.edu/abs/2006Sci...312.1650M). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.1126863](https://doi.org/10.1126%2Fscience.1126863). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16728594](https://pubmed.ncbi.nlm.nih.gov/16728594). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [36668814](https://api.semanticscholar.org/CorpusID:36668814).\",\"url\":\"Bibcode_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"104\",\"title\":\"** Knudson AG (April 1971). [\\\"Mutation and cancer: statistical study of retinoblastoma\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC389051). _Proceedings of the National Academy of Sciences of the United States of America_. **68** (4): 820â€“3\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1971PNAS...68..820K](https://ui.adsabs.harvard.edu/abs/1971PNAS...68..820K). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1073/pnas.68.4.820](https://doi.org/10.1073%2Fpnas.68.4.820). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [389051](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC389051). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [5279523](https://pubmed.ncbi.nlm.nih.gov/5279523).\",\"description\":\"104. **^** Knudson AG (April 1971). [\\\"Mutation and cancer: statistical study of retinoblastoma\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC389051). _Proceedings of the National Academy of Sciences of the United States of America_. **68** (4): 820â€“3\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1971PNAS...68..820K](https://ui.adsabs.harvard.edu/abs/1971PNAS...68..820K). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1073/pnas.68.4.820](https://doi.org/10.1073%2Fpnas.68.4.820). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [389051](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC389051). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [5279523](https://pubmed.ncbi.nlm.nih.gov/5279523).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC389051\",\"favicon\":\"\"},{\"id\":\"105\",\"title\":\"** Fodde R, Smits R (October 2002). \\\"Cancer biology. A matter of dosage\\\". _Science_. **298** (5594): 761â€“3\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.1077707](https://doi.org/10.1126%2Fscience.1077707). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12399571](https://pubmed.ncbi.nlm.nih.gov/12399571). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [50724](https://api.semanticscholar.org/CorpusID:50724).\",\"description\":\"105. **^** Fodde R, Smits R (October 2002). \\\"Cancer biology. A matter of dosage\\\". _Science_. **298** (5594): 761â€“3\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.1077707](https://doi.org/10.1126%2Fscience.1077707). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12399571](https://pubmed.ncbi.nlm.nih.gov/12399571). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [50724](https://api.semanticscholar.org/CorpusID:50724).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"106\",\"title\":\"** Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, et al. (January 2011). [\\\"Massive genomic rearrangement acquired in a single catastrophic event during cancer development\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065307). _Cell_. **144** (1): 27â€“40\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.cell.2010.11.055](https://doi.org/10.1016%2Fj.cell.2010.11.055). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3065307](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065307). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21215367](https://pubmed.ncbi.nlm.nih.gov/21215367).\",\"description\":\"106. **^** Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, et al. (January 2011). [\\\"Massive genomic rearrangement acquired in a single catastrophic event during cancer development\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065307). _Cell_. **144** (1): 27â€“40\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.cell.2010.11.055](https://doi.org/10.1016%2Fj.cell.2010.11.055). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3065307](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065307). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21215367](https://pubmed.ncbi.nlm.nih.gov/21215367).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065307\",\"favicon\":\"\"},{\"id\":\"107\",\"title\":\"** Kuipers EJ (March 1999). [\\\"Review article: exploring the link between Helicobacter pylori and gastric cancer\\\"](https://doi.org/10.1046%2Fj.1365-2036.1999.00002.x). _Alimentary Pharmacology \u0026 Therapeutics_. **13** (Suppl 1): 3â€“11\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1046/j.1365-2036.1999.00002.x](https://doi.org/10.1046%2Fj.1365-2036.1999.00002.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10209681](https://pubmed.ncbi.nlm.nih.gov/10209681).\",\"description\":\"107. **^** Kuipers EJ (March 1999). [\\\"Review article: exploring the link between Helicobacter pylori and gastric cancer\\\"](https://doi.org/10.1046%2Fj.1365-2036.1999.00002.x). _Alimentary Pharmacology \u0026 Therapeutics_. **13** (Suppl 1): 3â€“11\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1046/j.1365-2036.1999.00002.x](https://doi.org/10.1046%2Fj.1365-2036.1999.00002.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10209681](https://pubmed.ncbi.nlm.nih.gov/10209681).\",\"url\":\"https://doi.org/10.1046%2Fj.1365-2036.1999.00002.x\",\"favicon\":\"\"},{\"id\":\"108\",\"title\":\"** Kusters JG, van Vliet AH, Kuipers EJ (July 2006). [\\\"Pathogenesis of Helicobacter pylori infection\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1539101). _Clin. Microbiol. Rev_. **19** (3): 449â€“90\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1128/CMR.00054-05](https://doi.org/10.1128%2FCMR.00054-05). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1539101](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1539101). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16847081](https://pubmed.ncbi.nlm.nih.gov/16847081).\",\"description\":\"108. **^** Kusters JG, van Vliet AH, Kuipers EJ (July 2006). [\\\"Pathogenesis of Helicobacter pylori infection\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1539101). _Clin. Microbiol. Rev_. **19** (3): 449â€“90\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1128/CMR.00054-05](https://doi.org/10.1128%2FCMR.00054-05). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1539101](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1539101). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16847081](https://pubmed.ncbi.nlm.nih.gov/16847081).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1539101\",\"favicon\":\"\"},{\"id\":\"109\",\"title\":\"** Parkin DM (June 2006). [\\\"The global health burden of infection-associated cancers in the year 2002\\\"](https://doi.org/10.1002%2Fijc.21731). _Int. J. Cancer_. **118** (12): 3030â€“44\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/ijc.21731](https://doi.org/10.1002%2Fijc.21731). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16404738](https://pubmed.ncbi.nlm.nih.gov/16404738).\",\"description\":\"109. **^** Parkin DM (June 2006). [\\\"The global health burden of infection-associated cancers in the year 2002\\\"](https://doi.org/10.1002%2Fijc.21731). _Int. J. Cancer_. **118** (12): 3030â€“44\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/ijc.21731](https://doi.org/10.1002%2Fijc.21731). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16404738](https://pubmed.ncbi.nlm.nih.gov/16404738).\",\"url\":\"https://doi.org/10.1002%2Fijc.21731\",\"favicon\":\"\"},{\"id\":\"110\",\"title\":\"** Wroblewski LE, Peek RM, Wilson KT (October 2010). [\\\"Helicobacter pylori and gastric cancer: factors that modulate disease risk\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952980). _Clin. Microbiol. Rev_. **23** (4): 713â€“39\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1128/CMR.00011-10](https://doi.org/10.1128%2FCMR.00011-10). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2952980](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952980). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20930071](https://pubmed.ncbi.nlm.nih.gov/20930071).\",\"description\":\"110. **^** Wroblewski LE, Peek RM, Wilson KT (October 2010). [\\\"Helicobacter pylori and gastric cancer: factors that modulate disease risk\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952980). _Clin. Microbiol. Rev_. **23** (4): 713â€“39\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1128/CMR.00011-10](https://doi.org/10.1128%2FCMR.00011-10). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2952980](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952980). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20930071](https://pubmed.ncbi.nlm.nih.gov/20930071).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952980\",\"favicon\":\"\"},{\"id\":\"111\",\"title\":\"** Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, PiÃ±eros M, Znaor A, Bray F (April 2019). [\\\"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods\\\"](https://doi.org/10.1002%2Fijc.31937). _Int. J. Cancer_. **144** (8): 1941â€“1953\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/ijc.31937](https://doi.org/10.1002%2Fijc.31937). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30350310](https://pubmed.ncbi.nlm.nih.gov/30350310).\",\"description\":\"111. **^** Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, PiÃ±eros M, Znaor A, Bray F (April 2019). [\\\"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods\\\"](https://doi.org/10.1002%2Fijc.31937). _Int. J. Cancer_. **144** (8): 1941â€“1953\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/ijc.31937](https://doi.org/10.1002%2Fijc.31937). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30350310](https://pubmed.ncbi.nlm.nih.gov/30350310).\",\"url\":\"https://doi.org/10.1002%2Fijc.31937\",\"favicon\":\"\"},{\"id\":\"112\",\"title\":\"** Meurer LN, Bower DJ (April 2002). \\\"Management of Helicobacter pylori infection\\\". _Am Fam Physician_. **65** (7): 1327â€“36\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11996414](https://pubmed.ncbi.nlm.nih.gov/11996414).\",\"description\":\"112. **^** Meurer LN, Bower DJ (April 2002). \\\"Management of Helicobacter pylori infection\\\". _Am Fam Physician_. **65** (7): 1327â€“36\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11996414](https://pubmed.ncbi.nlm.nih.gov/11996414).\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"113\",\"title\":\"** Prabhu SR, Ranganathan S, Amarapurkar DN (November 1994). \\\"Helicobacter pylori in normal gastric mucosa\\\". _J Assoc Physicians India_. **42** (11): 863â€“4\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [7868485](https://pubmed.ncbi.nlm.nih.gov/7868485).\",\"description\":\"113. **^** Prabhu SR, Ranganathan S, Amarapurkar DN (November 1994). \\\"Helicobacter pylori in normal gastric mucosa\\\". _J Assoc Physicians India_. **42** (11): 863â€“4\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [7868485](https://pubmed.ncbi.nlm.nih.gov/7868485).\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"114\",\"title\":\"** White JR, Winter JA, Robinson K (2015). [\\\"Differential inflammatory response to Helicobacter pylori infection: etiology and clinical outcomes\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540215). _J Inflamm Res_. **8** : 137â€“47\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2147/JIR.S64888](https://doi.org/10.2147%2FJIR.S64888). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4540215](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540215). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26316793](https://pubmed.ncbi.nlm.nih.gov/26316793).\",\"description\":\"114. **^** White JR, Winter JA, Robinson K (2015). [\\\"Differential inflammatory response to Helicobacter pylori infection: etiology and clinical outcomes\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540215). _J Inflamm Res_. **8** : 137â€“47\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2147/JIR.S64888](https://doi.org/10.2147%2FJIR.S64888). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4540215](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540215). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26316793](https://pubmed.ncbi.nlm.nih.gov/26316793).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540215\",\"favicon\":\"\"},{\"id\":\"115\",\"title\":\"** Deng JY, Liang H (April 2014). [\\\"Clinical significance of lymph node metastasis in gastric cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983452). _World J. Gastroenterol_. **20** (14): 3967â€“75\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3748/wjg.v20.i14.3967](https://doi.org/10.3748%2Fwjg.v20.i14.3967). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3983452](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983452). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24744586](https://pubmed.ncbi.nlm.nih.gov/24744586).\",\"description\":\"115. **^** Deng JY, Liang H (April 2014). [\\\"Clinical significance of lymph node metastasis in gastric cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983452). _World J. Gastroenterol_. **20** (14): 3967â€“75\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3748/wjg.v20.i14.3967](https://doi.org/10.3748%2Fwjg.v20.i14.3967). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3983452](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983452). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24744586](https://pubmed.ncbi.nlm.nih.gov/24744586).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983452\",\"favicon\":\"\"},{\"id\":\"116\",\"title\":\"_**a**_ _**b**_ Valenzuela MA, Canales J, CorvalÃ¡n AH, Quest AF (December 2015). [\\\"Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671030). _World J. Gastroenterol_. **21** (45): 12742â€“56\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3748/wjg.v21.i45.12742](https://doi.org/10.3748%2Fwjg.v21.i45.12742). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4671030](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671030). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26668499](https://pubmed.ncbi.nlm.nih.gov/26668499).\",\"description\":\"116. ^ _**a**_ _**b**_ Valenzuela MA, Canales J, CorvalÃ¡n AH, Quest AF (December 2015). [\\\"Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671030). _World J. Gastroenterol_. **21** (45): 12742â€“56\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3748/wjg.v21.i45.12742](https://doi.org/10.3748%2Fwjg.v21.i45.12742). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4671030](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671030). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26668499](https://pubmed.ncbi.nlm.nih.gov/26668499).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671030\",\"favicon\":\"\"},{\"id\":\"117\",\"title\":\"** Raza Y, Khan A, Farooqui A, Mubarak M, Facista A, Akhtar SS, Khan S, Kazi JI, Bernstein C, Kazmi SU (2014). \\\"Oxidative DNA damage as a potential early biomarker of Helicobacter pylori associated carcinogenesis\\\". _Pathol. Oncol. Res_. **20** (4): 839â€“46\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s12253-014-9762-1](https://doi.org/10.1007%2Fs12253-014-9762-1). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24664859](https://pubmed.ncbi.nlm.nih.gov/24664859). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [18727504](https://api.semanticscholar.org/CorpusID:18727504).\",\"description\":\"117. **^** Raza Y, Khan A, Farooqui A, Mubarak M, Facista A, Akhtar SS, Khan S, Kazi JI, Bernstein C, Kazmi SU (2014). \\\"Oxidative DNA damage as a potential early biomarker of Helicobacter pylori associated carcinogenesis\\\". _Pathol. Oncol. Res_. **20** (4): 839â€“46\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s12253-014-9762-1](https://doi.org/10.1007%2Fs12253-014-9762-1). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24664859](https://pubmed.ncbi.nlm.nih.gov/24664859). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [18727504](https://api.semanticscholar.org/CorpusID:18727504).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"118\",\"title\":\"** Koeppel M, Garcia-Alcalde F, Glowinski F, Schlaermann P, Meyer TF (June 2015). [\\\"Helicobacter pylori Infection Causes Characteristic DNA Damage Patterns in Human Cells\\\"](https://doi.org/10.1016%2Fj.celrep.2015.05.030). _Cell Rep_. **11** (11): 1703â€“13\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.celrep.2015.05.030](https://doi.org/10.1016%2Fj.celrep.2015.05.030). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26074077](https://pubmed.ncbi.nlm.nih.gov/26074077).\",\"description\":\"118. **^** Koeppel M, Garcia-Alcalde F, Glowinski F, Schlaermann P, Meyer TF (June 2015). [\\\"Helicobacter pylori Infection Causes Characteristic DNA Damage Patterns in Human Cells\\\"](https://doi.org/10.1016%2Fj.celrep.2015.05.030). _Cell Rep_. **11** (11): 1703â€“13\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.celrep.2015.05.030](https://doi.org/10.1016%2Fj.celrep.2015.05.030). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26074077](https://pubmed.ncbi.nlm.nih.gov/26074077).\",\"url\":\"https://doi.org/10.1016%2Fj.celrep.2015.05.030\",\"favicon\":\"\"},{\"id\":\"119\",\"title\":\"_**a**_ _**b**_ Muhammad JS, Eladl MA, Khoder G (February 2019). [\\\"Helicobacter pylori-induced DNA Methylation as an Epigenetic Modulator of Gastric Cancer: Recent Outcomes and Future Direction\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471032). _Pathogens_. **8** (1): 23. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3390/pathogens8010023](https://doi.org/10.3390%2Fpathogens8010023). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6471032](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471032). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30781778](https://pubmed.ncbi.nlm.nih.gov/30781778).\",\"description\":\"119. ^ _**a**_ _**b**_ Muhammad JS, Eladl MA, Khoder G (February 2019). [\\\"Helicobacter pylori-induced DNA Methylation as an Epigenetic Modulator of Gastric Cancer: Recent Outcomes and Future Direction\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471032). _Pathogens_. **8** (1): 23. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3390/pathogens8010023](https://doi.org/10.3390%2Fpathogens8010023). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6471032](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471032). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30781778](https://pubmed.ncbi.nlm.nih.gov/30781778).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471032\",\"favicon\":\"\"},{\"id\":\"120\",\"title\":\"_**a**_ _**b**_ Noto JM, Peek RM (2011). [\\\"The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417373). _Front Cell Infect Microbiol_. **1** : 21. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3389/fcimb.2011.00021](https://doi.org/10.3389%2Ffcimb.2011.00021). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3417373](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417373). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22919587](https://pubmed.ncbi.nlm.nih.gov/22919587).\",\"description\":\"120. ^ _**a**_ _**b**_ Noto JM, Peek RM (2011). [\\\"The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417373). _Front Cell Infect Microbiol_. **1** : 21. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3389/fcimb.2011.00021](https://doi.org/10.3389%2Ffcimb.2011.00021). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3417373](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417373). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22919587](https://pubmed.ncbi.nlm.nih.gov/22919587).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417373\",\"favicon\":\"\"},{\"id\":\"121\",\"title\":\"** Santos JC, Ribeiro ML (August 2015). [\\\"Epigenetic regulation of DNA repair machinery in Helicobacter pylori-induced gastric carcinogenesis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533035). _World J. Gastroenterol_. **21** (30): 9021â€“37\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3748/wjg.v21.i30.9021](https://doi.org/10.3748%2Fwjg.v21.i30.9021). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4533035](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533035). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26290630](https://pubmed.ncbi.nlm.nih.gov/26290630).\",\"description\":\"121. **^** Santos JC, Ribeiro ML (August 2015). [\\\"Epigenetic regulation of DNA repair machinery in Helicobacter pylori-induced gastric carcinogenesis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533035). _World J. Gastroenterol_. **21** (30): 9021â€“37\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3748/wjg.v21.i30.9021](https://doi.org/10.3748%2Fwjg.v21.i30.9021). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4533035](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533035). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26290630](https://pubmed.ncbi.nlm.nih.gov/26290630).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533035\",\"favicon\":\"\"},{\"id\":\"122\",\"title\":\"_**a**_ _**b**_ Raza Y, Ahmed A, Khan A, Chishti AA, Akhter SS, Mubarak M, Bernstein C, Zaitlin B, Kazmi SU (February 2020). [\\\"Helicobacter pylori severely reduces expression of DNA repair proteins PMS2 and ERCC1 in gastritis and gastric cancer\\\"](https://doi.org/10.1016%2Fj.dnarep.2020.102836). _DNA Repair (Amst.)_. **89** 102836\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.dnarep.2020.102836](https://doi.org/10.1016%2Fj.dnarep.2020.102836). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [32143126](https://pubmed.ncbi.nlm.nih.gov/32143126).\",\"description\":\"122. ^ _**a**_ _**b**_ Raza Y, Ahmed A, Khan A, Chishti AA, Akhter SS, Mubarak M, Bernstein C, Zaitlin B, Kazmi SU (February 2020). [\\\"Helicobacter pylori severely reduces expression of DNA repair proteins PMS2 and ERCC1 in gastritis and gastric cancer\\\"](https://doi.org/10.1016%2Fj.dnarep.2020.102836). _DNA Repair (Amst.)_. **89** 102836\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.dnarep.2020.102836](https://doi.org/10.1016%2Fj.dnarep.2020.102836). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [32143126](https://pubmed.ncbi.nlm.nih.gov/32143126).\",\"url\":\"https://doi.org/10.1016%2Fj.dnarep.2020.102836\",\"favicon\":\"\"},{\"id\":\"123\",\"title\":\"** Dore MP, Pes GM, Bassotti G, Usai-Satta P (2016). [\\\"Dyspepsia: When and How to Test for Helicobacter pylori Infection\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864555). _Gastroenterol Res Pract_. **2016** : 8463614. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1155/2016/8463614](https://doi.org/10.1155%2F2016%2F8463614). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4864555](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864555). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27239194](https://pubmed.ncbi.nlm.nih.gov/27239194).\",\"description\":\"123. **^** Dore MP, Pes GM, Bassotti G, Usai-Satta P (2016). [\\\"Dyspepsia: When and How to Test for Helicobacter pylori Infection\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864555). _Gastroenterol Res Pract_. **2016** : 8463614. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1155/2016/8463614](https://doi.org/10.1155%2F2016%2F8463614). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4864555](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864555). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27239194](https://pubmed.ncbi.nlm.nih.gov/27239194).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864555\",\"favicon\":\"\"},{\"id\":\"124\",\"title\":\"** Borchsenius, SN; Daks, A; Fedorova, O; Chernova, O; Barlev, NA (2018). \\\"Effects of mycoplasma infection on the host organism response via p53/NF-ÎºB signaling\\\". _Journal of Cellular Physiology_. **234** (1): 171â€“180\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/jcp.26781](https://doi.org/10.1002%2Fjcp.26781). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30146800](https://pubmed.ncbi.nlm.nih.gov/30146800).\",\"description\":\"124. **^** Borchsenius, SN; Daks, A; Fedorova, O; Chernova, O; Barlev, NA (2018). \\\"Effects of mycoplasma infection on the host organism response via p53/NF-ÎºB signaling\\\". _Journal of Cellular Physiology_. **234** (1): 171â€“180\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/jcp.26781](https://doi.org/10.1002%2Fjcp.26781). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30146800](https://pubmed.ncbi.nlm.nih.gov/30146800).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"125\",\"title\":\"** Carrillo-Infante C, Abbadessa G, Bagella L, Giordano A (June 2007). [\\\"Viral infections as a cause of cancer (review)\\\"](https://doi.org/10.3892%2Fijo.30.6.1521). _International Journal of Oncology_. **30** (6): 1521â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3892/ijo.30.6.1521](https://doi.org/10.3892%2Fijo.30.6.1521). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17487374](https://pubmed.ncbi.nlm.nih.gov/17487374).\",\"description\":\"125. **^** Carrillo-Infante C, Abbadessa G, Bagella L, Giordano A (June 2007). [\\\"Viral infections as a cause of cancer (review)\\\"](https://doi.org/10.3892%2Fijo.30.6.1521). _International Journal of Oncology_. **30** (6): 1521â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3892/ijo.30.6.1521](https://doi.org/10.3892%2Fijo.30.6.1521). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17487374](https://pubmed.ncbi.nlm.nih.gov/17487374).\",\"url\":\"https://doi.org/10.3892%2Fijo.30.6.1521\",\"favicon\":\"\"},{\"id\":\"126\",\"title\":\"** Safdar A (2011). [_Management of Infections in Cancer Patients_](https://books.google.com/books?id=TpWhwLCDWWsC\u0026pg=PA478). Springer. p. 478\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-60761-643-6.\",\"description\":\"126. **^** Safdar A (2011). [_Management of Infections in Cancer Patients_](https://books.google.com/books?id=TpWhwLCDWWsC\u0026pg=PA478). Springer. p. 478\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-60761-643-6.\",\"url\":\"https://books.google.com/books?id=TpWhwLCDWWsC\u0026pg=PA478\",\"favicon\":\"\"},{\"id\":\"127\",\"title\":\"** Samaras V, Rafailidis PI, Mourtzoukou EG, Peppas G, Falagas ME (June 2010). [\\\"Chronic bacterial and parasitic infections and cancer: a review\\\"](https://doi.org/10.3855%2Fjidc.819). _Journal of Infection in Developing Countries_. **4** (5): 267â€“81\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3855/jidc.819](https://doi.org/10.3855%2Fjidc.819). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20539059](https://pubmed.ncbi.nlm.nih.gov/20539059).\",\"description\":\"127. **^** Samaras V, Rafailidis PI, Mourtzoukou EG, Peppas G, Falagas ME (June 2010). [\\\"Chronic bacterial and parasitic infections and cancer: a review\\\"](https://doi.org/10.3855%2Fjidc.819). _Journal of Infection in Developing Countries_. **4** (5): 267â€“81\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3855/jidc.819](https://doi.org/10.3855%2Fjidc.819). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20539059](https://pubmed.ncbi.nlm.nih.gov/20539059).\",\"url\":\"https://doi.org/10.3855%2Fjidc.819\",\"favicon\":\"\"},{\"id\":\"128\",\"title\":\"** Daniel FI, Cherubini K, Yurgel LS, de Figueiredo MA, Salum FG (February 2011). [\\\"The role of epigenetic transcription repression and DNA methyltransferases in cancer\\\"](https://doi.org/10.1002%2Fcncr.25482). _Cancer_. **117** (4): 677â€“87\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/cncr.25482](https://doi.org/10.1002%2Fcncr.25482). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20945317](https://pubmed.ncbi.nlm.nih.gov/20945317). Review.\",\"description\":\"128. **^** Daniel FI, Cherubini K, Yurgel LS, de Figueiredo MA, Salum FG (February 2011). [\\\"The role of epigenetic transcription repression and DNA methyltransferases in cancer\\\"](https://doi.org/10.1002%2Fcncr.25482). _Cancer_. **117** (4): 677â€“87\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/cncr.25482](https://doi.org/10.1002%2Fcncr.25482). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20945317](https://pubmed.ncbi.nlm.nih.gov/20945317). Review.\",\"url\":\"https://doi.org/10.1002%2Fcncr.25482\",\"favicon\":\"\"},{\"id\":\"129\",\"title\":\"** Kanwal R, Gupta S (April 2012). [\\\"Epigenetic modifications in cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590802). _Clinical Genetics_. **81** (4): 303â€“11\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1399-0004.2011.01809.x](https://doi.org/10.1111%2Fj.1399-0004.2011.01809.x). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3590802](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590802). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22082348](https://pubmed.ncbi.nlm.nih.gov/22082348).\",\"description\":\"129. **^** Kanwal R, Gupta S (April 2012). [\\\"Epigenetic modifications in cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590802). _Clinical Genetics_. **81** (4): 303â€“11\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1399-0004.2011.01809.x](https://doi.org/10.1111%2Fj.1399-0004.2011.01809.x). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3590802](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590802). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22082348](https://pubmed.ncbi.nlm.nih.gov/22082348).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590802\",\"favicon\":\"\"},{\"id\":\"130\",\"title\":\"** Pattani KM, Soudry E, Glazer CA, Ochs MF, Wang H, Schussel J, Sun W, Hennessey P, Mydlarz W, Loyo M, Demokan S, Smith IM, Califano JA (2012). Tao Q (ed.). [\\\"MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinoma\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454438). _PLOS ONE_. **7** (9): e45534. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2012PLoSO...745534P](https://ui.adsabs.harvard.edu/abs/2012PLoSO...745534P). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1371/journal.pone.0045534](https://doi.org/10.1371%2Fjournal.pone.0045534). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3454438](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454438). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23029077](https://pubmed.ncbi.nlm.nih.gov/23029077).\",\"description\":\"130. **^** Pattani KM, Soudry E, Glazer CA, Ochs MF, Wang H, Schussel J, Sun W, Hennessey P, Mydlarz W, Loyo M, Demokan S, Smith IM, Califano JA (2012). Tao Q (ed.). [\\\"MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinoma\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454438). _PLOS ONE_. **7** (9): e45534. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2012PLoSO...745534P](https://ui.adsabs.harvard.edu/abs/2012PLoSO...745534P). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1371/journal.pone.0045534](https://doi.org/10.1371%2Fjournal.pone.0045534). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3454438](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454438). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23029077](https://pubmed.ncbi.nlm.nih.gov/23029077).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454438\",\"favicon\":\"\"},{\"id\":\"131\",\"title\":\"** Sampath D, Liu C, Vasan K, Sulda M, Puduvalli VK, Wierda WG, Keating MJ (February 2012). [\\\"Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277352). _Blood_. **119** (5): 1162â€“72\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1182/blood-2011-05-351510](https://doi.org/10.1182%2Fblood-2011-05-351510). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3277352](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277352). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22096249](https://pubmed.ncbi.nlm.nih.gov/22096249).\",\"description\":\"131. **^** Sampath D, Liu C, Vasan K, Sulda M, Puduvalli VK, Wierda WG, Keating MJ (February 2012). [\\\"Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277352). _Blood_. **119** (5): 1162â€“72\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1182/blood-2011-05-351510](https://doi.org/10.1182%2Fblood-2011-05-351510). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3277352](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277352). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22096249](https://pubmed.ncbi.nlm.nih.gov/22096249).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277352\",\"favicon\":\"\"},{\"id\":\"132\",\"title\":\"** Hitchler MJ, Oberley LW, Domann FE (December 2008). [\\\"Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633123). _Free Radical Biology \u0026 Medicine_. **45** (11): 1573â€“80\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.freeradbiomed.2008.09.005](https://doi.org/10.1016%2Fj.freeradbiomed.2008.09.005). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2633123](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633123). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18845242](https://pubmed.ncbi.nlm.nih.gov/18845242).\",\"description\":\"132. **^** Hitchler MJ, Oberley LW, Domann FE (December 2008). [\\\"Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633123). _Free Radical Biology \u0026 Medicine_. **45** (11): 1573â€“80\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.freeradbiomed.2008.09.005](https://doi.org/10.1016%2Fj.freeradbiomed.2008.09.005). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2633123](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633123). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18845242](https://pubmed.ncbi.nlm.nih.gov/18845242).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633123\",\"favicon\":\"\"},{\"id\":\"133\",\"title\":\"** Baldassarre G, Battista S, Belletti B, Thakur S, Pentimalli F, Trapasso F, Fedele M, Pierantoni G, Croce CM, Fusco A (April 2003). [\\\"Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC150734). _Molecular and Cellular Biology_. **23** (7): 2225â€“38\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1128/MCB.23.7.2225-2238.2003](https://doi.org/10.1128%2FMCB.23.7.2225-2238.2003). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [150734](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC150734). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12640109](https://pubmed.ncbi.nlm.nih.gov/12640109).\",\"description\":\"133. **^** Baldassarre G, Battista S, Belletti B, Thakur S, Pentimalli F, Trapasso F, Fedele M, Pierantoni G, Croce CM, Fusco A (April 2003). [\\\"Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC150734). _Molecular and Cellular Biology_. **23** (7): 2225â€“38\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1128/MCB.23.7.2225-2238.2003](https://doi.org/10.1128%2FMCB.23.7.2225-2238.2003). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [150734](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC150734). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12640109](https://pubmed.ncbi.nlm.nih.gov/12640109).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC150734\",\"favicon\":\"\"},{\"id\":\"134\",\"title\":\"** Dalerba P, Cho RW, Clarke MF (2007). \\\"Cancer stem cells: models and concepts\\\". _Annual Review of Medicine_. **58** : 267â€“84\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1146/annurev.med.58.062105.204854](https://doi.org/10.1146%2Fannurev.med.58.062105.204854). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17002552](https://pubmed.ncbi.nlm.nih.gov/17002552).\",\"description\":\"134. **^** Dalerba P, Cho RW, Clarke MF (2007). \\\"Cancer stem cells: models and concepts\\\". _Annual Review of Medicine_. **58** : 267â€“84\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1146/annurev.med.58.062105.204854](https://doi.org/10.1146%2Fannurev.med.58.062105.204854). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17002552](https://pubmed.ncbi.nlm.nih.gov/17002552).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"135\",\"title\":\"** Zhang W, Hanks AN, Boucher K, Florell SR, Allen SM, Alexander A, Brash DE, Grossman D (January 2005). [\\\"UVB-induced apoptosis drives clonal expansion during skin tumor development\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292404). _Carcinogenesis_. **26** (1): 249â€“57\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/carcin/bgh300](https://doi.org/10.1093%2Fcarcin%2Fbgh300). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2292404](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292404). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15498793](https://pubmed.ncbi.nlm.nih.gov/15498793).\",\"description\":\"135. **^** Zhang W, Hanks AN, Boucher K, Florell SR, Allen SM, Alexander A, Brash DE, Grossman D (January 2005). [\\\"UVB-induced apoptosis drives clonal expansion during skin tumor development\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292404). _Carcinogenesis_. **26** (1): 249â€“57\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/carcin/bgh300](https://doi.org/10.1093%2Fcarcin%2Fbgh300). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2292404](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292404). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15498793](https://pubmed.ncbi.nlm.nih.gov/15498793).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292404\",\"favicon\":\"\"}],\"images\":[],\"fixedIssues\":[{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"According to the prevailing accepted theory of carcinogenesis, the somatic mutation theory, [mutations](Mutation \\\"Mutation\\\") in [DNA](DNA \\\"DNA\\\") and [epimutations](Epigenetics \\\"Epigenetics\\\") that lead to cancer disrupt these orderly processes by interfering with the programming regulating the processes, upsetting the normal balance between proliferation and cell death.[1][2][3][4][5]\",\"explanation\":\"Reference [1] (MajÃ©rus 2022) proposes a unifying theory based on mitochondrial dysfunction as the primary cause of cancer, with mutations as a consequence rather than the cause, which contradicts and does not support the description of the somatic mutation theory (SMT) as the prevailing accepted theory emphasizing DNA mutations and epimutations as drivers.\",\"fixedText\":\"Remove [1] from the citation list, retaining [2][3][4][5] which support SMT.\",\"evidenceSource\":\"Web search on paper title: Proposes mitochondrial dysfunction disrupts cell function leading to mutations; SMT refs [2]-[5] align with SMT.\"},{\"criticality\":\"Critical\",\"issueType\":\"Mechanism/Specification Error\",\"problematicText\":\"Finally [Oncovirinae](Oncovirus \\\"Oncovirus\\\"), [viruses](Virus \\\"Virus\\\") that contain an [oncogene](Oncogene \\\"Oncogene\\\"), are categorized as oncogenic because they trigger the growth of tumorous tissues in the [host](Host_\\\\(biology\\\\) \\\"Host \\\\(biology\\\\)\\\").\",\"explanation\":\"The term \\\"Oncovirinae\\\" specifically denotes a former subfamily of oncogenic retroviruses (RNA viruses), not all oncogenic viruses. Moreover, not all oncoviruses contain oncogenes; many (e.g., HPV, EBV) cause cancer via other mechanisms like insertional mutagenesis, chronic inflammation, or immune suppression, misrepresenting the mechanism.\",\"fixedText\":\"Revise to: \\\"Certain viruses, known as oncoviruses, can contribute to cancer by introducing or activating oncogenes or through other mechanisms, leading to viral transformation.\\\"\",\"evidenceSource\":\"[web:8] Merriam-Webster: Oncovirinae as former subfamily of tumor-forming RNA retroviruses; broader oncoviruses include DNA viruses without v-onc genes.\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"\\\"The role of iodine in marine fish (rich in iodine) and freshwater fish (iodine-deficient) is not completely understood, but it has been reported that freshwater fish are more susceptible to infectious and, in particular, neoplastic and atherosclerotic diseases, than marine fish.[94][95] Marine elasmobranch fishes such as sharks, stingrays etc. are much less affected by cancer than freshwater fishes\\\"\",\"explanation\":\"The claims promote the debunked myth that sharks and marine fish rarely get cancer, and lack evidence for higher neoplasia in freshwater vs. marine fish. Citations [94],[95] are speculative on iodine without strong empirical support for differential cancer incidence. Modern evidence shows sharks do get cancer, and no clear higher incidence in freshwater fish overall.\",\"fixedText\":\"Remove the entire \\\"In fish\\\" subsection as it is inaccurate, promotes myths, and is marginally relevant to human carcinogenesis biology.\",\"evidenceSource\":\"[](https://en.wikipedia.org/wiki/Sharks_Don%27t_Get_Cancer) [](https://www.nbcnews.com/sciencemain/forget-myth-sharks-do-get-cancer-even-great-whites-2d11703500) [](https://pubmed.ncbi.nlm.nih.gov/38520057/)\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"\\\"In a 2000 article by [Hanahan](Douglas_Hanahan \\\"Douglas Hanahan\\\") and [Weinberg](Robert_Weinberg_\\\\(biologist\\\\) \\\"Robert Weinberg \\\\(biologist\\\\)\\\"), the biological properties of malignant tumor cells were summarized as follows:[69]\\\"\",\"explanation\":\"The section presents the 2000 hallmarks without noting significant updates in 2011 and 2022 that added new hallmarks (e.g., immune evasion, tumor-promoting inflammation, genome instability/enabling characteristics, polymorphic microbiome) and in 2024 emphasizing systemic aspects. This omits key modern understanding of cancer biology as of 2025.\",\"fixedText\":\"Add a sentence noting subsequent updates to the hallmarks framework, citing recent reviews, while retaining the 2000 list for historical context.\",\"evidenceSource\":\"[69] (original 2000); [](https://pubmed.ncbi.nlm.nih.gov/35022204/) (2022 update); [](https://www.cell.com/cell/pdf/S0092-8674%2824%2900175-2.pdf) (2024)\"},{\"criticality\":\"Non-Critical\",\"issueType\":\"Mechanism/Specification Error\",\"problematicText\":\"\\\"Acquisition of ability to invade neighbouring [tissues]..., the defining property of invasive carcinoma. * Acquisition of ability to seed [metastases] at distant sites, a late-appearing property of some malignant tumors\\\"\",\"explanation\":\"The original 2000 paper combines \\\"tissue invasion and metastasis\\\" as a single hallmark; separating them misrepresents the original framework, though content is accurate.\",\"fixedText\":\"Combine into one bullet: \\\"Acquisition of the ability to invade tissue and metastasize to distant sites.\\\"\",\"evidenceSource\":\"[69]\"},{\"criticality\":\"Missing Information\",\"issueType\":\"Missing Information\",\"problematicText\":\"None\",\"explanation\":\"The section lacks mention of recent advances in cancer stem cell heterogeneity and their role in therapy resistance, which is central to modern cancer cell biology.\",\"fixedText\":\"Add a brief sentence in the cancer stem cells paragraph: \\\"Recent studies highlight the heterogeneity within cancer stem cell populations, contributing to tumor adaptability and resistance to therapies.\\\"\",\"evidenceSource\":\"[](https://aacrjournals.org/cancerdiscovery/article/14/4/674/741959/Cancer-Hallmarks-Piecing-the-Puzzle-Together) (2024 review)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"* _[Clonorchis sinensis](Clonorchis_sinensis \\\"Clonorchis sinensis\\\")_ (the organism causing [Clonorchiasis](Clonorchiasis \\\"Clonorchiasis\\\")) and _[Opisthorchis viverrini](Opisthorchis_viverrini \\\"Opisthorchis viverrini\\\")_ (causing [Opisthorchiasis](Opisthorchiasis \\\"Opisthorchiasis\\\")) are associated with [cholangiocarcinoma](Cholangiocarcinoma \\\"Cholangiocarcinoma\\\").[127]\",\"explanation\":\"Reference [127] (Daniel et al. 2011) discusses epigenetic repression and DNA methyltransferases in cancer, not helminth infections or their carcinogenic associations. This mismatches the claim about specific helminths and cancers.\",\"fixedText\":\"Replace [127] with a citation to IARC Monographs on biological agents (e.g., [](https://monographs.iarc.who.int/wp-content/uploads/2018/06/mono100B.pdf)) confirming the carcinogenic classifications of these helminths.\",\"evidenceSource\":\"[126] (Samaras et al. 2010, reviews chronic parasitic infections and cancer); IARC Monographs (e.g., Volume 100B, classifies Clonorchis sinensis, Opisthorchis viverrini, and Schistosoma haematobium as Group 1 carcinogens)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Furthermore, in light of the Darwinistic mechanisms of carcinogenesis, it has been theorized that the various forms of cancer can be categorized as pubertal and gerontological. Anthropological research is currently being conducted on cancer as a natural evolutionary process through which natural selection destroys environmentally inferior phenotypes while supporting others. According to this theory, cancer comes in two separate types: from birth to the end of puberty (approximately age 20) teleologically inclined toward supportive group dynamics, and from mid-life to death (approximately age 40+) teleologically inclined away from overpopulated group dynamics.\",\"explanation\":\"No citation is provided for this claim, which introduces an unsourced, speculative theory not supported by mainstream scientific literature on carcinogenesis. It risks presenting fringe or unverified ideas as established, violating neutrality and verifiability.\",\"fixedText\":\"Remove the entire unsourced paragraph to maintain verifiability and encyclopedic tone.\",\"evidenceSource\":\"None provided; contrasts with cited sources [67], [68] on standard somatic evolution models (Nowell 1976; Merlo 2006)\"}],\"slug\":\"Carcinogenesis\",\"title\":\"Carcinogenesis\",\"content\":\"$1f\",\"description\":\"Carcinogenesis\\n\\nCancers and tumors are caused by a series of mutations. Each mutation alters the behavior of the cell somewhat.\\n\\nCarcinogenesis, also called oncogenesis or tumorigenesis, is the...\",\"metadata\":{\"categories\":[],\"lastModified\":\"1761552900\",\"contentLength\":\"67243\",\"version\":\"1.0\",\"lastEditor\":\"system\",\"language\":\"en\",\"isRedirect\":false,\"redirectTarget\":\"\",\"isWithheld\":false},\"stats\":{\"totalViews\":\"71654\",\"recentViews\":\"71654\",\"dailyAvgViews\":2388.466552734375,\"qualityScore\":1,\"lastViewed\":\"1761884116\"},\"linkedPages\":null},\"found\":true},\"dataUpdateCount\":1,\"dataUpdatedAt\":1761884116573,\"error\":null,\"errorUpdateCount\":0,\"errorUpdatedAt\":0,\"fetchFailureCount\":0,\"fetchFailureReason\":null,\"fetchMeta\":null,\"isInvalidated\":false,\"status\":\"success\",\"fetchStatus\":\"idle\"},\"queryKey\":[\"page\",\"Carcinogenesis\"],\"queryHash\":\"[\\\"page\\\",\\\"Carcinogenesis\\\"]\"}]},\"children\":\"$L20\"}]\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"c:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"Carcinogenesis\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"Cancers and tumors are caused by a series of mutations. Each mutation alters the behavior of the cell somewhat. Carcinogenesis, also called oncogenesis or tumorigenesis, is the formation of a cancer, whereby normal cells are transformed into cancer cells. The process is characterized by changes at the cellular, genetic, and epigenetic levels and abnormal cell division. Cell division is a physiological process that occurs in almost all tissues and under a variety of circumstances. Normally, the...\"}],[\"$\",\"meta\",\"2\",{\"name\":\"author\",\"content\":\"system\"}],[\"$\",\"link\",\"3\",{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"meta\",\"4\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"5\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"link\",\"6\",{\"rel\":\"canonical\",\"href\":\"https://grokipedia.com/page/Carcinogenesis\"}],[\"$\",\"meta\",\"7\",{\"property\":\"og:title\",\"content\":\"Carcinogenesis\"}],[\"$\",\"meta\",\"8\",{\"property\":\"og:description\",\"content\":\"Cancers and tumors are caused by a series of mutations. Each mutation alters the behavior of the cell somewhat. Carcinogenesis, also called oncogenesis or tumorigenesis, is the formation of a cancer, whereby normal cells are transformed into cancer cells. The process is characterized by changes at the cellular, genetic, and epigenetic levels and abnormal cell division. Cell division is a physiological process that occurs in almost all tissues and under a variety of circumstances. Normally, the...\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:url\",\"content\":\"https://grokipedia.com/page/Carcinogenesis\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:locale\",\"content\":\"en\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:image:alt\",\"content\":\"Carcinogenesis\"}],[\"$\",\"meta\",\"16\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"17\",{\"property\":\"article:modified_time\",\"content\":\"1970-01-21T09:19:12.900Z\"}],[\"$\",\"meta\",\"18\",{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",\"20\",{\"name\":\"twitter:title\",\"content\":\"Carcinogenesis\"}],[\"$\",\"meta\",\"21\",{\"name\":\"twitter:description\",\"content\":\"Cancers and tumors are caused by a series of mutations. Each mutation alters the behavior of the cell somewhat. Carcinogenesis, also called oncogenesis or tumorigenesis, is the formation of a cancer, whereby normal cells are transformed into cancer cells. The process is characterized by changes at the cellular, genetic, and epigenetic levels and abnormal cell division. Cell division is a physiological process that occurs in almost all tissues and under a variety of circumstances. Normally, the...\"}],[\"$\",\"meta\",\"22\",{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"link\",\"23\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"$L21\",\"24\",{}]],\"error\":null,\"digest\":\"$undefined\"}\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"11:\"$c:metadata\"\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"22:I[61172,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"PageEditorProvider\"]\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"23:I[63493,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="ZTA0NTMyZjAtOWFjMy00NGM4LTkxZDktZWM0MTc5YzBkODVm">self.__next_f.push([1,"20:[\"$\",\"$L22\",null,{\"children\":[\"$\",\"$L23\",null,{\"slug\":\"Carcinogenesis\"}]}]\n"])</script></body></html>